Publications

  1. Camilleri M, Talley NJ. Are functional dyspepsia and gastroparesis really 'interchangeable' diseases? Gut. 2025 Aug 27 [Epub ahead of print]
    View PubMed
  2. Pasricha PJ, Talley NJ, Nguyen L, Abell T, Furness J, Pimentel M, International Foundation for Gastrointestinal Disorders. Names Matter: A Call to Neurogastroenterologists to Examine How We Can Improve the Nomenclature We Use to Describe the Disorders Our Patients Experience. Gastroenterology. 2025 Jul; 169 (1):9-11 Epub 2025 Feb 01
    View PubMed
  3. Pasricha PJ, Talley NJ, Nguyen L, Abell T, Furness J, Pimentel M, International Foundation for Gastrointestinal Disorders. Names Matter: A Call to Neurogastroenterologists to Examine How We Can Improve the Nomenclature We Use to Describe the Disorders Our Patients Experience. Gastroenterology. 2025 Jul; 169 (1):9-11 Epub 2025 Feb 01
    View PubMed
  4. Kamruzzaman M, Horowitz M, Polonsky WH, Talley NJ, Borg MA, Rayner CK, Jones KL, Marathe CS. Diabetes distress and depression are independently associated with gastrointestinal symptoms in type 2 diabetes in Bangladesh. Diabet Med. 2024 Nov; 41 (11):e15379 Epub 2024 June 17
    View PubMed
  5. Zamani M, Alizadeh-Tabari S, Murad MH, Singh S, Ananthakrishnan AN, Malekzadeh R, Talley NJ. Meta-analysis: Risk of lymphoma in patients with inflammatory bowel disease in population-based cohort studies. Aliment Pharmacol Ther. 2024 Nov; 60 (10):1264-1275 Epub 2024 Sept 23
    View PubMed
  6. Kamruzzaman M, Horowitz M, Polonsky WH, Talley NJ, Borg MA, Rayner CK, Jones KL, Marathe CS. Diabetes distress and depression are independently associated with gastrointestinal symptoms in type 2 diabetes in Bangladesh. Diabet Med. 2024 Nov; 41 (11):e15379 Epub 2024 June 17
    View PubMed
  7. Zamani M, Alizadeh-Tabari S, Murad MH, Singh S, Ananthakrishnan AN, Malekzadeh R, Talley NJ. Meta-analysis: Risk of lymphoma in patients with inflammatory bowel disease in population-based cohort studies. Aliment Pharmacol Ther. 2024 Nov; 60 (10):1264-1275 Epub 2024 Sept 23
    View PubMed
  8. Kulin D, Shah A, Fairlie T, Wong RK, Fang X, Ghoshal UC, Kashyap PC, Mulak A, Lee YY, Talley NJ, Koloski N, Jones MP, Holtmann GJ. The COVID-19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta-analysis. Neurogastroenterol Motil. 2024 Oct; 36 (10):e14878 Epub 2024 July 26
    View PubMed
  9. Kulin D, Shah A, Fairlie T, Wong RK, Fang X, Ghoshal UC, Kashyap PC, Mulak A, Lee YY, Talley NJ, Koloski N, Jones MP, Holtmann GJ. The COVID-19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta-analysis. Neurogastroenterol Motil. 2024 Oct; 36 (10):e14878 Epub 2024 July 26
    View PubMed
  10. Fairlie T, Shah A, Wong RK, Fang X, Ghoshal UC, Kashyap PC, Mulak A, Lee YY, Sperber AD, Koloski N, Moy N, Talley NJ, Jones MP, Holtmann G. A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut-brain interaction. Neurogastroenterol Motil. 2024 Sep; 36 (9):e14866 Epub 2024 July 15
    View PubMed
  11. Fairlie T, Shah A, Wong RK, Fang X, Ghoshal UC, Kashyap PC, Mulak A, Lee YY, Sperber AD, Koloski N, Moy N, Talley NJ, Jones MP, Holtmann G. A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut-brain interaction. Neurogastroenterol Motil. 2024 Sep; 36 (9):e14866 Epub 2024 July 15
    View PubMed
  12. Zamani M, Alizadeh-Tabari S, Murad MH, Ananthakrishnan AN, Malekzadeh R, Talley NJ. Meta-analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2024 Apr; 59 (8):918-927 Epub 2024 Feb 19
    View PubMed
  13. Zamani M, Alizadeh-Tabari S, Murad MH, Ananthakrishnan AN, Malekzadeh R, Talley NJ. Meta-analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2024 Apr; 59 (8):918-927 Epub 2024 Feb 19
    View PubMed
  14. Stretton B, Kovoor J, Bacchi S, Chang S, Ngoi B, Murray T, Bristow TC, Heng J, Gupta A, Ovenden C, Maddern G, Thompson CH, Heilbronn L, Boyd M, Rayner C, Talley NJ, Horowtiz M. Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes: a systematic review. Intern Med J. 2023 Aug; 53 (8):1311-1320 Epub 2023 June 21
    View PubMed
  15. Stretton B, Kovoor J, Bacchi S, Chang S, Ngoi B, Murray T, Bristow TC, Heng J, Gupta A, Ovenden C, Maddern G, Thompson CH, Heilbronn L, Boyd M, Rayner C, Talley NJ, Horowtiz M. Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes: a systematic review. Intern Med J. 2023 Aug; 53 (8):1311-1320 Epub 2023 June 21
    View PubMed
  16. Jones MP, Guthrie-Lyons L, Sato YA, Talley NJ. Factors Associated With Placebo Treatment Response in Functional Dyspepsia Clinical Trials. Am J Gastroenterol. 2023 Apr 1; 118 (4):685-691 Epub 2022 Dec 20
    View PubMed
  17. Jones MP, Guthrie-Lyons L, Sato YA, Talley NJ. Factors Associated With Placebo Treatment Response in Functional Dyspepsia Clinical Trials. Am J Gastroenterol. 2023 Apr 1; 118 (4):685-691 Epub 2022 Dec 20
    View PubMed
  18. Dellon ES, Gonsalves N, Abonia JP, Alexander JA, Arva NC, Atkins D, Attwood SE, Auth MKH, Bailey DD, Biederman L, Blanchard C, Bonis PA, Bose P, Bredenoord AJ, Chang JW, Chehade M, Collins MH, Di Lorenzo C, Dias JA, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox AT, Genta RM, Greuter T, Gupta SK, Hirano I, Hiremath GS, Horsley-Silva JL, Ishihara S, Ishimura N, Jensen ET, Gutierrez-Junquera C, Katzka DA, Khoury P, Kinoshita Y, Kliewer KL, Koletzko S, Leung J, Liacouras CA, Lucendo AJ, Martin LJ, McGowan EC, Menard-Katcher C, Metz DC, Miller TL, Moawad FJ, Muir AB, Mukkada VA, Murch S, Nhu QM, Nomura I, Nurko S, Ohtsuka Y, Oliva S, Orel R, Papadopoulou A, Patel DA, Pesek RD, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Ruffner MA, Safroneeva E, Schreiner P, Schoepfer A, Schroeder SR, Shah N, Souza RF, Spechler SJ, Spergel JM, Straumann A, Talley NJ, Thapar N, Vandenplas Y, Venkatesh RD, Vieira MC, von Arnim U, Walker MM, Wechsler JB, Wershil BK, Wright BL, Yamada Y, Yang GY, Zevit N, Rothenberg ME, Furuta GT, Aceves SS. International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clin Gastroenterol Hepatol. 2022 Nov; 20 (11):2474-2484.e3 Epub 2022 Feb 16
    View PubMed
  19. Dellon ES, Gonsalves N, Abonia JP, Alexander JA, Arva NC, Atkins D, Attwood SE, Auth MKH, Bailey DD, Biederman L, Blanchard C, Bonis PA, Bose P, Bredenoord AJ, Chang JW, Chehade M, Collins MH, Di Lorenzo C, Dias JA, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox AT, Genta RM, Greuter T, Gupta SK, Hirano I, Hiremath GS, Horsley-Silva JL, Ishihara S, Ishimura N, Jensen ET, Gutierrez-Junquera C, Katzka DA, Khoury P, Kinoshita Y, Kliewer KL, Koletzko S, Leung J, Liacouras CA, Lucendo AJ, Martin LJ, McGowan EC, Menard-Katcher C, Metz DC, Miller TL, Moawad FJ, Muir AB, Mukkada VA, Murch S, Nhu QM, Nomura I, Nurko S, Ohtsuka Y, Oliva S, Orel R, Papadopoulou A, Patel DA, Pesek RD, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Ruffner MA, Safroneeva E, Schreiner P, Schoepfer A, Schroeder SR, Shah N, Souza RF, Spechler SJ, Spergel JM, Straumann A, Talley NJ, Thapar N, Vandenplas Y, Venkatesh RD, Vieira MC, von Arnim U, Walker MM, Wechsler JB, Wershil BK, Wright BL, Yamada Y, Yang GY, Zevit N, Rothenberg ME, Furuta GT, Aceves SS. International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clin Gastroenterol Hepatol. 2022 Nov; 20 (11):2474-2484.e3 Epub 2022 Feb 16
    View PubMed
  20. Zand Irani M, Jones MP, Halland M, Herrick L, Choung RS, Saito Loftus YA, Walker MM, Murray JA, Talley NJ. Prevalence, symptoms and risk factor profile of rumination syndrome and functional dyspepsia: a population-based study. Aliment Pharmacol Ther. 2021 Dec; 54 (11-12):1416-1431 Epub 2021 Oct 09
    View PubMed
  21. Zand Irani M, Jones MP, Halland M, Herrick L, Choung RS, Saito Loftus YA, Walker MM, Murray JA, Talley NJ. Prevalence, symptoms and risk factor profile of rumination syndrome and functional dyspepsia: a population-based study. Aliment Pharmacol Ther. 2021 Dec; 54 (11-12):1416-1431 Epub 2021 Oct 09
    View PubMed
  22. Talley NJ. Changing Paradigms in Functional Gastrointestinal Disorders. Gastroenterol Hepatol (N Y). 2021 Sep; 17 (9):427-430
    View PubMed
  23. Talley NJ. Changing Paradigms in Functional Gastrointestinal Disorders. Gastroenterol Hepatol (N Y). 2021 Sep; 17 (9):427-430
    View PubMed
  24. Almazar AE, Penfield JD, Saito YA, Talley NJ. Survival Times of Patients With Menetrier's Disease and Risk of Gastric Cancer. Clin Gastroenterol Hepatol. 2021 Apr; 19(4):707-712. Epub 2020 Mar 14.
    View PubMed
  25. Almazar AE, Penfield JD, Saito YA, Talley NJ. Survival Times of Patients With Menetrier's Disease and Risk of Gastric Cancer. Clin Gastroenterol Hepatol. 2021 Apr; 19(4):707-712. Epub 2020 Mar 14.
    View PubMed
  26. Choung RS, Saito YA, Schleck CD, Harmsen WS, Zinsmeister AR, Murray JA, Talley NJ. The Natural History of Chronic Unexplained Gastrointestinal Disorders and Gastroesophageal Reflux During 20 Years: A US Population-Based Study. Mayo Clin Proc. 2021 Mar; 96 (3):563-576
    View PubMed
  27. Choung RS, Saito YA, Schleck CD, Harmsen WS, Zinsmeister AR, Murray JA, Talley NJ. The Natural History of Chronic Unexplained Gastrointestinal Disorders and Gastroesophageal Reflux During 20 Years: A US Population-Based Study. Mayo Clin Proc. 2021 Mar; 96 (3):563-576
    View PubMed
  28. Ford AC, Mahadeva S, Carbone MF, Lacy BE, Talley NJ. Functional dyspepsia. Lancet. 2020 Nov 21; 396(10263):1689-1702. Epub 2020 Oct 10.
    View PubMed
  29. Ford AC, Mahadeva S, Carbone MF, Lacy BE, Talley NJ. Functional dyspepsia. Lancet. 2020 Nov 21; 396(10263):1689-1702. Epub 2020 Oct 10.
    View PubMed
  30. Almazar AE, Chang JY, Larson JJ, Atkinson EJ, Locke GR, Talley NJ, Saito YA. Comparison of Lactase Variant MCM6 -13910 C>T Testing and Self-report of Dairy Sensitivity in Patients With Irritable Bowel Syndrome. J Clin Gastroenterol. 2019 Jul; 53(6):e227-e231.
    View PubMed
  31. Almazar AE, Chang JY, Larson JJ, Atkinson EJ, Locke GR, Talley NJ, Saito YA. Comparison of Lactase Variant MCM6 -13910 C>T Testing and Self-report of Dairy Sensitivity in Patients With Irritable Bowel Syndrome. J Clin Gastroenterol. 2019 Jul; 53(6):e227-e231.
    View PubMed
  32. Jones MP, Sato YA, Talley NJ. The Nepean Dyspepsia Index is a valid instrument for measuring quality-of-life in functional dyspepsia. Eur J Gastroenterol Hepatol. 2019 Mar; 31 (3):329-333
    View PubMed
  33. Halland M, Talley NJ, Jones M, Murray JA, Cameron R, Walker MM. Duodenal Pathology in Patients with Rumination Syndrome: Duodenal Eosinophilia and Increased Intraepithelial Lymphocytes. Dig Dis Sci. 2019 Mar; 64 (3):832-837 Epub 2018 Nov 26
    View PubMed
  34. Jones MP, Sato YA, Talley NJ. The Nepean Dyspepsia Index is a valid instrument for measuring quality-of-life in functional dyspepsia. Eur J Gastroenterol Hepatol. 2019 Mar; 31 (3):329-333
    View PubMed
  35. Halland M, Talley NJ, Jones M, Murray JA, Cameron R, Walker MM. Duodenal Pathology in Patients with Rumination Syndrome: Duodenal Eosinophilia and Increased Intraepithelial Lymphocytes. Dig Dis Sci. 2019 Mar; 64 (3):832-837 Epub 2018 Nov 26
    View PubMed
  36. Saito YA, Almazar AE, Tilkes KE, Choung RS, Van Norstrand MD, Schleck CD, Zinsmeister AR, Talley NJ. Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome. Aliment Pharmacol Ther. 2019 Feb; 49(4):389-397. Epub 2019 Jan 20.
    View PubMed
  37. Saito YA, Almazar AE, Tilkes KE, Choung RS, Van Norstrand MD, Schleck CD, Zinsmeister AR, Talley NJ. Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome. Aliment Pharmacol Ther. 2019 Feb; 49(4):389-397. Epub 2019 Jan 20.
    View PubMed
  38. Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, Spechler SJ, Attwood SE, Straumann A, Aceves SS, Alexander JA, Atkins D, Arva NC, Blanchard C, Bonis PA, Book WM, Capocelli KE, Chehade M, Cheng E, Collins MH, Davis CM, Dias JA, Di Lorenzo C, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox A, Gonsalves NP, Gupta SK, Katzka DA, Kinoshita Y, Menard-Katcher C, Kodroff E, Metz DC, Miehlke S, Muir AB, Mukkada VA, Murch S, Nurko S, Ohtsuka Y, Orel R, Papadopoulou A, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Rothenberg ME, Schoepfer A, Scott MM, Shah N, Sheikh J, Souza RF, Strobel MJ, Talley NJ, Vaezi MF, Vandenplas Y, Vieira MC, Walker MM, Wechsler JB, Wershil BK, Wen T, Yang GY, Hirano I, Bredenoord AJ. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018 Oct; 155 (4):1022-1033.e10 Epub 2018 Sept 06
    View PubMed
  39. Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, Spechler SJ, Attwood SE, Straumann A, Aceves SS, Alexander JA, Atkins D, Arva NC, Blanchard C, Bonis PA, Book WM, Capocelli KE, Chehade M, Cheng E, Collins MH, Davis CM, Dias JA, Di Lorenzo C, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox A, Gonsalves NP, Gupta SK, Katzka DA, Kinoshita Y, Menard-Katcher C, Kodroff E, Metz DC, Miehlke S, Muir AB, Mukkada VA, Murch S, Nurko S, Ohtsuka Y, Orel R, Papadopoulou A, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Rothenberg ME, Schoepfer A, Scott MM, Shah N, Sheikh J, Souza RF, Strobel MJ, Talley NJ, Vaezi MF, Vandenplas Y, Vieira MC, Walker MM, Wechsler JB, Wershil BK, Wen T, Yang GY, Hirano I, Bredenoord AJ. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018 Oct; 155 (4):1022-1033.e10 Epub 2018 Sept 06
    View PubMed
  40. Chang JY, Almazar AE, Richard Locke G 3rd, Larson JJ, Atkinson EJ, Talley NJ, Saito YA. Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome. Neurogastroenterol Motil. 2018 Sep; 30(9):e13356. Epub 2018 Apr 27.
    View PubMed
  41. Chang JY, Almazar AE, Richard Locke G 3rd, Larson JJ, Atkinson EJ, Talley NJ, Saito YA. Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome. Neurogastroenterol Motil. 2018 Sep; 30(9):e13356. Epub 2018 Apr 27.
    View PubMed
  42. Tack J, Corsetti M, Camilleri M, Quigley EM, Simren M, Suzuki H, Talley NJ, Tornblom H, Van Oudenhove L. Plausibility criteria for putative pathophysiological mechanisms in functional gastrointestinal disorders: a consensus of experts. Gut. 2018 Aug; 67 (8):1425-1433 Epub 2017 Aug 16
    View PubMed
  43. Tack J, Corsetti M, Camilleri M, Quigley EM, Simren M, Suzuki H, Talley NJ, Tornblom H, Van Oudenhove L. Plausibility criteria for putative pathophysiological mechanisms in functional gastrointestinal disorders: a consensus of experts. Gut. 2018 Aug; 67 (8):1425-1433 Epub 2017 Aug 16
    View PubMed
  44. Zinsmeister AR, Herrick LM, Saito Loftus YA, Schleck CD, Talley NJ. Identification and validation of functional gastrointestinal disorder subtypes using latent class analysis: a population-based study. Scand J Gastroenterol. 2018 May; 53 (5):549-558 Epub 2017 Nov 06
    View PubMed
  45. Zinsmeister AR, Herrick LM, Saito Loftus YA, Schleck CD, Talley NJ. Identification and validation of functional gastrointestinal disorder subtypes using latent class analysis: a population-based study. Scand J Gastroenterol. 2018 May; 53 (5):549-558 Epub 2017 Nov 06
    View PubMed
  46. Du YT, Rayner CK, Jones KL, Talley NJ, Horowitz M. Gastrointestinal Symptoms in Diabetes: Prevalence, Assessment, Pathogenesis, and Management. Diabetes Care. 2018 Mar; 41 (3):627-637
    View PubMed
  47. Herrick LM, Camilleri M, Schleck CD, Zinsmeister AR, Saito YA, Talley NJ. Effects of Amitriptyline and Escitalopram on Sleep and Mood in Patients With Functional Dyspepsia. Clin Gastroenterol Hepatol. 2018 Mar; 16 (3):401-406.e2 Epub 2017 Dec 01
    View PubMed
  48. Du YT, Rayner CK, Jones KL, Talley NJ, Horowitz M. Gastrointestinal Symptoms in Diabetes: Prevalence, Assessment, Pathogenesis, and Management. Diabetes Care. 2018 Mar; 41 (3):627-637
    View PubMed
  49. Herrick LM, Camilleri M, Schleck CD, Zinsmeister AR, Saito YA, Talley NJ. Effects of Amitriptyline and Escitalopram on Sleep and Mood in Patients With Functional Dyspepsia. Clin Gastroenterol Hepatol. 2018 Mar; 16 (3):401-406.e2 Epub 2017 Dec 01
    View PubMed
  50. Lacy BE, Ford AC, Talley NJ. Quality of Care and the Irritable Bowel Syndrome: Is Now the Time to Set Standards? Am J Gastroenterol. 2018 Feb; 113 (2):167-169 Epub 2017 Dec 05
    View PubMed
  51. Almazar AE, Talley NJ, Larson JJ, Atkinson EJ, Murray JA, Saito YA. Celiac disease is uncommon in irritable bowel syndrome in the USA. Eur J Gastroenterol Hepatol. 2018 Feb; 30(2):149-154.
    View PubMed
  52. Lacy BE, Saito YA, Camilleri M, Bouras E, DiBaise JK, Herrick LM, Szarka LA, Tilkes K, Zinsmeister AR, Talley NJ. Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia. Am J Gastroenterol. 2018 Feb; 113 (2):216-224 Epub 2017 Dec 19
    View PubMed
  53. Lacy BE, Ford AC, Talley NJ. Quality of Care and the Irritable Bowel Syndrome: Is Now the Time to Set Standards? Am J Gastroenterol. 2018 Feb; 113 (2):167-169 Epub 2017 Dec 05
    View PubMed
  54. Almazar AE, Talley NJ, Larson JJ, Atkinson EJ, Murray JA, Saito YA. Celiac disease is uncommon in irritable bowel syndrome in the USA. Eur J Gastroenterol Hepatol. 2018 Feb; 30(2):149-154.
    View PubMed
  55. Lacy BE, Saito YA, Camilleri M, Bouras E, DiBaise JK, Herrick LM, Szarka LA, Tilkes K, Zinsmeister AR, Talley NJ. Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia. Am J Gastroenterol. 2018 Feb; 113 (2):216-224 Epub 2017 Dec 19
    View PubMed
  56. Choung RS, Richard Locke G 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Multiple functional gastrointestinal disorders linked to gastroesophageal reflux and somatization: A population-based study. Neurogastroenterol Motil. 2017 Jul; 29 (7) Epub 2017 Mar 03
    View PubMed
  57. Choung RS, Richard Locke G 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Multiple functional gastrointestinal disorders linked to gastroesophageal reflux and somatization: A population-based study. Neurogastroenterol Motil. 2017 Jul; 29 (7) Epub 2017 Mar 03
    View PubMed
  58. Ford AC, Lacy BE, Talley NJ. Irritable Bowel Syndrome. N Engl J Med. 2017 Jun 29; 376 (26):2566-2578
    View PubMed
  59. Ford AC, Lacy BE, Talley NJ. Irritable Bowel Syndrome. N Engl J Med. 2017 Jun 29; 376 (26):2566-2578
    View PubMed
  60. Saito YA, Locke GR, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR, Talley NJ. Polymorphisms of 5-HTT LPR and GNß3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. Am J Gastroenterol. 2017 Jun; 112(6):903-909. Epub 2017 Mar 14.
    View PubMed
  61. Saito YA, Locke GR, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR, Talley NJ. Polymorphisms of 5-HTT LPR and GNß3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. Am J Gastroenterol. 2017 Jun; 112(6):903-909. Epub 2017 Mar 14.
    View PubMed
  62. Absah I, Rishi A, Talley NJ, Katzka D, Halland M. Rumination syndrome: pathophysiology, diagnosis, and treatment. Neurogastroenterol Motil. 2017 Apr; 29 (4) Epub 2016 Oct 20
    View PubMed
  63. Absah I, Rishi A, Talley NJ, Katzka D, Halland M. Rumination syndrome: pathophysiology, diagnosis, and treatment. Neurogastroenterol Motil. 2017 Apr; 29 (4) Epub 2016 Oct 20
    View PubMed
  64. Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2016 Oct; 1 (2):133-146 Epub 2016 Sept 08
    View PubMed
  65. Raslau D, Herrick LM, Locke GR, Schleck CD, Zinsmeister AR, Almazar A, Talley NJ, Saito YA. Irritable bowel syndrome and the perinatal period: lower birth weight increases the risk. Neurogastroenterol Motil. 2016 Oct; 28(10):1518-24. Epub 2016 May 18.
    View PubMed
  66. Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2016 Oct; 1 (2):133-146 Epub 2016 Sept 08
    View PubMed
  67. Raslau D, Herrick LM, Locke GR, Schleck CD, Zinsmeister AR, Almazar A, Talley NJ, Saito YA. Irritable bowel syndrome and the perinatal period: lower birth weight increases the risk. Neurogastroenterol Motil. 2016 Oct; 28(10):1518-24. Epub 2016 May 18.
    View PubMed
  68. Talley NJ. Board Review Vignette: Irritable Bowel Syndrome. Am J Gastroenterol. 2016 Sep; 111 (9):1223-5 Epub 2016 Aug 16
    View PubMed
  69. Talley NJ. Board Review Vignette: Irritable Bowel Syndrome. Am J Gastroenterol. 2016 Sep; 111 (9):1223-5 Epub 2016 Aug 16
    View PubMed
  70. Clark K, Lam LT, Talley NJ, Quinn J, Blight A, Byfieldt N, Currow DC. Assessing the Presence and Severity of Constipation with Plain Radiographs in Constipated Palliative Care Patients. J Palliat Med. 2016 Jun; 19 (6):617-21 Epub 2016 May 20
    View PubMed
  71. Clark K, Lam LT, Talley NJ, Quinn J, Blight A, Byfieldt N, Currow DC. Assessing the Presence and Severity of Constipation with Plain Radiographs in Constipated Palliative Care Patients. J Palliat Med. 2016 Jun; 19 (6):617-21 Epub 2016 May 20
    View PubMed
  72. Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ. Gastroduodenal Disorders. Gastroenterology. 2016 May; 150 (6):1380-92
    View PubMed
  73. Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ. Gastroduodenal Disorders. Gastroenterology. 2016 May; 150 (6):1380-92
    View PubMed
  74. Choung RS, Rey E, Richard Locke G 3rd, Schleck CD, Baum C, Zinsmeister AR, Talley NJ. Chronic constipation and co-morbidities: A prospective population-based nested case-control study. United European Gastroenterol J. 2016 Feb; 4 (1):142-51 Epub 2015 Nov 11
    View PubMed
  75. Choung RS, Rey E, Richard Locke G 3rd, Schleck CD, Baum C, Zinsmeister AR, Talley NJ. Chronic constipation and co-morbidities: A prospective population-based nested case-control study. United European Gastroenterol J. 2016 Feb; 4 (1):142-51 Epub 2015 Nov 11
    View PubMed
  76. Ek WE, Reznichenko A, Ripke S, Niesler B, Zucchelli M, Rivera NV, Schmidt PT, Pedersen NL, Magnusson P, Talley NJ, Holliday EG, Houghton L, Gazouli M, Karamanolis G, Rappold G, Burwinkel B, Surowy H, Rafter J, Assadi G, Li L, Papadaki E, Gambaccini D, Marchi S, Colucci R, Blandizzi C, Barbaro R, Karling P, Walter S, Ohlsson B, Tornblom H, Bresso F, Andreasson A, Dlugosz A, Simren M, Agreus L, Lindberg G, Boeckxstaens G, Bellini M, Stanghellini V, Barbara G, Daly MJ, Camilleri M, Wouters MM, D'Amato M. Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts. Gut. 2015 Nov; 64 (11):1774-82 Epub 2014 Sept 23
    View PubMed
  77. Ek WE, Reznichenko A, Ripke S, Niesler B, Zucchelli M, Rivera NV, Schmidt PT, Pedersen NL, Magnusson P, Talley NJ, Holliday EG, Houghton L, Gazouli M, Karamanolis G, Rappold G, Burwinkel B, Surowy H, Rafter J, Assadi G, Li L, Papadaki E, Gambaccini D, Marchi S, Colucci R, Blandizzi C, Barbaro R, Karling P, Walter S, Ohlsson B, Tornblom H, Bresso F, Andreasson A, Dlugosz A, Simren M, Agreus L, Lindberg G, Boeckxstaens G, Bellini M, Stanghellini V, Barbara G, Daly MJ, Camilleri M, Wouters MM, D'Amato M. Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts. Gut. 2015 Nov; 64 (11):1774-82 Epub 2014 Sept 23
    View PubMed
  78. Paula H, Grover M, Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders. Neurogastroenterol Motil. 2015 Nov; 27 (11):1580-6 Epub 2015 Aug 24
    View PubMed
  79. Paula H, Grover M, Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders. Neurogastroenterol Motil. 2015 Nov; 27 (11):1580-6 Epub 2015 Aug 24
    View PubMed
  80. Choung RS, Rubio-Tapia A, Lahr BD, Kyle RA, Camilleri MJ, Locke GR 3rd, Talley NJ, Murray JA. Evidence Against Routine Testing of Patients With Functional Gastrointestinal Disorders for Celiac Disease: A Population-based Study. Clin Gastroenterol Hepatol. 2015 Nov; 13 (11):1937-43 Epub 2015 May 16
    View PubMed
  81. Choung RS, Rubio-Tapia A, Lahr BD, Kyle RA, Camilleri MJ, Locke GR 3rd, Talley NJ, Murray JA. Evidence Against Routine Testing of Patients With Functional Gastrointestinal Disorders for Celiac Disease: A Population-based Study. Clin Gastroenterol Hepatol. 2015 Nov; 13 (11):1937-43 Epub 2015 May 16
    View PubMed
  82. Herrick LM, Locke GR 3rd, Schleck CD, Zinsmeister AR, Treder V, Talley NJ. Dyspepsia in the community: value of a community-based mailed survey to identify potential participants for a randomized clinical trial. Scand J Gastroenterol. 2015 Aug; 50 (8):959-64 Epub 2015 Mar 11
    View PubMed
  83. Crowell MD, Umar SB, Lacy BE, Jones MP, DiBaise JK, Talley NJ. Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool. Dig Dis Sci. 2015 Aug; 60 (8):2270-9 Epub 2015 Apr 05
    View PubMed
  84. Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR. Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Gastroenterology. 2015 Aug; 149(2):340-9.e2. Epub 2015 Apr 25.
    View PubMed
  85. Crowell MD, Umar SB, Lacy BE, Jones MP, DiBaise JK, Talley NJ. Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool. Dig Dis Sci. 2015 Aug; 60 (8):2270-9 Epub 2015 Apr 05
    View PubMed
  86. Herrick LM, Locke GR 3rd, Schleck CD, Zinsmeister AR, Treder V, Talley NJ. Dyspepsia in the community: value of a community-based mailed survey to identify potential participants for a randomized clinical trial. Scand J Gastroenterol. 2015 Aug; 50 (8):959-64 Epub 2015 Mar 11
    View PubMed
  87. Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR. Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Gastroenterology. 2015 Aug; 149(2):340-9.e2. Epub 2015 Apr 25.
    View PubMed
  88. Brummond NR, Locke GR 3rd, Choung RS, Chang JY, Schleck CD, Zinsmeister AR, Talley NJ. Effects of Birth Cohorts on the Irritable Bowel Syndrome Support Early-Life Risk Factors. Dig Dis Sci. 2015 Jul; 60 (7):2112-8 Epub 2015 Feb 14
    View PubMed
  89. Brummond NR, Locke GR 3rd, Choung RS, Chang JY, Schleck CD, Zinsmeister AR, Talley NJ. Effects of Birth Cohorts on the Irritable Bowel Syndrome Support Early-Life Risk Factors. Dig Dis Sci. 2015 Jul; 60 (7):2112-8 Epub 2015 Feb 14
    View PubMed
  90. Chang JY, Locke GR III, Schleck CD, Zinsmeister AR, Talley NJ. Lack of familial aggregation in chronic constipation excluding irritable bowel syndrome: a population-based study. Dig Dis Sci. 2015 May; 60(5):1358-65.
    View PubMed
  91. Chang JY, Locke GR III, Schleck CD, Zinsmeister AR, Talley NJ. Lack of familial aggregation in chronic constipation excluding irritable bowel syndrome: a population-based study. Dig Dis Sci. 2015 May; 60(5):1358-65.
    View PubMed
  92. Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J, Aldulaimi D, Ho KY, Odze R, Meltzer SJ, Quigley E, Gittens S, Watson P, Zaninotto G, Iyer PG, Alexandre L, Ang Y, Callaghan J, Harrison R, Singh R, Bhandari P, Bisschops R, Geramizadeh B, Kaye P, Krishnadath S, Fennerty MB, Manner H, Nason KS, Pech O, Konda V, Ragunath K, Rahman I, Romero Y, Sampliner R, Siersema PD, Tack J, Tham TC, Trudgill N, Weinberg DS, Wang J, Wang K, Wong JY, Attwood S, Malfertheiner P, MacDonald D, Barr H, Ferguson MK, Jankowski J, BOB CAT Consortium. BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015 May; 110 (5):662-82; quiz 683 Epub 2015 Apr 14
    View PubMed
  93. Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J, Aldulaimi D, Ho KY, Odze R, Meltzer SJ, Quigley E, Gittens S, Watson P, Zaninotto G, Iyer PG, Alexandre L, Ang Y, Callaghan J, Harrison R, Singh R, Bhandari P, Bisschops R, Geramizadeh B, Kaye P, Krishnadath S, Fennerty MB, Manner H, Nason KS, Pech O, Konda V, Ragunath K, Rahman I, Romero Y, Sampliner R, Siersema PD, Tack J, Tham TC, Trudgill N, Weinberg DS, Wang J, Wang K, Wong JY, Attwood S, Malfertheiner P, MacDonald D, Barr H, Ferguson MK, Jankowski J, BOB CAT Consortium. BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015 May; 110 (5):662-82; quiz 683 Epub 2015 Apr 14
    View PubMed
  94. Keshteli AH, Feizi A, Esmaillzadeh A, Zaribaf F, Feinle-Bisset C, Talley NJ, Adibi P. Patterns of dietary behaviours identified by latent class analysis are associated with chronic uninvestigated dyspepsia. Br J Nutr. 2015 Mar 14; 113: (5)803-12.
    View PubMed
  95. Keshteli AH, Feizi A, Esmaillzadeh A, Zaribaf F, Feinle-Bisset C, Talley NJ, Adibi P. Patterns of dietary behaviours identified by latent class analysis are associated with chronic uninvestigated dyspepsia. Br J Nutr. 2015 Mar 14; 113: (5)803-12.
    View PubMed
  96. Knight JR, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Family history of mental illness or alcohol abuse and the irritable bowel syndrome. J Psychosom Res. 2015 Mar; 78 (3):237-41 Epub 2014 Dec 03
    View PubMed
  97. Knight JR, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Family history of mental illness or alcohol abuse and the irritable bowel syndrome. J Psychosom Res. 2015 Mar; 78 (3):237-41 Epub 2014 Dec 03
    View PubMed
  98. Elias MK, Kopacova J, Arora AS, Dierkhising RA, Enders FT, Katzka DA, Kryzer LA, Halland M, Smyrk TC, Talley NJ, Alexander JA. The diagnosis of esophageal eosinophilia is not increased in the summer months. Dysphagia. 2015 Feb; 30 (1):67-73 Epub 2014 Oct 07
    View PubMed
  99. Cho SY, Choung RS, Saito YA, Schleck CD, Zinsmeister AR, Locke GR 3rd, Talley NJ. Prevalence and risk factors for dysphagia: a USA community study. Neurogastroenterol Motil. 2015 Feb; 27 (2):212-9 Epub 2014 Nov 06
    View PubMed
  100. Elias MK, Kopacova J, Arora AS, Dierkhising RA, Enders FT, Katzka DA, Kryzer LA, Halland M, Smyrk TC, Talley NJ, Alexander JA. The diagnosis of esophageal eosinophilia is not increased in the summer months. Dysphagia. 2015 Feb; 30 (1):67-73 Epub 2014 Oct 07
    View PubMed
  101. Cho SY, Choung RS, Saito YA, Schleck CD, Zinsmeister AR, Locke GR 3rd, Talley NJ. Prevalence and risk factors for dysphagia: a USA community study. Neurogastroenterol Motil. 2015 Feb; 27 (2):212-9 Epub 2014 Nov 06
    View PubMed
  102. Gentile N, Katzka D, Ravi K, Trenkner S, Enders F, Killian J, Kryzer L, Talley NJ, Alexander J. Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther. 2014 Dec; 40 (11-12):1333-40 Epub 2014 Oct 07
    View PubMed
  103. Gentile N, Katzka D, Ravi K, Trenkner S, Enders F, Killian J, Kryzer L, Talley NJ, Alexander J. Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther. 2014 Dec; 40 (11-12):1333-40 Epub 2014 Oct 07
    View PubMed
  104. Taha F, Lipsitz JD, Galea S, Demmer RT, Talley NJ, Goodwin RD. Anxiety disorders and risk of self-reported ulcer: a 10-year longitudinal study among US adults. Gen Hosp Psychiatry. 2014 Nov-Dec; 36 (6):674-9 Epub 2014 July 22
    View PubMed
  105. Taha F, Lipsitz JD, Galea S, Demmer RT, Talley NJ, Goodwin RD. Anxiety disorders and risk of self-reported ulcer: a 10-year longitudinal study among US adults. Gen Hosp Psychiatry. 2014 Nov-Dec; 36 (6):674-9 Epub 2014 July 22
    View PubMed
  106. Barboza JL, Talley NJ, Moshiree B. Current and emerging pharmacotherapeutic options for irritable bowel syndrome. Drugs. 2014 Oct; 74 (16):1849-1870
    View PubMed
  107. Barboza JL, Talley NJ, Moshiree B. Current and emerging pharmacotherapeutic options for irritable bowel syndrome. Drugs. 2014 Oct; 74 (16):1849-1870
    View PubMed
  108. Pleyer C, Bittner H, Locke GR 3rd, Choung RS, Zinsmeister AR, Schleck CD, Herrick LM, Talley NJ. Overdiagnosis of gastro-esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community. Neurogastroenterol Motil. 2014 Aug; 26(8):1163-71. Epub 2014 Jun 11.
    View PubMed
  109. Gupta M, Beebe TJ, Dunagan KT, Schleck CD, Zinsmeister AR, Talley NJ, Locke GR 3rd, Iyer PG. Screening for Barrett's esophagus: results from a population-based survey. Dig Dis Sci. 2014 Aug; 59(8):1831-50. Epub 2014 Mar 21.
    View PubMed
  110. Pleyer C, Bittner H, Locke GR 3rd, Choung RS, Zinsmeister AR, Schleck CD, Herrick LM, Talley NJ. Overdiagnosis of gastro-esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community. Neurogastroenterol Motil. 2014 Aug; 26(8):1163-71. Epub 2014 Jun 11.
    View PubMed
  111. Gupta M, Beebe TJ, Dunagan KT, Schleck CD, Zinsmeister AR, Talley NJ, Locke GR 3rd, Iyer PG. Screening for Barrett's esophagus: results from a population-based survey. Dig Dis Sci. 2014 Aug; 59(8):1831-50. Epub 2014 Mar 21.
    View PubMed
  112. Halland M, Almazar A, Lee R, Atkinson E, Larson J, Talley NJ, Saito YA. A case-control study of childhood trauma in the development of irritable bowel syndrome. Neurogastroenterol Motil. 2014 Jul; 26(7):990-8. Epub 2014 May 11.
    View PubMed
  113. Halland M, Almazar A, Lee R, Atkinson E, Larson J, Talley NJ, Saito YA. A case-control study of childhood trauma in the development of irritable bowel syndrome. Neurogastroenterol Motil. 2014 Jul; 26(7):990-8. Epub 2014 May 11.
    View PubMed
  114. Beyder A, Mazzone A, Strege PR, Tester DJ, Saito YA, Bernard CE, Enders FT, Ek WE, Schmidt PT, Dlugosz A, Lindberg G, Karling P, Ohlsson B, Gazouli M, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Camilleri M, Locke GR, Talley NJ, D'Amato M, Ackerman MJ, Farrugia G. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. Gastroenterology. 2014 Jun; 146 (7):1659-1668 Epub 2014 Mar 05
    View PubMed
  115. Beyder A, Mazzone A, Strege PR, Tester DJ, Saito YA, Bernard CE, Enders FT, Ek WE, Schmidt PT, Dlugosz A, Lindberg G, Karling P, Ohlsson B, Gazouli M, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Camilleri M, Locke GR, Talley NJ, D'Amato M, Ackerman MJ, Farrugia G. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. Gastroenterology. 2014 Jun; 146 (7):1659-1668 Epub 2014 Mar 05
    View PubMed
  116. Vazquez-Elizondo G, Ngamruengphong S, Khrisna M, Devault KR, Talley NJ, Achem SR. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther. 2013 Nov; 38 (10):1312-9 Epub 2013 Oct 05
    View PubMed
  117. Vazquez-Elizondo G, Ngamruengphong S, Khrisna M, Devault KR, Talley NJ, Achem SR. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther. 2013 Nov; 38 (10):1312-9 Epub 2013 Oct 05
    View PubMed
  118. Halland M, Koloski NA, Jones M, Byles J, Chiarelli P, Forder P, Talley NJ. Prevalence correlates and impact of fecal incontinence among older women. Dis Colon Rectum. 2013 Sep; 56 (9):1080-6
    View PubMed
  119. Halland M, Koloski NA, Jones M, Byles J, Chiarelli P, Forder P, Talley NJ. Prevalence correlates and impact of fecal incontinence among older women. Dis Colon Rectum. 2013 Sep; 56 (9):1080-6
    View PubMed
  120. Ludvigsson JF, Aro P, Walker MM, Vieth M, Agreus L, Talley NJ, Murray JA, Ronkainen J. Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study. Scand J Gastroenterol. 2013 Jul; 48(7):808-14. Epub 2013 May 14.
    View PubMed
  121. Ludvigsson JF, Aro P, Walker MM, Vieth M, Agreus L, Talley NJ, Murray JA, Ronkainen J. Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study. Scand J Gastroenterol. 2013 Jul; 48(7):808-14. Epub 2013 May 14.
    View PubMed
  122. Lacy BE, Weiser KT, Kennedy AT, Crowell MD, Talley NJ. Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther. 2013 Jul; 38(2):170-7. Epub 2013 Jun 03.
    View PubMed
  123. Lacy BE, Weiser KT, Kennedy AT, Crowell MD, Talley NJ. Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther. 2013 Jul; 38(2):170-7. Epub 2013 Jun 03.
    View PubMed
  124. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Associations between medication use and functional gastrointestinal disorders: a population-based study. Neurogastroenterol Motil. 2013 May; 25 (5):413-9, e298 Epub 2013 Jan 29
    View PubMed
  125. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Associations between medication use and functional gastrointestinal disorders: a population-based study. Neurogastroenterol Motil. 2013 May; 25 (5):413-9, e298 Epub 2013 Jan 29
    View PubMed
  126. Topazian M, Camilleri M, Enders FT, Clain JE, Gleeson FC, Levy MJ, Rajan E, Nehra V, Dierkhising RA, Collazo-Clavell ML, Talley NJ, Clark MM. Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight. Clin Gastroenterol Hepatol. 2013 Feb; 11 (2):145-50.e1 Epub 2012 Oct 09
    View PubMed
  127. Leggett CL, Nelsen EM, Tian J, Schleck CB, Zinsmeister AR, Dunagan KT, Locke GR 3rd, Wang KK, Talley NJ, Iyer PG. Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study. Mayo Clin Proc. 2013 Feb; 88 (2):157-65
    View PubMed
  128. Topazian M, Camilleri M, Enders FT, Clain JE, Gleeson FC, Levy MJ, Rajan E, Nehra V, Dierkhising RA, Collazo-Clavell ML, Talley NJ, Clark MM. Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight. Clin Gastroenterol Hepatol. 2013 Feb; 11 (2):145-50.e1 Epub 2012 Oct 09
    View PubMed
  129. Leggett CL, Nelsen EM, Tian J, Schleck CB, Zinsmeister AR, Dunagan KT, Locke GR 3rd, Wang KK, Talley NJ, Iyer PG. Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study. Mayo Clin Proc. 2013 Feb; 88 (2):157-65
    View PubMed
  130. Rajan E, Gostout CJ, Aimore Bonin E, Moran EA, Locke RG, Szarka LA, Talley NJ, Deters JL, Miller CA, Knipschield MA, Lurken MS, Stoltz GJ, Bernard CE, Grover M, Farrugia G. Endoscopic full-thickness biopsy of the gastric wall with defect closure by using an endoscopic suturing device: survival porcine study. Gastrointest Endosc. 2012 Nov; 76 (5):1014-9
    View PubMed
  131. Rajan E, Gostout CJ, Aimore Bonin E, Moran EA, Locke RG, Szarka LA, Talley NJ, Deters JL, Miller CA, Knipschield MA, Lurken MS, Stoltz GJ, Bernard CE, Grover M, Farrugia G. Endoscopic full-thickness biopsy of the gastric wall with defect closure by using an endoscopic suturing device: survival porcine study. Gastrointest Endosc. 2012 Nov; 76 (5):1014-9
    View PubMed
  132. Saito YA, Larson JJ, Atkinson EJ, Ryu E, Almazar AE, Petersen GM, Talley NJ. The role of 5-HTT LPR and GNß3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci. 2012 Oct; 57(10):2650-7. Epub 2012 Aug 02.
    View PubMed
  133. Saito YA, Larson JJ, Atkinson EJ, Ryu E, Almazar AE, Petersen GM, Talley NJ. The role of 5-HTT LPR and GNß3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci. 2012 Oct; 57(10):2650-7. Epub 2012 Aug 02.
    View PubMed
  134. Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TC, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JA. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012 Aug; 143(2):336-46. Epub 2012 Apr 24.
    View PubMed
  135. Talley NJ. Dietary modification as a treatment for irritable bowel syndrome. Gastroenterol Hepatol (N Y). 2012 Aug; 8 (8):552-4
    View PubMed
  136. Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TC, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JA. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012 Aug; 143(2):336-46. Epub 2012 Apr 24.
    View PubMed
  137. Talley NJ. Dietary modification as a treatment for irritable bowel syndrome. Gastroenterol Hepatol (N Y). 2012 Aug; 8 (8):552-4
    View PubMed
  138. Lacy BE, Talley NJ, Locke GR 3rd, Bouras EP, DiBaise JK, El-Serag HB, Abraham BP, Howden CW, Moayyedi P, Prather C. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012 Jul; 36(1):3-15. Epub 2012 May 16.
    View PubMed
  139. Alexander JA, Jung KW, Arora AS, Enders F, Katzka DA, Kephardt GM, Kita H, Kryzer LA, Romero Y, Smyrk TC, Talley NJ. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012 Jul; 10 (7):742-749.e1 Epub 2012 Apr 01
    View PubMed
  140. Myasoedova E, Matteson EL, Talley NJ, Crowson CS. Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study. J Rheumatol. 2012 Jul; 39 (7):1355-62 Epub 2012 Apr 01
    View PubMed
  141. Myasoedova E, Matteson EL, Talley NJ, Crowson CS. Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study. J Rheumatol. 2012 Jul; 39 (7):1355-62 Epub 2012 Apr 01
    View PubMed
  142. Lacy BE, Talley NJ, Locke GR 3rd, Bouras EP, DiBaise JK, El-Serag HB, Abraham BP, Howden CW, Moayyedi P, Prather C. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012 Jul; 36(1):3-15. Epub 2012 May 16.
    View PubMed
  143. Alexander JA, Jung KW, Arora AS, Enders F, Katzka DA, Kephardt GM, Kita H, Kryzer LA, Romero Y, Smyrk TC, Talley NJ. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012 Jul; 10 (7):742-749.e1 Epub 2012 Apr 01
    View PubMed
  144. Herrick LM, Locke GR 3rd, Zinsmeister AR, Talley NJ. Challenges and lessons learned in conducting comparative-effectiveness trials. Am J Gastroenterol. 2012 May; 107 (5):644-9
    View PubMed
  145. Lee J, Huprich J, Kujath C, Ravi K, Enders F, Smyrk TC, Katzka DA, Talley NJ, Alexander JA. Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy. Clin Gastroenterol Hepatol. 2012 May; 10 (5):481-6 Epub 2012 Feb 03
    View PubMed
  146. Talley NJ, Locke GR 3rd, Herrick LM, Silvernail VM, Prather CM, Lacy BE, DiBaise JK, Howden CW, Brenner DM, Bouras EP, El-Serag HB, Abraham BP, Moayyedi P, Zinsmeister AR. Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials. 2012 May; 33 (3):523-33 Epub 2012 Feb 10
    View PubMed
  147. Choung RS, Locke GR 3rd, Rey E, Schleck CD, Baum C, Zinsmeister AR, Talley NJ. Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol. 2012 May; 10 (5):494-500 Epub 2012 Jan 28
    View PubMed
  148. Herrick LM, Locke GR 3rd, Zinsmeister AR, Talley NJ. Challenges and lessons learned in conducting comparative-effectiveness trials. Am J Gastroenterol. 2012 May; 107 (5):644-9
    View PubMed
  149. Lee J, Huprich J, Kujath C, Ravi K, Enders F, Smyrk TC, Katzka DA, Talley NJ, Alexander JA. Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy. Clin Gastroenterol Hepatol. 2012 May; 10 (5):481-6 Epub 2012 Feb 03
    View PubMed
  150. Talley NJ, Locke GR 3rd, Herrick LM, Silvernail VM, Prather CM, Lacy BE, DiBaise JK, Howden CW, Brenner DM, Bouras EP, El-Serag HB, Abraham BP, Moayyedi P, Zinsmeister AR. Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials. 2012 May; 33 (3):523-33 Epub 2012 Feb 10
    View PubMed
  151. Choung RS, Locke GR 3rd, Rey E, Schleck CD, Baum C, Zinsmeister AR, Talley NJ. Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol. 2012 May; 10 (5):494-500 Epub 2012 Jan 28
    View PubMed
  152. Adibi P, Keshteli AH, Esmaillzadeh A, Afshar H, Roohafza H, Bagherian-Sararoudi R, Daghaghzadeh H, Soltanian N, Feinle-Bisset C, Boyce P, Talley NJ. The study on the epidemiology of psychological, alimentary health and nutrition (SEPAHAN): overview of methodology. Journal Of Research In Medical Sciences. 2012 Mar; 17:S292-8.
  153. Adibi P, Keshteli AH, Esmaillzadeh A, Afshar H, Roohafza H, Bagherian-Sararoudi R, Daghaghzadeh H, Soltanian N, Feinle-Bisset C, Boyce P, Talley NJ. The study on the epidemiology of psychological, alimentary health and nutrition (SEPAHAN): overview of methodology. Journal Of Research In Medical Sciences. 2012 Mar; 17:S292-8.
  154. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil. 2012 Mar; 24 (3):229-34, e106 Epub 2011 Dec 12
    View PubMed
  155. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil. 2012 Mar; 24 (3):229-34, e106 Epub 2011 Dec 12
    View PubMed
  156. Chang JY, Talley NJ, Locke GR 3rd, Katzka DA, Schleck CD, Zinsmeister AR, Dunagan KT, Wu TT, Wang KK, Prasad GA. Population screening for barrett esophagus: a prospective randomized pilot study. Mayo Clin Proc. 2011 Dec; 86 (12):1174-80
    View PubMed
  157. Chang JY, Talley NJ, Locke GR 3rd, Katzka DA, Schleck CD, Zinsmeister AR, Dunagan KT, Wu TT, Wang KK, Prasad GA. Population screening for barrett esophagus: a prospective randomized pilot study. Mayo Clin Proc. 2011 Dec; 86 (12):1174-80
    View PubMed
  158. van Zanten SV, Wahlqvist P, Talley NJ, Halling K, Vakil N, Lauritsen K, Flook N, Persson T, Bolling-Sternevald E, STARS II Investigators. Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study. Aliment Pharmacol Ther. 2011 Oct; 34(7):714-23. Epub 2011 Aug 17.
    View PubMed
  159. van Zanten SV, Wahlqvist P, Talley NJ, Halling K, Vakil N, Lauritsen K, Flook N, Persson T, Bolling-Sternevald E, STARS II Investigators. Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study. Aliment Pharmacol Ther. 2011 Oct; 34(7):714-23. Epub 2011 Aug 17.
    View PubMed
  160. Walker MM, Talley NJ. Clinical value of duodenal biopsies--beyond the diagnosis of coeliac disease. Pathol Res Pract. 2011 Sep 15; 207(9):538-44. Epub 2011 Sep 22.
    View PubMed
  161. Walker MM, Talley NJ. Clinical value of duodenal biopsies--beyond the diagnosis of coeliac disease. Pathol Res Pract. 2011 Sep 15; 207(9):538-44. Epub 2011 Sep 22.
    View PubMed
  162. Jung KW, Talley NJ, Romero Y, Katzka DA, Schleck CD, Zinsmeister AR, Dunagan KT, Lutzke LS, Wu TT, Wang KK, Frederickson M, Geno DM, Locke GR, Prasad GA. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study. Am J Gastroenterol. 2011 Aug; 106 (8):1447-55; quiz 1456 Epub 2011 Apr 12
    View PubMed
  163. Jung KW, Talley NJ, Romero Y, Katzka DA, Schleck CD, Zinsmeister AR, Dunagan KT, Lutzke LS, Wu TT, Wang KK, Frederickson M, Geno DM, Locke GR, Prasad GA. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study. Am J Gastroenterol. 2011 Aug; 106 (8):1447-55; quiz 1456 Epub 2011 Apr 12
    View PubMed
  164. Ravi K, Talley NJ, Smyrk TC, Katzka DA, Kryzer L, Romero Y, Arora AS, Alexander JA. Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis? Dig Dis Sci. 2011 Jul; 56 (7):1981-6 Epub 2011 Feb 06
    View PubMed
  165. Katz KD, Rashtak S, Lahr BD, Melton LJ, Krause PK, Maggi K, Talley NJ, Murray JA. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol. 2011 Jul; 106(7):1333-9. Epub 2011 Mar 01.
    View PubMed
  166. Ravi K, Talley NJ, Smyrk TC, Katzka DA, Kryzer L, Romero Y, Arora AS, Alexander JA. Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis? Dig Dis Sci. 2011 Jul; 56 (7):1981-6 Epub 2011 Feb 06
    View PubMed
  167. Katz KD, Rashtak S, Lahr BD, Melton LJ, Krause PK, Maggi K, Talley NJ, Murray JA. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol. 2011 Jul; 106(7):1333-9. Epub 2011 Mar 01.
    View PubMed
  168. Achem SR, Almansa C, Krishna M, Heckman MG, Wolfsen HC, Talley NJ, DeVault KR. Oesophageal eosinophilic infiltration in patients with noncardiac chest pain. Aliment Pharmacol Ther. 2011 Jun; 33(11):1194-201. Epub 2011 Apr 05.
    View PubMed
  169. Talley NJ. Irritable bowel syndrome: rational therapy. Consultant. 2011 Jun; 51(6):341-7.
  170. Achem SR, Almansa C, Krishna M, Heckman MG, Wolfsen HC, Talley NJ, DeVault KR. Oesophageal eosinophilic infiltration in patients with noncardiac chest pain. Aliment Pharmacol Ther. 2011 Jun; 33(11):1194-201. Epub 2011 Apr 05.
    View PubMed
  171. Talley NJ. Irritable bowel syndrome: rational therapy. Consultant. 2011 Jun; 51(6):341-7.
  172. Choung RS, Ruff KC, Malhotra A, Herrick L, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Talley NJ, Saito YA. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther. 2011 May; 33 (9):1059-67 Epub 2011 Mar 13
    View PubMed
  173. Choung RS, Ruff KC, Malhotra A, Herrick L, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Talley NJ, Saito YA. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther. 2011 May; 33 (9):1059-67 Epub 2011 Mar 13
    View PubMed
  174. Pittock SJ, Lennon VA, Dege CL, Talley NJ, Locke GR 3rd. Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci. 2011 May; 56 (5):1452-9 Epub 2010 Dec 23
    View PubMed
  175. Pittock SJ, Lennon VA, Dege CL, Talley NJ, Locke GR 3rd. Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci. 2011 May; 56 (5):1452-9 Epub 2010 Dec 23
    View PubMed
  176. Beebe TJ, Ziegenfuss JY, St Sauver JL, Jenkins SM, Haas L, Davern ME, Talley NJ. Health Insurance Portability and Accountability Act (HIPAA) authorization and survey nonresponse bias. Med Care. 2011 Apr; 49 (4):365-70
    View PubMed
  177. Beebe TJ, Ziegenfuss JY, St Sauver JL, Jenkins SM, Haas L, Davern ME, Talley NJ. Health Insurance Portability and Accountability Act (HIPAA) authorization and survey nonresponse bias. Med Care. 2011 Apr; 49 (4):365-70
    View PubMed
  178. Ford AC, Achkar JP, Khan KJ, Kane SV, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):601-16. Epub 2011 Mar 15.
    View PubMed
  179. Wang YR, Talley NJ, Picco MF. Overlap irritable bowel syndrome, inflammatory bowel disease, and diverticular disease. J Clin Gastroenterol. 2011 Apr; 45(Suppl 1):S36-42.
  180. Ford AC, Kane SV, Khan KJ, Achkar JP, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):617-29. Epub 2011 Mar 15.
    View PubMed
  181. Talley NJ, Abreu MT, Achkar JP, Bernstein CN, Dubinsky MC, Hanauer SB, Kane SV, Sandborn WJ, Ullman TA, Moayyedi P, American College of Gastroenterology IBD Task Force. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol. 2011 Apr; 106 Suppl 1:S2-25; quiz S26.
    View PubMed
  182. Ford AC, Kane SV, Khan KJ, Achkar JP, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):617-29. Epub 2011 Mar 15.
    View PubMed
  183. Ford AC, Achkar JP, Khan KJ, Kane SV, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):601-16. Epub 2011 Mar 15.
    View PubMed
  184. Talley NJ, Abreu MT, Achkar JP, Bernstein CN, Dubinsky MC, Hanauer SB, Kane SV, Sandborn WJ, Ullman TA, Moayyedi P, American College of Gastroenterology IBD Task Force. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol. 2011 Apr; 106 Suppl 1:S2-25; quiz S26.
    View PubMed
  185. Wang YR, Talley NJ, Picco MF. Overlap irritable bowel syndrome, inflammatory bowel disease, and diverticular disease. J Clin Gastroenterol. 2011 Apr; 45(Suppl 1):S36-42.
  186. Dinning PG, Jones M, Hunt L, Fuentealba SE, Kalanter J, King DW, Lubowski DZ, Talley NJ, Cook IJ. Factor analysis identifies subgroups of constipation. World J Gastroenterol. 2011 Mar 21; 17(11):1468-74.
    View PubMed
  187. Dinning PG, Jones M, Hunt L, Fuentealba SE, Kalanter J, King DW, Lubowski DZ, Talley NJ, Cook IJ. Factor analysis identifies subgroups of constipation. World J Gastroenterol. 2011 Mar 21; 17(11):1468-74.
    View PubMed
  188. Spergel JM, Book WM, Mays E, Song L, Shah SS, Talley NJ, Bonis PA. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr. 2011 Mar; 52(3):300-6.
    View PubMed
  189. Ang D, Talley NJ, Simren M, Janssen P, Boeckxstaens G, Tack J. Review article: endpoints used in functional dyspepsia drug therapy trials. Aliment Pharmacol Ther. 2011 Mar; 33(6):634-49. Epub 2011 Jan 12.
    View PubMed
  190. Spergel JM, Book WM, Mays E, Song L, Shah SS, Talley NJ, Bonis PA. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr. 2011 Mar; 52(3):300-6.
    View PubMed
  191. Ang D, Talley NJ, Simren M, Janssen P, Boeckxstaens G, Tack J. Review article: endpoints used in functional dyspepsia drug therapy trials. Aliment Pharmacol Ther. 2011 Mar; 33(6):634-49. Epub 2011 Jan 12.
    View PubMed
  192. Talley NJ. Rumination syndrome. Gastroenterol Hepatol (N Y). 2011 Feb; 7 (2):117-8
    View PubMed
  193. Talley NJ. Rumination syndrome. Gastroenterol Hepatol (N Y). 2011 Feb; 7 (2):117-8
    View PubMed
  194. Lacy BE, Talley NJ, Camilleri M. Functional dyspepsia: time to change clinical trial design? Am J Gastroenterol. 2010 Dec; 105 (12):2525-9
    View PubMed
  195. Lacy BE, Talley NJ, Camilleri M. Functional dyspepsia: time to change clinical trial design? Am J Gastroenterol. 2010 Dec; 105 (12):2525-9
    View PubMed
  196. Choung RS, Herrick LM, Locke GR 3rd, Zinsmeister AR, Talley NJ. Irritable bowel syndrome and chronic pelvic pain: a population-based study. J Clin Gastroenterol. 2010 Nov-Dec; 44 (10):696-701
    View PubMed
  197. Choung RS, Herrick LM, Locke GR 3rd, Zinsmeister AR, Talley NJ. Irritable bowel syndrome and chronic pelvic pain: a population-based study. J Clin Gastroenterol. 2010 Nov-Dec; 44 (10):696-701
    View PubMed
  198. Aro P, Ronkainen J, Storskrubb T, Vieth M, Engstrand L, Johansson SE, Bolling-Sternevald E, Bolinder G, Alving K, Talley NJ, Agreus L. Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study). Eur J Epidemiol. 2010 Oct; 25(10):741-50. Epub 2010 Jul 29.
    View PubMed
  199. Aro P, Ronkainen J, Storskrubb T, Vieth M, Engstrand L, Johansson SE, Bolling-Sternevald E, Bolinder G, Alving K, Talley NJ, Agreus L. Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study). Eur J Epidemiol. 2010 Oct; 25(10):741-50. Epub 2010 Jul 29.
    View PubMed
  200. McElhiney J, Lohse MR, Arora AS, Peloquin JM, Geno DM, Kuntz MM, Enders FB, Fredericksen M, Abdalla AA, Khan Y, Talley NJ, Diehl NN, Beebe TJ, Harris AM, Farrugia G, Graner DE, Murray JA, Locke GR 3rd, Grothe RM, Crowell MD, Francis DL, Grudell AM, Dabade T, Ramirez A, Alkhatib M, Alexander JA, Kimber J, Prasad G, Zinsmeister AR, Romero Y. The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia. 2010 Sep; 25 (3):221-30 Epub 2009 Oct 24
    View PubMed
  201. McElhiney J, Lohse MR, Arora AS, Peloquin JM, Geno DM, Kuntz MM, Enders FB, Fredericksen M, Abdalla AA, Khan Y, Talley NJ, Diehl NN, Beebe TJ, Harris AM, Farrugia G, Graner DE, Murray JA, Locke GR 3rd, Grothe RM, Crowell MD, Francis DL, Grudell AM, Dabade T, Ramirez A, Alkhatib M, Alexander JA, Kimber J, Prasad G, Zinsmeister AR, Romero Y. The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia. 2010 Sep; 25 (3):221-30 Epub 2009 Oct 24
    View PubMed
  202. Chang JY, Choung RS, Lee RM, Locke GR 3rd, Schleck CD, Zinsmeister AR, Smyrk TC, Talley NJ. A shift in the clinical spectrum of eosinophilic gastroenteritis toward the mucosal disease type. Clin Gastroenterol Hepatol. 2010 Aug; 8 (8):669-75; quiz e88 Epub 2010 May 06
    View PubMed
  203. Chang JY, Choung RS, Lee RM, Locke GR 3rd, Schleck CD, Zinsmeister AR, Smyrk TC, Talley NJ. A shift in the clinical spectrum of eosinophilic gastroenteritis toward the mucosal disease type. Clin Gastroenterol Hepatol. 2010 Aug; 8 (8):669-75; quiz e88 Epub 2010 May 06
    View PubMed
  204. Walker MM, Murray JA, Ronkainen J, Aro P, Storskrubb T, D'Amato M, Lahr B, Talley NJ, Agreus L. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology. 2010 Jul; 139(1):112-9. Epub 2010 Apr 13.
    View PubMed
  205. Walker MM, Murray JA, Ronkainen J, Aro P, Storskrubb T, D'Amato M, Lahr B, Talley NJ, Agreus L. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology. 2010 Jul; 139(1):112-9. Epub 2010 Apr 13.
    View PubMed
  206. Chang JY, Talley NJ. Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment. Trends Pharmacol Sci. 2010 Jul; 31 (7):326-34 Epub 2010 June 01
    View PubMed
  207. Chang JY, Talley NJ. Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment. Trends Pharmacol Sci. 2010 Jul; 31 (7):326-34 Epub 2010 June 01
    View PubMed
  208. Beebe TJ, Rey E, Ziegenfuss JY, Jenkins S, Lackore K, Talley NJ, Locke RG 3rd. Shortening a survey and using alternative forms of prenotification: impact on response rate and quality. BMC Med Res Methodol. 2010 Jun 8; 10:50 Epub 2010 June 08
    View PubMed
  209. Beebe TJ, Rey E, Ziegenfuss JY, Jenkins S, Lackore K, Talley NJ, Locke RG 3rd. Shortening a survey and using alternative forms of prenotification: impact on response rate and quality. BMC Med Res Methodol. 2010 Jun 8; 10:50 Epub 2010 June 08
    View PubMed
  210. Walker MM, Salehian SS, Murray CE, Rajendran A, Hoare JM, Negus R, Powell N, Talley NJ. Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia. Aliment Pharmacol Ther. 2010 Jun; 31(11):1229-36. Epub 2010 Mar 04.
    View PubMed
  211. Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010 Jun; 8(6):498-503. Epub 2010 Mar 19.
    View PubMed
  212. Walker MM, Salehian SS, Murray CE, Rajendran A, Hoare JM, Negus R, Powell N, Talley NJ. Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia. Aliment Pharmacol Ther. 2010 Jun; 31(11):1229-36. Epub 2010 Mar 04.
    View PubMed
  213. Gururatsakul M, Holloway RH, Talley NJ, Holtmann GJ. Association between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunction. J Gastroenterol Hepatol. 2010 Jun; 25(6):1162-9.
    View PubMed
  214. Rey E, Locke GR, Jung HK, Malhotra A, Choung RS, Beebe TJ, Schleck CD, Zinsmeister AR, Talley NJ. Measurement of abdominal symptoms by validated questionnaire: a 3-month recall timeframe as recommended by Rome III is not superior to a 1-year recall timeframe. Aliment Pharmacol Ther. 2010 Jun; 31 (11):1237-47 Epub 2010 Mar 06
    View PubMed
  215. Rey E, Locke GR, Jung HK, Malhotra A, Choung RS, Beebe TJ, Schleck CD, Zinsmeister AR, Talley NJ. Measurement of abdominal symptoms by validated questionnaire: a 3-month recall timeframe as recommended by Rome III is not superior to a 1-year recall timeframe. Aliment Pharmacol Ther. 2010 Jun; 31 (11):1237-47 Epub 2010 Mar 06
    View PubMed
  216. Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010 Jun; 8(6):498-503. Epub 2010 Mar 19.
    View PubMed
  217. Gururatsakul M, Holloway RH, Talley NJ, Holtmann GJ. Association between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunction. J Gastroenterol Hepatol. 2010 Jun; 25(6):1162-9.
    View PubMed
  218. Walter SA, Kjellstrom L, Nyhlin H, Talley NJ, Agreus L. Assessment of normal bowel habits in the general adult population: the Popcol study. Scand J Gastroenterol. 2010 May; 45(5):556-66.
    View PubMed
  219. Walter SA, Kjellstrom L, Nyhlin H, Talley NJ, Agreus L. Assessment of normal bowel habits in the general adult population: the Popcol study. Scand J Gastroenterol. 2010 May; 45(5):556-66.
    View PubMed
  220. Rubio-Tapia A, Talley NJ, Gurudu SR, Wu TT, Murray JA. Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol. 2010 Apr; 8 (4):344-349.e3 Epub 2010 Jan 06
    View PubMed
  221. Saito YA, Petersen GM, Larson JJ, Atkinson EJ, Fridley BL, de Andrade M, Locke GR 3rd, Zimmerman JM, Almazar-Elder AE, Talley NJ. Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol. 2010 Apr; 105(4):833-41. Epub 2010 Mar 16.
    View PubMed
  222. Saito YA, Petersen GM, Larson JJ, Atkinson EJ, Fridley BL, de Andrade M, Locke GR 3rd, Zimmerman JM, Almazar-Elder AE, Talley NJ. Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol. 2010 Apr; 105(4):833-41. Epub 2010 Mar 16.
    View PubMed
  223. Chang JY, Locke GR 3rd, McNally MA, Halder SL, Schleck CD, Zinsmeister AR, Talley NJ. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol. 2010 Apr; 105 (4):822-32 Epub 2010 Feb 16
    View PubMed
  224. Leise MD, Locke GR 3rd, Locke GR 3rd, Dierkhising RA, Zinsmeister AR, Reeder GS, Talley NJ. Patients dismissed from the hospital with a diagnosis of noncardiac chest pain: cardiac outcomes and health care utilization. Mayo Clin Proc. 2010 Apr; 85 (4):323-30 Epub 2010 Mar 01
    View PubMed
  225. Tack J, Talley NJ. Gastroduodenal disorders. Am J Gastroenterol. 2010 Apr; 105(4):757-63.
    View PubMed
  226. Chang JY, Locke GR 3rd, McNally MA, Halder SL, Schleck CD, Zinsmeister AR, Talley NJ. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol. 2010 Apr; 105 (4):822-32 Epub 2010 Feb 16
    View PubMed
  227. Leise MD, Locke GR 3rd, Locke GR 3rd, Dierkhising RA, Zinsmeister AR, Reeder GS, Talley NJ. Patients dismissed from the hospital with a diagnosis of noncardiac chest pain: cardiac outcomes and health care utilization. Mayo Clin Proc. 2010 Apr; 85 (4):323-30 Epub 2010 Mar 01
    View PubMed
  228. Rubio-Tapia A, Talley NJ, Gurudu SR, Wu TT, Murray JA. Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol. 2010 Apr; 8 (4):344-349.e3 Epub 2010 Jan 06
    View PubMed
  229. Tack J, Talley NJ. Gastroduodenal disorders. Am J Gastroenterol. 2010 Apr; 105(4):757-63.
    View PubMed
  230. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol. 2010 Mar; 105 (3):652-61 Epub 2009 Oct 27
    View PubMed
  231. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol. 2010 Mar; 105 (3):652-61 Epub 2009 Oct 27
    View PubMed
  232. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010 Mar; 59(3):325-32. Epub 2008 Dec 17.
    View PubMed
  233. Gururatsakul M, Holloway RH, Adam B, Liebregts T, Talley NJ, Holtmann GJ. The ageing gut: diminished symptom response to a standardized nutrient stimulus. Neurogastroenterol Motil. 2010 Mar; 22(3):246-e77. Epub 2009 Oct 08.
    View PubMed
  234. Haag S, Senf W, Tagay S, Heuft G, Gerken G, Talley NJ, Holtmann G. Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia? Neurogastroenterol Motil. 2010 Mar; 22(3):262-e79. Epub 2009 Oct 08.
    View PubMed
  235. Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol. 2010 Mar; 7(3):146-56. Epub 2010 Feb 02.
    View PubMed
  236. Gururatsakul M, Holloway RH, Adam B, Liebregts T, Talley NJ, Holtmann GJ. The ageing gut: diminished symptom response to a standardized nutrient stimulus. Neurogastroenterol Motil. 2010 Mar; 22(3):246-e77. Epub 2009 Oct 08.
    View PubMed
  237. Haag S, Senf W, Tagay S, Heuft G, Gerken G, Talley NJ, Holtmann G. Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia? Neurogastroenterol Motil. 2010 Mar; 22(3):262-e79. Epub 2009 Oct 08.
    View PubMed
  238. Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol. 2010 Mar; 7(3):146-56. Epub 2010 Feb 02.
    View PubMed
  239. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010 Mar; 59(3):325-32. Epub 2008 Dec 17.
    View PubMed
  240. Kephart GM, Alexander JA, Arora AS, Romero Y, Smyrk TC, Talley NJ, Kita H. Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. Am J Gastroenterol. 2010 Feb; 105 (2):298-307 Epub 2009 Nov 03
    View PubMed
  241. Kephart GM, Alexander JA, Arora AS, Romero Y, Smyrk TC, Talley NJ, Kita H. Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. Am J Gastroenterol. 2010 Feb; 105 (2):298-307 Epub 2009 Nov 03
    View PubMed
  242. Rey E, Choung RS, Schleck CD, Zinsmeister AR, Locke GR 3rd, Talley NJ. Onset and risk factors for fecal incontinence in a US community. Am J Gastroenterol. 2010 Feb; 105 (2):412-9 Epub 2009 Oct 20
    View PubMed
  243. Rey E, Choung RS, Schleck CD, Zinsmeister AR, Locke GR 3rd, Talley NJ. Onset and risk factors for fecal incontinence in a US community. Am J Gastroenterol. 2010 Feb; 105 (2):412-9 Epub 2009 Oct 20
    View PubMed
  244. Ford AC, Guyatt GH, Talley NJ, Moayyedi P. Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome. Am J Gastroenterol. 2010 Feb; 105(2):280-8. Epub 2009 Nov 17.
    View PubMed
  245. Ford AC, Guyatt GH, Talley NJ, Moayyedi P. Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome. Am J Gastroenterol. 2010 Feb; 105(2):280-8. Epub 2009 Nov 17.
    View PubMed
  246. Emmanuel AV, Tack J, Quigley EM, Talley NJ. Pharmacological management of constipation. Neurogastroenterol Motil. 2009 Dec; 21 Suppl 2:41-54.
    View PubMed
  247. Cook IJ, Talley NJ, Benninga MA, Rao SS, Scott SM. Chronic constipation: overview and challenges. Neurogastroenterol Motil. 2009 Dec; 21 Suppl 2:1-8.
    View PubMed
  248. Emmanuel AV, Tack J, Quigley EM, Talley NJ. Pharmacological management of constipation. Neurogastroenterol Motil. 2009 Dec; 21 Suppl 2:41-54.
    View PubMed
  249. Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report. Gastroenterology. 2009 Dec; 137(6):1944-53.e1-3. Epub 2009 Aug 23.
    View PubMed
  250. Cook IJ, Talley NJ, Benninga MA, Rao SS, Scott SM. Chronic constipation: overview and challenges. Neurogastroenterol Motil. 2009 Dec; 21 Suppl 2:1-8.
    View PubMed
  251. Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1279-86. Epub 2009 Aug 12.
    View PubMed
  252. Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report. Gastroenterology. 2009 Dec; 137(6):1944-53.e1-3. Epub 2009 Aug 23.
    View PubMed
  253. Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1279-86. Epub 2009 Aug 12.
    View PubMed
  254. Talley NJ. So you aspire to be a Professor? World J Gastroenterol. 2009 Nov 28; 15(44):5626-5627.
    View PubMed
  255. Talley NJ. So you aspire to be a Professor? World J Gastroenterol. 2009 Nov 28; 15(44):5626-5627.
    View PubMed
  256. Eslick GD, Kalantar JS, Talley NJ. Rectal bleeding: epidemiology, associated risk factors, and health care seeking behaviour: a population-based study. Colorectal Dis. 2009 Nov; 11(9):921-6. Epub 2008 Oct 21.
    View PubMed
  257. Eslick GD, Kalantar JS, Talley NJ. Rectal bleeding: epidemiology, associated risk factors, and health care seeking behaviour: a population-based study. Colorectal Dis. 2009 Nov; 11(9):921-6. Epub 2008 Oct 21.
    View PubMed
  258. Rey E, Talley NJ. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis. 2009 Nov; 41 (11):772-80 Epub 2009 Aug 08
    View PubMed
  259. Kennedy AT, Weiser KT, Crowell MD, Talley NJ, Lacy BE. Functional dyspepsia: Validation and results of a novel survey instrument to evaluate patient knowledge and perceptions. J Clin Gastroenterol. 2009 Nov-Dec; 43 (10):933-40
    View PubMed
  260. Rey E, Talley NJ. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis. 2009 Nov; 41 (11):772-80 Epub 2009 Aug 08
    View PubMed
  261. Kennedy AT, Weiser KT, Crowell MD, Talley NJ, Lacy BE. Functional dyspepsia: Validation and results of a novel survey instrument to evaluate patient knowledge and perceptions. J Clin Gastroenterol. 2009 Nov-Dec; 43 (10):933-40
    View PubMed
  262. Jiang X, Locke GR, Zinsmeister AR, Schleck CD, Talley NJ. Health care seeking for abdominal bloating and visible distention. Aliment Pharmacol Ther. 2009 Oct; 30 (7):775-83 Epub 2009 June 25
    View PubMed
  263. Talley NJ, Choung RS. Whither dyspepsia? A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009. J Gastroenterol Hepatol. 2009 Oct; 24 Suppl 3:S20-8
    View PubMed
  264. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA, Second Asia-Pacific Conference. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol. 2009 Oct; 24(10):1587-600.
    View PubMed
  265. Saito YA, Talley NJ. AJG series: molecular biology for clinicians. Am J Gastroenterol. 2009 Oct; 104 (10):2583-7 Epub 2009 June 23
    View PubMed
  266. Prasad GA, Alexander JA, Schleck CD, Zinsmeister AR, Smyrk TC, Elias RM, Locke GR 3rd, Talley NJ. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2009 Oct; 7 (10):1055-61 Epub 2009 July 01
    View PubMed
  267. Jiang X, Locke GR, Zinsmeister AR, Schleck CD, Talley NJ. Health care seeking for abdominal bloating and visible distention. Aliment Pharmacol Ther. 2009 Oct; 30 (7):775-83 Epub 2009 June 25
    View PubMed
  268. Talley NJ, Choung RS. Whither dyspepsia? A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009. J Gastroenterol Hepatol. 2009 Oct; 24 Suppl 3:S20-8
    View PubMed
  269. DeVault KR, Talley NJ. Insights into the future of gastric acid suppression. Nat Rev Gastroenterol Hepatol. 2009 Sep; 6 (9):524-32
    View PubMed
  270. Gathaiya N, Locke GR 3rd, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil. 2009 Sep; 21 (9):922-e69 Epub 2009 June 02
    View PubMed
  271. DeVault KR, Talley NJ. Insights into the future of gastric acid suppression. Nat Rev Gastroenterol Hepatol. 2009 Sep; 6 (9):524-32
    View PubMed
  272. Gathaiya N, Locke GR 3rd, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil. 2009 Sep; 21 (9):922-e69 Epub 2009 June 02
    View PubMed
  273. Vakil N, Talley N, van Zanten SV, Flook N, Persson T, Bjorck E, Lind T, Bolling-Sternevald E, STARS I Study Group. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol. 2009 Jul; 7(7):756-61. Epub 2009 Apr 10.
    View PubMed
  274. Aro P, Talley NJ, Ronkainen J, Storskrubb T, Vieth M, Johansson SE, Bolling-Sternevald E, Agreus L. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009 Jul; 137(1):94-100. Epub 2009 Mar 26.
    View PubMed
  275. Aro P, Talley NJ, Ronkainen J, Storskrubb T, Vieth M, Johansson SE, Bolling-Sternevald E, Agreus L. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009 Jul; 137(1):94-100. Epub 2009 Mar 26.
    View PubMed
  276. Vakil N, Talley N, van Zanten SV, Flook N, Persson T, Bjorck E, Lind T, Bolling-Sternevald E, STARS I Study Group. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol. 2009 Jul; 7(7):756-61. Epub 2009 Apr 10.
    View PubMed
  277. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule. Am J Gastroenterol. 2009 Jul; 104 (7):1772-9 Epub 2009 June 02
    View PubMed
  278. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule. Am J Gastroenterol. 2009 Jul; 104 (7):1772-9 Epub 2009 June 02
    View PubMed
  279. Talley NJ. Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia. Am J Gastroenterol. 2009 Jun; 104(6):1339-41.
    View PubMed
  280. Talley NJ. Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia. Am J Gastroenterol. 2009 Jun; 104(6):1339-41.
    View PubMed
  281. Goodwin RD, Keyes KM, Stein MB, Talley NJ. Peptic ulcer and mental disorders among adults in the community: the role of nicotine and alcohol use disorders. Psychosom Med. 2009 May; 71(4):463-8.
    View PubMed
  282. Goodwin RD, Keyes KM, Stein MB, Talley NJ. Peptic ulcer and mental disorders among adults in the community: the role of nicotine and alcohol use disorders. Psychosom Med. 2009 May; 71(4):463-8.
    View PubMed
  283. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study. Am J Gastroenterol. 2009 May; 104 (5):1199-204 Epub 2009 Apr 14
    View PubMed
  284. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study. Am J Gastroenterol. 2009 May; 104 (5):1199-204 Epub 2009 Apr 14
    View PubMed
  285. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, Mullan B, Talley NJ. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009 Apr; 136 (4):1225-33 Epub 2008 Dec 24
    View PubMed
  286. Almansa C, Krishna M, Buchner AM, Ghabril MS, Talley N, DeVault KR, Wolfsen H, Raimondo M, Guarderas JC, Achem SR. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009 Apr; 104 (4):828-33 Epub 2009 Feb 24
    View PubMed
  287. Walker MM, Talley NJ, Prabhakar M, Pennaneac'h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS, Zinsmeister AR, Agreus L. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009 Apr 1; 29(7):765-73. Epub 2009 Jan 17.
    View PubMed
  288. Almansa C, Krishna M, Buchner AM, Ghabril MS, Talley N, DeVault KR, Wolfsen H, Raimondo M, Guarderas JC, Achem SR. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009 Apr; 104 (4):828-33 Epub 2009 Feb 24
    View PubMed
  289. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, Mullan B, Talley NJ. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009 Apr; 136 (4):1225-33 Epub 2008 Dec 24
    View PubMed
  290. Walker MM, Talley NJ, Prabhakar M, Pennaneac'h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS, Zinsmeister AR, Agreus L. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009 Apr 1; 29(7):765-73. Epub 2009 Jan 17.
    View PubMed
  291. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond). 2009 Mar; 33 (3):342-53 Epub 2009 Jan 13
    View PubMed
  292. Talley NJ, Seon Choung R. Functional (non-ulcer) dyspepsia and gastroparesis--differentiating these conditions and practical management approaches. Rev Gastroenterol Disord. 2009 Spring; 9(2):E48-53.
    View PubMed
  293. Talley NJ, Seon Choung R. Functional (non-ulcer) dyspepsia and gastroparesis--differentiating these conditions and practical management approaches. Rev Gastroenterol Disord. 2009 Spring; 9(2):E48-53.
    View PubMed
  294. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond). 2009 Mar; 33 (3):342-53 Epub 2009 Jan 13
    View PubMed
  295. Saito YA, Strege PR, Tester DJ, Locke GR 3rd, Talley NJ, Bernard CE, Rae JL, Makielski JC, Ackerman MJ, Farrugia G. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy. Am J Physiol Gastrointest Liver Physiol. 2009 Feb; 296 (2):G211-8 Epub 2008 Dec 04
    View PubMed
  296. Cremonini F, Camilleri M, Zinsmeister AR, Herrick LM, Beebe T, Talley NJ. Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil. 2009 Feb; 21(2):128-35. Epub 2008 Sep 18.
    View PubMed
  297. Eslick GD, Talley NJ. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study. J Clin Gastroenterol. 2009 Feb; 43(2):111-7.
    View PubMed
  298. Cremonini F, Camilleri M, Zinsmeister AR, Herrick LM, Beebe T, Talley NJ. Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil. 2009 Feb; 21(2):128-35. Epub 2008 Sep 18.
    View PubMed
  299. Eslick GD, Talley NJ. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study. J Clin Gastroenterol. 2009 Feb; 43(2):111-7.
    View PubMed
  300. Saito YA, Strege PR, Tester DJ, Locke GR 3rd, Talley NJ, Bernard CE, Rae JL, Makielski JC, Ackerman MJ, Farrugia G. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy. Am J Physiol Gastrointest Liver Physiol. 2009 Feb; 296 (2):G211-8 Epub 2008 Dec 04
    View PubMed
  301. Rex DK, Talley NJ, Katz PO, Sandborn WJ, Hanauer SB. Report From the ACG: Highlights of the 72nd Annual Scientific Meeting of the American College of Gastroenterology, October 12-17, 2007, Philadelphia, PA. Rev Gastroenterol Disord. 2008 Winter; 8(1):42-57.
  302. Rex DK, Talley NJ, Katz PO, Sandborn WJ, Hanauer SB. Report From the ACG: Highlights of the 72nd Annual Scientific Meeting of the American College of Gastroenterology, October 12-17, 2007, Philadelphia, PA. Rev Gastroenterol Disord. 2008 Winter; 8(1):42-57.
  303. Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut. 2008 Nov; 57(11):1545-53. Epub 2008 Aug 01.
    View PubMed
  304. Talley NJ. Genetics and functional bowel disease. J Pediatr Gastroenterol Nutr. 2008 Nov; 47(5):680-2.
    View PubMed
  305. Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut. 2008 Nov; 57(11):1545-53. Epub 2008 Aug 01.
    View PubMed
  306. Bunch TJ, Packer DL, Jahangir A, Locke GR, Talley NJ, Gersh BJ, Roy RR, Hodge DO, Asirvatham SJ. Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. Am J Cardiol. 2008 Nov 1; 102 (9):1207-11 Epub 2008 Aug 27
    View PubMed
  307. Talley NJ. Genetics and functional bowel disease. J Pediatr Gastroenterol Nutr. 2008 Nov; 47(5):680-2.
    View PubMed
  308. Chitkara DK, Talley NJ, Schleck C, Zinsmeister AR, Shah ND, Locke GR. Recollection of childhood abdominal pain in adults with functional gastrointestinal disorders. Scan J Gastroenterol. 2008 Nov:1-7.
  309. Chitkara DK, Talley NJ, Schleck C, Zinsmeister AR, Shah ND, Locke GR. Recollection of childhood abdominal pain in adults with functional gastrointestinal disorders. Scan J Gastroenterol. 2008 Nov:1-7.
  310. Bunch TJ, Packer DL, Jahangir A, Locke GR, Talley NJ, Gersh BJ, Roy RR, Hodge DO, Asirvatham SJ. Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. Am J Cardiol. 2008 Nov 1; 102 (9):1207-11 Epub 2008 Aug 27
    View PubMed
  311. Ford AC, Talley NJ, Veldhuyzen van Zanten SJ, Vakil NB, Simel DL, Moayyedi P. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA. 2008 Oct 15; 300(15):1793-805.
    View PubMed
  312. Ford AC, Talley NJ, Veldhuyzen van Zanten SJ, Vakil NB, Simel DL, Moayyedi P. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA. 2008 Oct 15; 300(15):1793-805.
    View PubMed
  313. Quan C, Talley NJ, Jones MP, Howell S, Horowitz M. Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol. 2008 Sep; 20(9):888-97.
    View PubMed
  314. Eslick GD, Talley NJ. Natural history and predictors of outcome for non-cardiac chest pain: a prospective 4-year cohort study. Neurogastroenterol Motil. 2008 Sep; 20(9):989-97. Epub 2008 May 06.
    View PubMed
  315. Eslick GD, Talley NJ. Natural history and predictors of outcome for non-cardiac chest pain: a prospective 4-year cohort study. Neurogastroenterol Motil. 2008 Sep; 20(9):989-97. Epub 2008 May 06.
    View PubMed
  316. Quan C, Talley NJ, Jones MP, Howell S, Horowitz M. Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol. 2008 Sep; 20(9):888-97.
    View PubMed
  317. McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study. Aliment Pharmacol Ther. 2008 Aug 1; 28 (3):334-43
    View PubMed
  318. Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD, Kralstein J, Earnest DL, Ligozio G, Cohard-Radice M. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol. 2008 Aug; 103(8):1906-19. Epub 2008 Jul 04.
    View PubMed
  319. Quan C, Talley NJ, Jones MP, Spies J, Horowitz M. Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up. Am J Gastroenterol. 2008 Aug; 103(8):2023-30.
    View PubMed
  320. Jones MP, Talley NJ, Eslick GD, Dubois D, Tack J. Community subgroups in dyspepsia and their association with weight loss. Am J Gastroenterol. 2008 Aug; 103(8):2051-60.
    View PubMed
  321. Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD, Kralstein J, Earnest DL, Ligozio G, Cohard-Radice M. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol. 2008 Aug; 103(8):1906-19. Epub 2008 Jul 04.
    View PubMed
  322. Quan C, Talley NJ, Jones MP, Spies J, Horowitz M. Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up. Am J Gastroenterol. 2008 Aug; 103(8):2023-30.
    View PubMed
  323. Jones MP, Talley NJ, Eslick GD, Dubois D, Tack J. Community subgroups in dyspepsia and their association with weight loss. Am J Gastroenterol. 2008 Aug; 103(8):2051-60.
    View PubMed
  324. Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2008 Aug; 103 (8):2043-50
    View PubMed
  325. Saito YA, Talley NJ. Genetics of irritable bowel syndrome. Am J Gastroenterol. 2008 Aug; 103 (8):2100-4; quiz 2105 Epub 2008 July 05
    View PubMed
  326. McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study. Aliment Pharmacol Ther. 2008 Aug 1; 28 (3):334-43
    View PubMed
  327. Saito YA, Talley NJ. Genetics of irritable bowel syndrome. Am J Gastroenterol. 2008 Aug; 103 (8):2100-4; quiz 2105 Epub 2008 July 05
    View PubMed
  328. Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Sumiyama K, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Endoscopic "no hole" full-thickness biopsy of the stomach to detect myenteric ganglia. Gastrointest Endosc. 2008 Aug; 68 (2):301-7 Epub 2008 Feb 11
    View PubMed
  329. Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2008 Aug; 103 (8):2043-50
    View PubMed
  330. Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Sumiyama K, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Endoscopic "no hole" full-thickness biopsy of the stomach to detect myenteric ganglia. Gastrointest Endosc. 2008 Aug; 68 (2):301-7 Epub 2008 Feb 11
    View PubMed
  331. Shah ND, Chitkara DK, Locke GR, Meek PD, Talley NJ. Ambulatory care for constipation in the United States, 1993-2004. Am J Gastroenterol. 2008 Jul; 103 (7):1746-53 Epub 2008 June 28
    View PubMed
  332. Saito YA, Zimmerman JM, Harmsen WS, De Andrade M, Locke GR 3rd, Petersen GM, Talley NJ. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil. 2008 Jul; 20 (7):790-7
    View PubMed
  333. Saito YA, Zimmerman JM, Harmsen WS, De Andrade M, Locke GR 3rd, Petersen GM, Talley NJ. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil. 2008 Jul; 20 (7):790-7
    View PubMed
  334. Shah ND, Chitkara DK, Locke GR, Meek PD, Talley NJ. Ambulatory care for constipation in the United States, 1993-2004. Am J Gastroenterol. 2008 Jul; 103 (7):1746-53 Epub 2008 June 28
    View PubMed
  335. Talley NJ. Chronic unexplained diarrhea: what to do when the initial workup is negative? Rev Gastroenterol Disord. 2008 Summer; 8(3):178-85.
    View PubMed
  336. Walker MM, Talley NJ. Functional gastrointestinal disorders and the potential role of eosinophils. Gastroenterol Clin North Am. 2008 Jun; 37(2):383-95, vi.
    View PubMed
  337. Talley NJ. Chronic unexplained diarrhea: what to do when the initial workup is negative? Rev Gastroenterol Disord. 2008 Summer; 8(3):178-85.
    View PubMed
  338. Walker MM, Talley NJ. Functional gastrointestinal disorders and the potential role of eosinophils. Gastroenterol Clin North Am. 2008 Jun; 37(2):383-95, vi.
    View PubMed
  339. Talley NJ, Choung RS, Camilleri M, Dierkhising RA, Zinsmeister AR. Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther. 2008 Jun 1; 27 (11):1122-31 Epub 2008 Mar 07
    View PubMed
  340. Choung RS, Talley NJ. Epidemiology and clinical presentation of stress-related peptic damage and chronic peptic ulcer. Curr Mol Med. 2008 Jun; 8 (4):253-7
    View PubMed
  341. Prasad GA, Talley NJ. Eosinophilic esophagitis in adults. Gastroenterol Clin North Am. 2008 Jun; 37(2):349-68, v-vi.
    View PubMed
  342. Talley NJ. Gut eosinophilia in food allergy and systemic and autoimmune diseases. Gastroenterol Clin North Am. 2008 Jun; 37(2):307-32, v.
    View PubMed
  343. Talley NJ. Eosinophilic and autoimmune gastrointestinal disease: new insights and new entities. Preface. Gastroenterol Clin North Am. 2008 Jun; 37(2):xi-xii.
    View PubMed
  344. Talley NJ, Choung RS, Camilleri M, Dierkhising RA, Zinsmeister AR. Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther. 2008 Jun 1; 27 (11):1122-31 Epub 2008 Mar 07
    View PubMed
  345. Jiang X, Locke GR 3rd, Choung RS, Zinsmeister AR, Schleck CD, Talley NJ. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut. 2008 Jun; 57 (6):756-63
    View PubMed
  346. Choung RS, Talley NJ. Epidemiology and clinical presentation of stress-related peptic damage and chronic peptic ulcer. Curr Mol Med. 2008 Jun; 8 (4):253-7
    View PubMed
  347. Prasad GA, Talley NJ. Eosinophilic esophagitis in adults. Gastroenterol Clin North Am. 2008 Jun; 37(2):349-68, v-vi.
    View PubMed
  348. Talley NJ. Gut eosinophilia in food allergy and systemic and autoimmune diseases. Gastroenterol Clin North Am. 2008 Jun; 37(2):307-32, v.
    View PubMed
  349. Talley NJ. Eosinophilic and autoimmune gastrointestinal disease: new insights and new entities. Preface. Gastroenterol Clin North Am. 2008 Jun; 37(2):xi-xii.
    View PubMed
  350. Talley NJ, Tack J, Ptak T, Gupta R, Giguere M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut. 2008 Jun; 57 (6):740-6 Epub 2007 Oct 26
    View PubMed
  351. Jiang X, Locke GR 3rd, Choung RS, Zinsmeister AR, Schleck CD, Talley NJ. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut. 2008 Jun; 57 (6):756-63
    View PubMed
  352. Talley NJ, Tack J, Ptak T, Gupta R, Giguere M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut. 2008 Jun; 57 (6):740-6 Epub 2007 Oct 26
    View PubMed
  353. Stevens JE, Russo A, Maddox AF, Rayner CK, Phillips L, Talley NJ, Giguere M, Horowitz M, Jones KL. Effect of itopride on gastric emptying in longstanding diabetes mellitus. Neurogastroenterol Motil. 2008 May; 20(5):456-63. Epub 2008 Jan 07.
    View PubMed
  354. Eslick GD, Talley NJ. Dysphagia: epidemiology, risk factors and impact on quality of life--a population-based study. Aliment Pharmacol Ther. 2008 May; 27(10):971-9. Epub 2008 Feb 28.
    View PubMed
  355. Tuteja AK, Talley NJ, Joos SK, Tolman KG, Hickam DH. Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders. Am J Gastroenterol. 2008 May; 103(5):1241-8. Epub 2008 Apr 16.
    View PubMed
  356. Stevens JE, Russo A, Maddox AF, Rayner CK, Phillips L, Talley NJ, Giguere M, Horowitz M, Jones KL. Effect of itopride on gastric emptying in longstanding diabetes mellitus. Neurogastroenterol Motil. 2008 May; 20(5):456-63. Epub 2008 Jan 07.
    View PubMed
  357. Eslick GD, Talley NJ. Dysphagia: epidemiology, risk factors and impact on quality of life--a population-based study. Aliment Pharmacol Ther. 2008 May; 27(10):971-9. Epub 2008 Feb 28.
    View PubMed
  358. Tuteja AK, Talley NJ, Joos SK, Tolman KG, Hickam DH. Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders. Am J Gastroenterol. 2008 May; 103(5):1241-8. Epub 2008 Apr 16.
    View PubMed
  359. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil. 2008 May; 20 Suppl 1:121-9
    View PubMed
  360. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil. 2008 May; 20 Suppl 1:121-9
    View PubMed
  361. Haag S, Senf W, Hauser W, Tagay S, Grandt D, Heuft G, Gerken G, Talley NJ, Holtmann G. Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety. Aliment Pharmacol Ther. 2008 Apr 1; 27(7):561-71. Epub 2008 Jan 16.
    View PubMed
  362. Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ, Nehra V, Talley NJ. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg. 2008 Apr; 18 (4):401-7 Epub 2008 Feb 20
    View PubMed
  363. Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ, Nehra V, Talley NJ. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg. 2008 Apr; 18 (4):401-7 Epub 2008 Feb 20
    View PubMed
  364. Talley NJ. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol. 2008 Apr; 103 (4):820-2
    View PubMed
  365. Haag S, Senf W, Hauser W, Tagay S, Grandt D, Heuft G, Gerken G, Talley NJ, Holtmann G. Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety. Aliment Pharmacol Ther. 2008 Apr 1; 27(7):561-71. Epub 2008 Jan 16.
    View PubMed
  366. Talley NJ. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol. 2008 Apr; 103 (4):820-2
    View PubMed
  367. Talley NJ. Commentary: Controversies in NICE guidance on irritable bowel syndrome. BMJ. 2008 Mar 8; 336 (7643):558-9
    View PubMed
  368. Talley NJ. Commentary: Controversies in NICE guidance on irritable bowel syndrome. BMJ. 2008 Mar 8; 336 (7643):558-9
    View PubMed
  369. Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, Xiao SD, Lam SK, Goh KL, Chiba T, Uemura N, Kim JG, Kim N, Ang TL, Mahachai V, Mitchell H, Rani AA, Liou JM, Vilaichone RK, Sollano J, Asia-Pacific Gastric Cancer Consensus Conference. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol. 2008 Mar; 23(3):351-65.
    View PubMed
  370. Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008 Mar; 103 (3):510-4
    View PubMed
  371. Choung RS, Cremonini F, Thapa P, Zinsmeister AR, Talley NJ. The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. Neurogastroenterol Motil. 2008 Mar; 20 (3):220-7 Epub 2007 Nov 20
    View PubMed
  372. Choung RS, Ferguson DD, Murray JA, Kammer PP, Dierkhising RA, Zinsmeister AR, Nurbhai S, Landau SB, Talley NJ. A novel partial 5HT3 agonist DDP733 after a standard refluxogenic meal reduces reflux events: a randomized, double-blind, placebo-controlled pharmacodynamic study. Aliment Pharmacol Ther. 2008 Mar 1; 27 (5):404-11 Epub 2007 Dec 11
    View PubMed
  373. Choung RS, Cremonini F, Thapa P, Zinsmeister AR, Talley NJ. The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. Neurogastroenterol Motil. 2008 Mar; 20 (3):220-7 Epub 2007 Nov 20
    View PubMed
  374. Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008 Mar; 103 (3):510-4
    View PubMed
  375. Choung RS, Ferguson DD, Murray JA, Kammer PP, Dierkhising RA, Zinsmeister AR, Nurbhai S, Landau SB, Talley NJ. A novel partial 5HT3 agonist DDP733 after a standard refluxogenic meal reduces reflux events: a randomized, double-blind, placebo-controlled pharmacodynamic study. Aliment Pharmacol Ther. 2008 Mar 1; 27 (5):404-11 Epub 2007 Dec 11
    View PubMed
  376. Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, Xiao SD, Lam SK, Goh KL, Chiba T, Uemura N, Kim JG, Kim N, Ang TL, Mahachai V, Mitchell H, Rani AA, Liou JM, Vilaichone RK, Sollano J, Asia-Pacific Gastric Cancer Consensus Conference. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol. 2008 Mar; 23(3):351-65.
    View PubMed
  377. Moayyedi P, Burch N, Akhtar-Danesh N, Enaganti SK, Harrison R, Talley NJ, Jankowski J. Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther. 2008 Feb 15; 27(4):316-20. Epub 2007 Dec 06.
    View PubMed
  378. Moayyedi P, Burch N, Akhtar-Danesh N, Enaganti SK, Harrison R, Talley NJ, Jankowski J. Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther. 2008 Feb 15; 27(4):316-20. Epub 2007 Dec 06.
    View PubMed
  379. Hammer J, Talley NJ. Value of different diagnostic criteria for the irritable bowel syndrome among men and women. J Clin Gastroenterol. 2008 Feb; 42(2):160-6.
    View PubMed
  380. Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Levy MJ, Sumiyama K, de la Mora-Levy JG, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Evaluation of endoscopic approaches for deep gastric-muscle-wall biopsies: what works? Gastrointest Endosc. 2008 Feb; 67 (2):297-303 Epub 2007 Oct 29
    View PubMed
  381. Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Levy MJ, Sumiyama K, de la Mora-Levy JG, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Evaluation of endoscopic approaches for deep gastric-muscle-wall biopsies: what works? Gastrointest Endosc. 2008 Feb; 67 (2):297-303 Epub 2007 Oct 29
    View PubMed
  382. Hammer J, Talley NJ. Value of different diagnostic criteria for the irritable bowel syndrome among men and women. J Clin Gastroenterol. 2008 Feb; 42(2):160-6.
    View PubMed
  383. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther. 2007 Dec; 26 (11-12):1521-8 Epub 2007 Oct 05
    View PubMed
  384. Prasad GA, Talley NJ, Romero Y, Arora AS, Kryzer LA, Smyrk TC, Alexander JA. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 2007 Dec; 102 (12):2627-32 Epub 2007 Aug 31
    View PubMed
  385. Prasad GA, Talley NJ, Romero Y, Arora AS, Kryzer LA, Smyrk TC, Alexander JA. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 2007 Dec; 102 (12):2627-32 Epub 2007 Aug 31
    View PubMed
  386. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther. 2007 Dec; 26 (11-12):1521-8 Epub 2007 Oct 05
    View PubMed
  387. Chang JY, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic constipation and a possible role of analgesics. Neurogastroenterol Motil. 2007 Nov; 19(11):905-11.
    View PubMed
  388. Crane SJ, Talley NJ. Chronic gastrointestinal symptoms in the elderly. Clin Geriatr Med. 2007 Nov; 23(4):721-34, v.
    View PubMed
  389. Chang JY, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic constipation and a possible role of analgesics. Neurogastroenterol Motil. 2007 Nov; 19(11):905-11.
    View PubMed
  390. Crane SJ, Talley NJ. Chronic gastrointestinal symptoms in the elderly. Clin Geriatr Med. 2007 Nov; 23(4):721-34, v.
    View PubMed
  391. van Zanten SV, Flook N, Talley NJ, Vakil N, Lauritsen K, Bolling-Sternevald E, Persson T, Bjorck E, Svedberg LE, STARS II Study Group. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study. Aliment Pharmacol Ther. 2007 Sep 1; 26(5):665-72.
    View PubMed
  392. Talley NJ. Functional nausea and vomiting. Aust Fam Physician. 2007 Sep; 36(9):694-7.
    View PubMed
  393. Chitkara DK, Talley NJ, Locke GR 3rd, Weaver AL, Katusic SK, De Schepper H, Rucker MJ. Medical presentation of constipation from childhood to early adulthood: a population-based cohort study. Clin Gastroenterol Hepatol. 2007 Sep; 5(9):1059-64. Epub 2007 Jul 13.
    View PubMed
  394. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol. 2007 Sep; 102(9):1983-9. Epub 2007 Jun 20.
    View PubMed
  395. Talley NJ, Vakil N, Lauritsen K, van Zanten SV, Flook N, Bolling-Sternevald E, Persson T, Bjorck E, Lind T, STARS I Study Group. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response? Aliment Pharmacol Ther. 2007 Sep 1; 26(5):673-82.
    View PubMed
  396. Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007 Sep; 133 (3):799-807 Epub 2007 June 20
    View PubMed
  397. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol. 2007 Sep; 102(9):1983-9. Epub 2007 Jun 20.
    View PubMed
  398. van Zanten SV, Flook N, Talley NJ, Vakil N, Lauritsen K, Bolling-Sternevald E, Persson T, Bjorck E, Svedberg LE, STARS II Study Group. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study. Aliment Pharmacol Ther. 2007 Sep 1; 26(5):665-72.
    View PubMed
  399. Talley NJ, Vakil N, Lauritsen K, van Zanten SV, Flook N, Bolling-Sternevald E, Persson T, Bjorck E, Lind T, STARS I Study Group. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response? Aliment Pharmacol Ther. 2007 Sep 1; 26(5):673-82.
    View PubMed
  400. Talley NJ. Functional nausea and vomiting. Aust Fam Physician. 2007 Sep; 36(9):694-7.
    View PubMed
  401. Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007 Sep; 133 (3):799-807 Epub 2007 June 20
    View PubMed
  402. Chitkara DK, Talley NJ, Locke GR 3rd, Weaver AL, Katusic SK, De Schepper H, Rucker MJ. Medical presentation of constipation from childhood to early adulthood: a population-based cohort study. Clin Gastroenterol Hepatol. 2007 Sep; 5(9):1059-64. Epub 2007 Jul 13.
    View PubMed
  403. Halder SL, Talley NJ. Functional Dyspepsia: A New Rome III Paradigm. Curr Treat Options Gastroenterol. 2007 Aug; 10 (4):259-72
    View PubMed
  404. Halder SL, Talley NJ. Functional Dyspepsia: A New Rome III Paradigm. Curr Treat Options Gastroenterol. 2007 Aug; 10 (4):259-72
    View PubMed
  405. Crane SJ, Locke GR 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, Romero Y, Talley NJ. Subsite-specific risk factors for esophageal and gastric adenocarcinoma. Am J Gastroenterol. 2007 Aug; 102(8):1596-602. Epub 2007 Apr 24.
    View PubMed
  406. Jung HK, Halder S, McNally M, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther. 2007 Aug 1; 26 (3):453-61
    View PubMed
  407. Jung HK, Halder S, McNally M, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther. 2007 Aug 1; 26 (3):453-61
    View PubMed
  408. Crane SJ, Locke GR 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, Romero Y, Talley NJ. Subsite-specific risk factors for esophageal and gastric adenocarcinoma. Am J Gastroenterol. 2007 Aug; 102(8):1596-602. Epub 2007 Apr 24.
    View PubMed
  409. Cash BD, Chang E, Talley NJ, Wald A. Fresh perspectives in chronic constipation and other functional bowel disorders. Rev Gastroenterol Disord. 2007 Summer; 7(3):116-33.
    View PubMed
  410. Saito YA, Locke GR 3rd, Zimmerman JM, Holtmann G, Slusser JP, de Andrade M, Petersen GM, Talley NJ. A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil. 2007 Jun; 19(6):465-70.
    View PubMed
  411. Lembo A, Zaman M, Jones M, Talley NJ. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther. 2007 Jun 1; 25(11):1343-50.
    View PubMed
  412. Harrison R, Perry I, Haddadin W, McDonald S, Bryan R, Abrams K, Sampliner R, Talley NJ, Moayyedi P, Jankowski JA. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007 Jun; 102(6):1154-61. Epub 2007 Apr 13.
    View PubMed
  413. Cash BD, Chang E, Talley NJ, Wald A. Fresh perspectives in chronic constipation and other functional bowel disorders. Rev Gastroenterol Disord. 2007 Summer; 7(3):116-33.
    View PubMed
  414. Lembo A, Zaman M, Jones M, Talley NJ. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther. 2007 Jun 1; 25(11):1343-50.
    View PubMed
  415. Harrison R, Perry I, Haddadin W, McDonald S, Bryan R, Abrams K, Sampliner R, Talley NJ, Moayyedi P, Jankowski JA. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007 Jun; 102(6):1154-61. Epub 2007 Apr 13.
    View PubMed
  416. Saito YA, Locke GR 3rd, Zimmerman JM, Holtmann G, Slusser JP, de Andrade M, Petersen GM, Talley NJ. A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil. 2007 Jun; 19(6):465-70.
    View PubMed
  417. Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007 May; 5 (5):534-40 Epub 2007 Apr 11
    View PubMed
  418. Ronkainen J, Talley NJ, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Walker MM, Agreus L. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 2007 May; 56(5):615-20.
    View PubMed
  419. Ronkainen J, Talley NJ, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Walker MM, Agreus L. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 2007 May; 56(5):615-20.
    View PubMed
  420. Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007 May; 5 (5):534-40 Epub 2007 Apr 11
    View PubMed
  421. Haag S, Senf W, Tagay S, Langkafel M, Braun-Lang U, Pietsch A, Heuft G, Talley NJ, Holtmann G. Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther. 2007 Apr 15; 25(8):973-86.
    View PubMed
  422. Haag S, Senf W, Tagay S, Langkafel M, Braun-Lang U, Pietsch A, Heuft G, Talley NJ, Holtmann G. Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther. 2007 Apr 15; 25(8):973-86.
    View PubMed
  423. Hawkey CJ, Jones RH, Yeomans ND, Scheiman JM, Talley NJ, Goldstein JL, Ahlbom H, Naesdal J. Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2007 Apr 1; 25(7):813-21.
    View PubMed
  424. Hawkey CJ, Jones RH, Yeomans ND, Scheiman JM, Talley NJ, Goldstein JL, Ahlbom H, Naesdal J. Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2007 Apr 1; 25(7):813-21.
    View PubMed
  425. McNally MA, Talley NJ. Current treatments in functional dyspepsia. Curr Treat Options Gastroenterol. 2007 Mar; 10(2):157-68.
    View PubMed
  426. McNally MA, Talley NJ. Current treatments in functional dyspepsia. Curr Treat Options Gastroenterol. 2007 Mar; 10(2):157-68.
    View PubMed
  427. Talley NJ. Functional Gastrointestinal Disorders in 2007 and Rome III: something new, something borrowed, something objective. Rev Gastroenterol Disord. 2007 Spring; 7(2):97-105.
    View PubMed
  428. Choung RS, Talley NJ, Peterson J, Camilleri M, Burton D, Harmsen WS, Zinsmeister AR. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil. 2007 Mar; 19 (3):180-7
    View PubMed
  429. Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ, Holtmann G. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007 Mar; 132(3):913-20.
    View PubMed
  430. Talley NJ. Functional Gastrointestinal Disorders in 2007 and Rome III: something new, something borrowed, something objective. Rev Gastroenterol Disord. 2007 Spring; 7(2):97-105.
    View PubMed
  431. Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ, Holtmann G. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007 Mar; 132(3):913-20.
    View PubMed
  432. Choung RS, Talley NJ, Peterson J, Camilleri M, Burton D, Harmsen WS, Zinsmeister AR. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil. 2007 Mar; 19 (3):180-7
    View PubMed
  433. Crane SJ, Richard Locke G 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, Joseph Melton L 3rd, Romero Y, Talley NJ. The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther. 2007 Feb 15; 25 (4):447-53
    View PubMed
  434. Crane SJ, Richard Locke G 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, Joseph Melton L 3rd, Romero Y, Talley NJ. The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther. 2007 Feb 15; 25 (4):447-53
    View PubMed
  435. Richter JE, Talley NJ. American Journal of Gastroenterology 2006: The Best Clinical GI Journal in the World. Am J Gastroenterol. 2007 Feb; 102(2):229-31.
    View PubMed
  436. Richter JE, Talley NJ. American Journal of Gastroenterology 2006: The Best Clinical GI Journal in the World. Am J Gastroenterol. 2007 Feb; 102(2):229-31.
    View PubMed
  437. Chitkara DK, Talley NJ, Weaver AL, Katusic SK, De Schepper H, Rucker MJ, Locke GR 3rd. Incidence of presentation of common functional gastrointestinal disorders in children from birth to 5 years: a cohort study. Clin Gastroenterol Hepatol. 2007 Feb; 5 (2):186-91 Epub 2006 Aug 08
    View PubMed
  438. Liebregts T, Adam B, Bertel A, Lackner C, Neumann J, Talley NJ, Gerken G, Holtmann G. Psychological stress and the severity of post-inflammatory visceral hyperalgesia. Eur J Pain. 2007 Feb; 11(2):216-22.
    View PubMed
  439. Liebregts T, Adam B, Bertel A, Lackner C, Neumann J, Talley NJ, Gerken G, Holtmann G. Psychological stress and the severity of post-inflammatory visceral hyperalgesia. Eur J Pain. 2007 Feb; 11(2):216-22.
    View PubMed
  440. Chitkara DK, Talley NJ, Weaver AL, Katusic SK, De Schepper H, Rucker MJ, Locke GR 3rd. Incidence of presentation of common functional gastrointestinal disorders in children from birth to 5 years: a cohort study. Clin Gastroenterol Hepatol. 2007 Feb; 5 (2):186-91 Epub 2006 Aug 08
    View PubMed
  441. Crowell MD, Decker GA, Levy R, Jeffrey R, Talley NJ. Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity. Am J Gastroenterol. 2006 Dec; 101(12):2848-56; quiz 2914. Epub 2006 Oct 06.
    View PubMed
  442. Crowell MD, Decker GA, Levy R, Jeffrey R, Talley NJ. Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity. Am J Gastroenterol. 2006 Dec; 101(12):2848-56; quiz 2914. Epub 2006 Oct 06.
    View PubMed
  443. Halder SL, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Influence of alcohol consumption on IBS and dyspepsia. Neurogastroenterol Motil. 2006 Nov; 18(11):1001-8.
    View PubMed
  444. Talley NJ. Irritable bowel syndrome. Intern Med J. 2006 Nov; 36 (11):724-8
    View PubMed
  445. Chitkara DK, Van Tilburg M, Whitehead WE, Talley NJ. Teaching diaphragmatic breathing for rumination syndrome. Am J Gastroenterol. 2006 Nov; 101(11):2449-52.
    View PubMed
  446. Chitkara DK, Van Tilburg M, Whitehead WE, Talley NJ. Teaching diaphragmatic breathing for rumination syndrome. Am J Gastroenterol. 2006 Nov; 101(11):2449-52.
    View PubMed
  447. Cremonini F, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil. 2006 Nov; 18(11):987-94.
    View PubMed
  448. Halder SL, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Influence of alcohol consumption on IBS and dyspepsia. Neurogastroenterol Motil. 2006 Nov; 18(11):1001-8.
    View PubMed
  449. Cremonini F, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil. 2006 Nov; 18(11):987-94.
    View PubMed
  450. Talley NJ. Irritable bowel syndrome. Intern Med J. 2006 Nov; 36 (11):724-8
    View PubMed
  451. Talley NJ, Camilleri M, Burton D, Thomforde G, Koch K, Rucker MJ, Peterson J, Zinsmeister AR, Earnest DL. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Aliment Pharmacol Ther. 2006 Sep 1; 24 (5):859-67
    View PubMed
  452. Talley NJ, Camilleri M, Burton D, Thomforde G, Koch K, Rucker MJ, Peterson J, Zinsmeister AR, Earnest DL. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Aliment Pharmacol Ther. 2006 Sep 1; 24 (5):859-67
    View PubMed
  453. Storskrubb T, Aro P, Ronkainen J, Wreiber K, Nyhlin H, Bolling-Sternevald E, Talley NJ, Engstrand L, Agreus L. Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population. Helicobacter. 2006 Aug; 11(4):224-30.
    View PubMed
  454. Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006 Aug; 131(2):390-401; quiz 659-60.
    View PubMed
  455. Storskrubb T, Aro P, Ronkainen J, Wreiber K, Nyhlin H, Bolling-Sternevald E, Talley NJ, Engstrand L, Agreus L. Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population. Helicobacter. 2006 Aug; 11(4):224-30.
    View PubMed
  456. Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006 Aug; 131(2):390-401; quiz 659-60.
    View PubMed
  457. Talley NJ, Armstrong D, Junghard O, Wiklund I. Predictors of treatment response in patients with non-erosive reflux disease. Aliment Pharmacol Ther. 2006 Jul 15; 24 (2):371-6
    View PubMed
  458. Hammer J, Talley NJ. Disturbed bowel habits in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006 Jul 15; 24(2):405-10.
    View PubMed
  459. Talley NJ, Armstrong D, Junghard O, Wiklund I. Predictors of treatment response in patients with non-erosive reflux disease. Aliment Pharmacol Ther. 2006 Jul 15; 24 (2):371-6
    View PubMed
  460. Hammer J, Talley NJ. Disturbed bowel habits in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006 Jul 15; 24(2):405-10.
    View PubMed
  461. Chitkara DK, Bredenoord AJ, Talley NJ, Whitehead WE. Aerophagia and rumination: recognition and therapy. Curr Treat Options Gastroenterol. 2006 Jul; 9(4):305-13.
    View PubMed
  462. Chitkara DK, Bredenoord AJ, Talley NJ, Whitehead WE. Aerophagia and rumination: recognition and therapy. Curr Treat Options Gastroenterol. 2006 Jul; 9(4):305-13.
    View PubMed
  463. Talley NJ. Overlapping abdominal symptoms: why do GERD and IBS often coexist? Drugs Today (Barc). 2006 Jul; 42 Suppl B:3-8.
    View PubMed
  464. Talley NJ. Overlapping abdominal symptoms: why do GERD and IBS often coexist? Drugs Today (Barc). 2006 Jul; 42 Suppl B:3-8.
    View PubMed
  465. Vakil N, Talley NJ, Stolte M, Sundin M, Junghard O, Bolling-Sternevald E. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006 Jul 1; 24(1):55-63.
    View PubMed
  466. Talley NJ, Locke GR, Lahr BD, Zinsmeister AR, Tougas G, Ligozio G, Rojavin MA, Tack J. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut. 2006 Jul; 55 (7):933-9 Epub 2005 Dec 01
    View PubMed
  467. Talley NJ, Locke GR, Lahr BD, Zinsmeister AR, Tougas G, Ligozio G, Rojavin MA, Tack J. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut. 2006 Jul; 55 (7):933-9 Epub 2005 Dec 01
    View PubMed
  468. Vakil N, Talley NJ, Stolte M, Sundin M, Junghard O, Bolling-Sternevald E. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006 Jul 1; 24(1):55-63.
    View PubMed
  469. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006 Jun 24; 367(9528):2086-100.
    View PubMed
  470. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006 Jun 24; 367(9528):2086-100.
    View PubMed
  471. Ronkainen J, Aro P, Storskrubb T, Lind T, Bolling-Sternevald E, Junghard O, Talley NJ, Agreus L. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther. 2006 Jun 15; 23(12):1725-33.
    View PubMed
  472. Choung RS, Locke GR 3rd, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Alternating bowel pattern: what do people mean? Aliment Pharmacol Ther. 2006 Jun 15; 23 (12):1749-55
    View PubMed
  473. Ronkainen J, Aro P, Storskrubb T, Lind T, Bolling-Sternevald E, Junghard O, Talley NJ, Agreus L. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther. 2006 Jun 15; 23(12):1725-33.
    View PubMed
  474. Choung RS, Locke GR 3rd, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Alternating bowel pattern: what do people mean? Aliment Pharmacol Ther. 2006 Jun 15; 23 (12):1749-55
    View PubMed
  475. Hanauer SB, Sandborn WJ, Vakil N, Katz PO, Talley NJ, Rex DK, Hawes RH, Guda NM, Freeman ML, Keeffe EB, Balart LA. Best of DDW 2006. Rev Gastroenterol Disord. 2006 Summer; 6(3):153-89.
    View PubMed
  476. Hanauer SB, Sandborn WJ, Vakil N, Katz PO, Talley NJ, Rex DK, Hawes RH, Guda NM, Freeman ML, Keeffe EB, Balart LA. Best of DDW 2006. Rev Gastroenterol Disord. 2006 Summer; 6(3):153-89.
    View PubMed
  477. Howell SC, Quine S, Talley NJ. Low social class is linked to upper gastrointestinal symptoms in an Australian sample of urban adults. Scand J Gastroenterol. 2006 Jun; 41(6):657-66.
    View PubMed
  478. Saito YA, Talley NJ, de Andrade M, Petersen GM. Case-control genetic association studies in gastrointestinal disease: review and recommendations. Am J Gastroenterol. 2006 Jun; 101(6):1379-89.
    View PubMed
  479. Andresen V, Camilleri M, Kim HJ, Stephens DA, Carlson PJ, Talley NJ, Saito YA, Urrutia R, Zinsmeister AR. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology. 2006 Jun; 130(7):1985-94.
    View PubMed
  480. Aro P, Storskrubb T, Ronkainen J, Bolling-Sternevald E, Engstrand L, Vieth M, Stolte M, Talley NJ, Agreus L. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol. 2006 Jun 1; 163(11):1025-34. Epub 2006 Mar 22.
    View PubMed
  481. Saito YA, Talley NJ, de Andrade M, Petersen GM. Case-control genetic association studies in gastrointestinal disease: review and recommendations. Am J Gastroenterol. 2006 Jun; 101(6):1379-89.
    View PubMed
  482. Andresen V, Camilleri M, Kim HJ, Stephens DA, Carlson PJ, Talley NJ, Saito YA, Urrutia R, Zinsmeister AR. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology. 2006 Jun; 130(7):1985-94.
    View PubMed
  483. Aro P, Storskrubb T, Ronkainen J, Bolling-Sternevald E, Engstrand L, Vieth M, Stolte M, Talley NJ, Agreus L. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol. 2006 Jun 1; 163(11):1025-34. Epub 2006 Mar 22.
    View PubMed
  484. Howell SC, Quine S, Talley NJ. Low social class is linked to upper gastrointestinal symptoms in an Australian sample of urban adults. Scand J Gastroenterol. 2006 Jun; 41(6):657-66.
    View PubMed
  485. Design of Treatment Trials Committee, Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, Veldhuyzen van Zanten SJ. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology. 2006 Apr; 130(5):1538-51.
    View PubMed
  486. Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FK, Tulassay Z, Rainoldi JL, Szczepanski L, Ung KA, Kleczkowski D, Ahlbom H, Naesdal J, Hawkey C. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol. 2006 Apr; 101(4):701-10. Epub 2006 Feb 22.
    View PubMed
  487. Design of Treatment Trials Committee, Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, Veldhuyzen van Zanten SJ. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology. 2006 Apr; 130(5):1538-51.
    View PubMed
  488. Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FK, Tulassay Z, Rainoldi JL, Szczepanski L, Ung KA, Kleczkowski D, Ahlbom H, Naesdal J, Hawkey C. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol. 2006 Apr; 101(4):701-10. Epub 2006 Feb 22.
    View PubMed
  489. Tally NJ. Chronic constipation and irritable bowel syndrome: epidemiology, presentation, and diagnosis... includes discussion. Advanced Studies in Medicine. 2006 Apr; 6(4A):S225-31, S251-3.
  490. Talley NJ. How effective is fluoxetine for the treatment of pain and constipation-predominant irritable bowel syndrome? Nat Clin Pract Gastroenterol Hepatol. 2006 Apr; 3(4):196-7.
    View PubMed
  491. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006 Apr; 130(5):1466-79.
    View PubMed
  492. Talley NJ, Locke GR, Lahr BD, Zinsmeister AR, Cohard-Radice M, D'Elia TV, Tack J, Earnest DL. Predictors of the placebo response in functional dyspepsia. Aliment Pharmacol Ther. 2006 Apr 1; 23(7):923-36.
    View PubMed
  493. Talley NJ, Locke GR, Lahr BD, Zinsmeister AR, Cohard-Radice M, D'Elia TV, Tack J, Earnest DL. Predictors of the placebo response in functional dyspepsia. Aliment Pharmacol Ther. 2006 Apr 1; 23(7):923-36.
    View PubMed
  494. Talley NJ. How effective is fluoxetine for the treatment of pain and constipation-predominant irritable bowel syndrome? Nat Clin Pract Gastroenterol Hepatol. 2006 Apr; 3(4):196-7.
    View PubMed
  495. Tally NJ. Chronic constipation and irritable bowel syndrome: epidemiology, presentation, and diagnosis... includes discussion. Advanced Studies in Medicine. 2006 Apr; 6(4A):S225-31, S251-3.
  496. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006 Apr; 130(5):1466-79.
    View PubMed
  497. Malfertheiner P, Fass R, Quigley EM, Modlin IM, Malagelada JR, Moss SF, Holtmann G, Goh KL, Katelaris P, Stanghellini V, Talley NJ, Tytgat GN, Wright NA. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression. Aliment Pharmacol Ther. 2006 Mar 15; 23(6):683-90.
    View PubMed
  498. Malfertheiner P, Fass R, Quigley EM, Modlin IM, Malagelada JR, Moss SF, Holtmann G, Goh KL, Katelaris P, Stanghellini V, Talley NJ, Tytgat GN, Wright NA. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression. Aliment Pharmacol Ther. 2006 Mar 15; 23(6):683-90.
    View PubMed
  499. Talley NJ. A unifying hypothesis for the functional gastrointestinal disorders: really multiple diseases or one irritable gut? Rev Gastroenterol Disord. 2006 Spring; 6(2):72-8.
    View PubMed
  500. Talley NJ. A unifying hypothesis for the functional gastrointestinal disorders: really multiple diseases or one irritable gut? Rev Gastroenterol Disord. 2006 Spring; 6(2):72-8.
    View PubMed
  501. Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med. 2006 Feb 23; 354(8):832-40.
    View PubMed
  502. Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med. 2006 Feb 23; 354(8):832-40.
    View PubMed
  503. Talley NJ, Richter J. Nobel Prize in Medicine awarded to a Gastroenterologist in 2005. Am J Gastroenterol. 2006 Feb; 101(2):211.
    View PubMed
  504. Talley NJ, Richter J. Nobel Prize in Medicine awarded to a Gastroenterologist in 2005. Am J Gastroenterol. 2006 Feb; 101(2):211.
    View PubMed
  505. Talley NJ. Differentiating functional constipation from constipation-predominant irritable bowel syndrome: management implications. Rev Gastroenterol Disord. 2005 Winter; 5 (1):1-9
    View PubMed
  506. Saito YA, Locke GR, Weaver AL, Zinsmeister AR, Talley NJ. Diet and functional gastrointestinal disorders: a population-based case-control study. Am J Gastroenterol. 2005 Dec; 100 (12):2743-8
    View PubMed
  507. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agreus L. Prevalence of Barrett's esophagus in the general population: An endoscopic study. Gastroenterology. 2005 Dec; 129(6):1825-31.
    View PubMed
  508. Saito YA, Locke GR, Weaver AL, Zinsmeister AR, Talley NJ. Diet and functional gastrointestinal disorders: a population-based case-control study. Am J Gastroenterol. 2005 Dec; 100 (12):2743-8
    View PubMed
  509. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agreus L. Prevalence of Barrett's esophagus in the general population: An endoscopic study. Gastroenterology. 2005 Dec; 129(6):1825-31.
    View PubMed
  510. Talley N. Stop your intestines from rebelling. Bottom Line/Health. 2005 Dec; 19(12):5-6.
  511. Talley N. Stop your intestines from rebelling. Bottom Line/Health. 2005 Dec; 19(12):5-6.
  512. Talley NJ. Differentiating functional constipation from constipation-predominant irritable bowel syndrome: management implications. Rev Gastroenterol Disord. 2005 Winter; 5 (1):1-9
    View PubMed
  513. Wise JL, Locke GR, Zinsmeister AR, Talley NJ. Risk factors for non-cardiac chest pain in the community. Aliment Pharmacol Ther. 2005 Nov 15; 22 (10):1023-31
    View PubMed
  514. Wise JL, Locke GR, Zinsmeister AR, Talley NJ. Risk factors for non-cardiac chest pain in the community. Aliment Pharmacol Ther. 2005 Nov 15; 22 (10):1023-31
    View PubMed
  515. Saito YA, Petersen GM, Locke GR 3rd, Locke GR, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005 Nov; 3 (11):1057-65
    View PubMed
  516. Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005 Nov; 129 (5):1756-80
    View PubMed
  517. Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005 Nov; 129 (5):1756-80
    View PubMed
  518. Saito YA, Petersen GM, Locke GR 3rd, Locke GR, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005 Nov; 3 (11):1057-65
    View PubMed
  519. Yeomans ND, Lanas AI, Talley NJ, Thomson ABR, Daneshjoo R, Eriksson B, Appelman-Eszczuk S, Langstrom G, Naesdal J, Serrano P, Singh M, Skelly MM, Hawkey CJ. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther. 2005 Nov 1; 22(9):795-801.
    View PubMed
  520. Chitkara DK, Bredenoord AJ, Rucker MJ, Talley NJ. Aerophagia in adults: a comparison with functional dyspepsia. Aliment Pharmacol Ther2005 Nov 1; 22(9):855-8.
    View PubMed
  521. Yeomans ND, Lanas AI, Talley NJ, Thomson ABR, Daneshjoo R, Eriksson B, Appelman-Eszczuk S, Langstrom G, Naesdal J, Serrano P, Singh M, Skelly MM, Hawkey CJ. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther. 2005 Nov 1; 22(9):795-801.
    View PubMed
  522. Chitkara DK, Bredenoord AJ, Rucker MJ, Talley NJ. Aerophagia in adults: a comparison with functional dyspepsia. Aliment Pharmacol Ther2005 Nov 1; 22(9):855-8.
    View PubMed
  523. Howell S, Poulton R, Talley NJ. The natural history of childhood abdominal pain and its association with adult irritable bowel syndrome: Birth-cohort study. Am J Gastroenterol. 2005 Sep; 100(9):2071-8.
    View PubMed
  524. Howell S, Poulton R, Talley NJ. The natural history of childhood abdominal pain and its association with adult irritable bowel syndrome: Birth-cohort study. Am J Gastroenterol. 2005 Sep; 100(9):2071-8.
    View PubMed
  525. Ahlawat SK, Richard Locke G, Weaver AL, Farmer SA, Yawn BP, Talley NJ. Dyspepsia consulters and patterns of management: a population-based study. Aliment Pharmacol Ther. 2005 Aug 1; 22 (3):251-9
    View PubMed
  526. Ahlawat SK, Richard Locke G, Weaver AL, Farmer SA, Yawn BP, Talley NJ. Dyspepsia consulters and patterns of management: a population-based study. Aliment Pharmacol Ther. 2005 Aug 1; 22 (3):251-9
    View PubMed
  527. Fajardo NR, Cremonini F, Talley NJ. Frontiers in functional dyspepsia. Curr Gastroenterol Rep. 2005 Aug; 7 (4):289-96
    View PubMed
  528. Halder SL, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2005 Aug; 8 (4):325-36
    View PubMed
  529. Fajardo NR, Cremonini F, Talley NJ. Frontiers in functional dyspepsia. Curr Gastroenterol Rep. 2005 Aug; 7 (4):289-96
    View PubMed
  530. Burton DD, Kim HJ, Camilleri M, Stephens DA, Mullan BP, O'Connor MK, Talley NJ. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol. 2005 Aug; 289: (2)G261-6.
    View PubMed
  531. Halder SL, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2005 Aug; 8 (4):325-36
    View PubMed
  532. Chitkara DK, Bredenood AJ, Wang M, Rucker MJ, Talley NJ. Aerophagia in children: characterization of a functional gastrointestinal disorder. Neurogastroenterol Motil. 2005 Aug; 17(4):518-22.
    View PubMed
  533. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in western countries: A systematic review. Am J Gastroenterol. 2005 Aug; 100(8):1868-75.
    View PubMed
  534. Chitkara DK, Bredenood AJ, Wang M, Rucker MJ, Talley NJ. Aerophagia in children: characterization of a functional gastrointestinal disorder. Neurogastroenterol Motil. 2005 Aug; 17(4):518-22.
    View PubMed
  535. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in western countries: A systematic review. Am J Gastroenterol. 2005 Aug; 100(8):1868-75.
    View PubMed
  536. Burton DD, Kim HJ, Camilleri M, Stephens DA, Mullan BP, O'Connor MK, Talley NJ. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol. 2005 Aug; 289: (2)G261-6.
    View PubMed
  537. Nandurkar S, Locke GR 3rd, Murray JA, Melton LJ 3rd, Zinsmeister AR, Dierkhising R, Talley NJ. Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol. 2005 Jul; 100(7):1459-65.
    View PubMed
  538. Nandurkar S, Locke GR 3rd, Murray JA, Melton LJ 3rd, Zinsmeister AR, Dierkhising R, Talley NJ. Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol. 2005 Jul; 100(7):1459-65.
    View PubMed
  539. Fawcett JP, Barbezat GO, Poulton R, Milne BJ, Xia HH, Talley NJ. Helicobacter pylori serology in a birth cohort of New Zealanders from age 11 to 26. World J Gastroenterol. 2005 Jun 7; 11(21):3273-6.
    View PubMed
  540. Fawcett JP, Barbezat GO, Poulton R, Milne BJ, Xia HH, Talley NJ. Helicobacter pylori serology in a birth cohort of New Zealanders from age 11 to 26. World J Gastroenterol. 2005 Jun 7; 11(21):3273-6.
    View PubMed
  541. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am. 2005 Jun; 34(2):189-204.
    View PubMed
  542. Cremonini F, Wise J, Moayyedi P, Talley NJ. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol. 2005 Jun; 100(6):1226-32.
    View PubMed
  543. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005 Jun; 3 (6):543-52
    View PubMed
  544. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005 Jun; 3 (6):543-52
    View PubMed
  545. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am. 2005 Jun; 34(2):189-204.
    View PubMed
  546. Cremonini F, Wise J, Moayyedi P, Talley NJ. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol. 2005 Jun; 100(6):1226-32.
    View PubMed
  547. Hawkey C, Talley NJ, Yeomans ND, Jones R, Sung JJY, Langstrom G, Naesdal J, Scheiman JM. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors. Am J Gastroenterol. 2005 May; 100(5):1028-36.
    View PubMed
  548. Hawkey C, Talley NJ, Yeomans ND, Jones R, Sung JJY, Langstrom G, Naesdal J, Scheiman JM. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors. Am J Gastroenterol. 2005 May; 100(5):1028-36.
    View PubMed
  549. Locke GR 3rd, Zinsmeister AR, Fett SL, Melton LJ 3rd, Talley NJ. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil. 2005 Feb; 17 (1):29-34
    View PubMed
  550. Kamm MA, Muller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, Hugot-Cournez S, Nault B. Tegaserod for the treatment of chronic constipation: A randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol. 2005 Feb; 100(2):362-72.
    View PubMed
  551. Talley NJ, Wiklund I. Patient reported outcomes in gastroesophageal reflux disease: an overview of available measures. Qual Life Res. 2005 Feb; 14 (1):21-33
    View PubMed
  552. Locke GR 3rd, Zinsmeister AR, Fett SL, Melton LJ 3rd, Talley NJ. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil. 2005 Feb; 17 (1):29-34
    View PubMed
  553. Cuddihy MT, Locke GR, Wahner-Roedler D, Dierkhising R, Zinsmeister AR, Long KH, Talley NJ. Dyspepsia management in primary care: a management trial. Int J Clin Pract. 2005 Feb; 59(2):194-201.
    View PubMed
  554. Kamm MA, Muller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, Hugot-Cournez S, Nault B. Tegaserod for the treatment of chronic constipation: A randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol. 2005 Feb; 100(2):362-72.
    View PubMed
  555. Talley NJ, Wiklund I. Patient reported outcomes in gastroesophageal reflux disease: an overview of available measures. Qual Life Res. 2005 Feb; 14 (1):21-33
    View PubMed
  556. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scand J Gastroenterol. 2005 Feb; 40(3):275-85.
    View PubMed
  557. Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, Engstrand L, Nyhlin H, Bolling-Sternevald E, Talley NJ, Agreus L. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H-pylori infection: A report on histology and H-pylori detection in the general adult population. Scand J Gastroenterol. 2005 Feb; 40(3):302-11.
    View PubMed
  558. Cremonini F, Talley NJ. Treatments targeting putative mechanisms in irritable bowel syndrome. Nat Clin Pract Gastroenterol Hepatol. 2005 Feb; 2(2):82-8.
    View PubMed
  559. Cremonini F, Talley NJ. Treatments targeting putative mechanisms in irritable bowel syndrome. Nat Clin Pract Gastroenterol Hepatol. 2005 Feb; 2(2):82-8.
    View PubMed
  560. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scand J Gastroenterol. 2005 Feb; 40(3):275-85.
    View PubMed
  561. Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, Engstrand L, Nyhlin H, Bolling-Sternevald E, Talley NJ, Agreus L. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H-pylori infection: A report on histology and H-pylori detection in the general adult population. Scand J Gastroenterol. 2005 Feb; 40(3):302-11.
    View PubMed
  562. Cuddihy MT, Locke GR, Wahner-Roedler D, Dierkhising R, Zinsmeister AR, Long KH, Talley NJ. Dyspepsia management in primary care: a management trial. Int J Clin Pract. 2005 Feb; 59(2):194-201.
    View PubMed
  563. de la Loge C, Trudeau E, Marquis P, Kahrilas P, Stanghellini V, Talley NJ, Tack J, Revicki DA, Rentz AM, Dubois D. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res. 2004 Dec; 13(10):1751-62.
    View PubMed
  564. Rentz AM, Kahrilas P, Stanghellini V, Tack J, Talley NJ, de la Loge C, Trudeau E, Dubois D, Revicki DA. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004 Dec; 13(10):1737-49.
    View PubMed
  565. de la Loge C, Trudeau E, Marquis P, Kahrilas P, Stanghellini V, Talley NJ, Tack J, Revicki DA, Rentz AM, Dubois D. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res. 2004 Dec; 13(10):1751-62.
    View PubMed
  566. Rentz AM, Kahrilas P, Stanghellini V, Tack J, Talley NJ, de la Loge C, Trudeau E, Dubois D, Revicki DA. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004 Dec; 13(10):1737-49.
    View PubMed
  567. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Svardsudd K, Talley NJ, Junghard O, Johansson SE, Wiklund I, Agreus L. Validation of the translation and cross-cultural adaptation into Finnish of the Abdominal Symptom Questionnaire, the Hospital Anxiety and Depression Scale and the Complaint Score Questionnaire. Scand J Gastroenterol. 2004 Dec; 39(12):1201-8.
    View PubMed
  568. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson SE, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol. 2004 Dec; 39(12):1280-8.
    View PubMed
  569. Talley NJ. Management of chronic constipation. Reviews in Gastroenterological Disorders. 2004 Win; 4(1):18-24.
  570. Vege SS, Locke GR 3rd, Weaver AL, Farmer SA, Melton LJ 3rd, Talley NJ. Functional gastrointestinal disorders among people with sleep disturbances: a population-based study. Mayo Clin Proc. 2004 Dec; 79(12):1501-6.
    View PubMed
  571. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Svardsudd K, Talley NJ, Junghard O, Johansson SE, Wiklund I, Agreus L. Validation of the translation and cross-cultural adaptation into Finnish of the Abdominal Symptom Questionnaire, the Hospital Anxiety and Depression Scale and the Complaint Score Questionnaire. Scand J Gastroenterol. 2004 Dec; 39(12):1201-8.
    View PubMed
  572. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson SE, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol. 2004 Dec; 39(12):1280-8.
    View PubMed
  573. Vege SS, Locke GR 3rd, Weaver AL, Farmer SA, Melton LJ 3rd, Talley NJ. Functional gastrointestinal disorders among people with sleep disturbances: a population-based study. Mayo Clin Proc. 2004 Dec; 79(12):1501-6.
    View PubMed
  574. Talley NJ. Management of chronic constipation. Reviews in Gastroenterological Disorders. 2004 Win; 4(1):18-24.
  575. Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ. The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology. 2004 Nov; 127(5):1329-37.
    View PubMed
  576. Cremonini F, Talley NJ. Review article: the overlap between functional dyspepsia and irritable bowel syndrome -- a tale of one or two disorders? Aliment Pharmacol Ther. 2004 Nov; 20 Suppl 7:40-9
    View PubMed
  577. Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ. The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology. 2004 Nov; 127(5):1329-37.
    View PubMed
  578. Cremonini F, Talley NJ. Review article: the overlap between functional dyspepsia and irritable bowel syndrome -- a tale of one or two disorders? Aliment Pharmacol Ther. 2004 Nov; 20 Suppl 7:40-9
    View PubMed
  579. Eslick GD, Talley NJ. Non-cardiac chest pain: predictors of health care seeking, the types of health care professional consulted, work absenteeism and interruption of daily activities. Alimentary Pharmacology & Therapeutics. 2004 Oct 15; 20(8):909-15.
    View PubMed
  580. Eslick GD, Talley NJ. Non-cardiac chest pain: predictors of health care seeking, the types of health care professional consulted, work absenteeism and interruption of daily activities. Alimentary Pharmacology & Therapeutics. 2004 Oct 15; 20(8):909-15.
    View PubMed
  581. Delgado-Aros S, Locke GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004 Sep; 99 (9):1801-6
    View PubMed
  582. Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: A birth cohort study. Am J Gastroenterol. 2004 Sep; 99(9):1807-14.
    View PubMed
  583. Nandurkar S, Locke GR, Fett S, Zinsmeister AR, Cameron AJ, Talley NJ. Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther. 2004 Sep 1; 20 (5):497-505
    View PubMed
  584. Friedrich WN, Whiteside SP, Talley NJ. Noncoercive sexual contact with similarly aged individuals: what is the impact? J Interpers Violence. 2004 Sep; 19(9):1075-84.
    View PubMed
  585. Delgado-Aros S, Locke GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004 Sep; 99 (9):1801-6
    View PubMed
  586. Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: A birth cohort study. Am J Gastroenterol. 2004 Sep; 99(9):1807-14.
    View PubMed
  587. Friedrich WN, Whiteside SP, Talley NJ. Noncoercive sexual contact with similarly aged individuals: what is the impact? J Interpers Violence. 2004 Sep; 19(9):1075-84.
    View PubMed
  588. Nandurkar S, Locke GR, Fett S, Zinsmeister AR, Cameron AJ, Talley NJ. Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther. 2004 Sep 1; 20 (5):497-505
    View PubMed
  589. Armstrong D, Talley NJ, Lauritsen K, Moum B, Lind T, Tunturi-Hihnala H, Venables T, Green J, Bigard MA, Mossner J, Junghard O. The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Alimentary Pharmacology & Therapeutics. 2004 Aug 15; 20(4):413-21.
    View PubMed
  590. Armstrong D, Talley NJ, Lauritsen K, Moum B, Lind T, Tunturi-Hihnala H, Venables T, Green J, Bigard MA, Mossner J, Junghard O. The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Alimentary Pharmacology & Therapeutics. 2004 Aug 15; 20(4):413-21.
    View PubMed
  591. Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004 Aug; 16 (4):413-9
    View PubMed
  592. Howell S, Talley NJ, Quine S, Poulton R. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol. 2004 Aug; 99(8):1572-8.
    View PubMed
  593. Cremonini F, Delgado-Aros S, Talley NJ. Functional dyspepsia: drugs for new (and old) therapeutic targets. Best Pract Res Clin Gastroenterol. 2004 Aug; 18 (4):717-33
    View PubMed
  594. Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004 Aug; 16 (4):413-9
    View PubMed
  595. Howell S, Talley NJ, Quine S, Poulton R. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol. 2004 Aug; 99(8):1572-8.
    View PubMed
  596. Cremonini F, Delgado-Aros S, Talley NJ. Functional dyspepsia: drugs for new (and old) therapeutic targets. Best Pract Res Clin Gastroenterol. 2004 Aug; 18 (4):717-33
    View PubMed
  597. Talley NJ. What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia. Alimentary Pharmacology & Therapeutics. 2004 Jul; 20(Suppl 2):23-30.
    View PubMed
  598. Talley NJ. What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia. Alimentary Pharmacology & Therapeutics. 2004 Jul; 20(Suppl 2):23-30.
    View PubMed
  599. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004 May; 13(4):833-44.
    View PubMed
  600. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004 May; 13(4):833-44.
    View PubMed
  601. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut. 2004 May 1; 53(5):666-72.
    View PubMed
  602. Locke GR, Yawn BP, Wollan PC, Melton LJ, Lydick E, Talley NJ. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther. 2004 May 1; 19(9):1025-31.
    View PubMed
  603. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004 May; 53(Suppl 4):1-24.
    View PubMed
  604. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut. 2004 May 1; 53(5):666-72.
    View PubMed
  605. Locke GR, Yawn BP, Wollan PC, Melton LJ, Lydick E, Talley NJ. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther. 2004 May 1; 19(9):1025-31.
    View PubMed
  606. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004 May; 53(Suppl 4):1-24.
    View PubMed
  607. Holtmann G, Siffert W, Haag S, Mueller N, Langkafel M, Senf W, Zotz R, Talley NJ. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functioncal) dyspepsia. Gastroenterology. 2004 Apr; 126(4):971-9.
    View PubMed
  608. Delgado-Aros S, Cremonini F, Talley NJ. Treatment of Functional Dyspepsia. Curr Treat Options Gastroenterol. 2004 Apr; 7 (2):121-131
    View PubMed
  609. Holtmann G, Kutscher SU, Haag S, Langkafel M, Heuft G, Neufang-Hueber J, Goebell H, Senf W, Talley NJ. Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia - A randomized, double-blind placebo-controlled crossover study. Dig Dis Sci. 2004 Apr; 49(4):672-9.
    View PubMed
  610. Locke GR 3rd, Murray JA, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc. 2004 Apr; 79(4):476-82.
    View PubMed
  611. Fock KM, Talley N, Hunt R, Fass R, Nandurkar S, Lam SK, Goh KL, Sollano J. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004 Apr; 19(4):357-67.
    View PubMed
  612. Holtmann G, Siffert W, Haag S, Mueller N, Langkafel M, Senf W, Zotz R, Talley NJ. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functioncal) dyspepsia. Gastroenterology. 2004 Apr; 126(4):971-9.
    View PubMed
  613. Camilleri M, Talley NJ. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil. 2004 Apr; 16(2):135-42.
    View PubMed
  614. Locke GR 3rd, Murray JA, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc. 2004 Apr; 79(4):476-82.
    View PubMed
  615. Fock KM, Talley N, Hunt R, Fass R, Nandurkar S, Lam SK, Goh KL, Sollano J. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004 Apr; 19(4):357-67.
    View PubMed
  616. Delgado-Aros S, Cremonini F, Talley NJ. Treatment of Functional Dyspepsia. Curr Treat Options Gastroenterol. 2004 Apr; 7 (2):121-131
    View PubMed
  617. Camilleri M, Talley NJ. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil. 2004 Apr; 16(2):135-42.
    View PubMed
  618. Holtmann G, Kutscher SU, Haag S, Langkafel M, Heuft G, Neufang-Hueber J, Goebell H, Senf W, Talley NJ. Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia - A randomized, double-blind placebo-controlled crossover study. Dig Dis Sci. 2004 Apr; 49(4):672-9.
    View PubMed
  619. El-Serag HB, Talley NJ. Systematic review: The prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004 Mar 15; 19(6):643-54.
    View PubMed
  620. El-Serag HB, Talley NJ. Systematic review: The prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004 Mar 15; 19(6):643-54.
    View PubMed
  621. Locke GR 3rd, Locke GR, Weaver AL, Melton LJ 3rd, Melton LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol. 2004 Feb; 99 (2):350-7
    View PubMed
  622. Locke GR 3rd, Locke GR, Weaver AL, Melton LJ 3rd, Melton LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol. 2004 Feb; 99 (2):350-7
    View PubMed
  623. Saito YA, Talley NJ, J Melton L, Fett S, Melton LJ, Zinsmeister AR, Locke GR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil. 2003 Dec; 15 (6):687-94
    View PubMed
  624. Kalantar JS, Locke GR, Zinsmeister AR, Beighley CM, Talley NJ. Familial aggregation of irritable bowel syndrome: a prospective study. Gut. 2003 Dec 1; 52(12):1703-7.
    View PubMed
  625. Kalantar JS, Locke GR, Zinsmeister AR, Beighley CM, Talley NJ. Familial aggregation of irritable bowel syndrome: a prospective study. Gut. 2003 Dec 1; 52(12):1703-7.
    View PubMed
  626. Saito YA, Talley NJ, J Melton L, Fett S, Melton LJ, Zinsmeister AR, Locke GR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil. 2003 Dec; 15 (6):687-94
    View PubMed
  627. Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003 Nov; 98 (11):2454-9
    View PubMed
  628. Locke GR, Zinsmeister AR, Talley NJ. Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc. 2003 Nov; 58 (5):661-70
    View PubMed
  629. Locke GR, Zinsmeister AR, Talley NJ. Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc. 2003 Nov; 58 (5):661-70
    View PubMed
  630. Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003 Nov; 98 (11):2454-9
    View PubMed
  631. El-Serag HB, Talley NJ. Systematic review: health-related quality of life in functional dyspepsia. Alimentary Pharmacology & Therapeutics. 2003 Aug 15; 18(4):387-93.
    View PubMed
  632. El-Serag HB, Talley NJ. Systematic review: health-related quality of life in functional dyspepsia. Alimentary Pharmacology & Therapeutics. 2003 Aug 15; 18(4):387-93.
    View PubMed
  633. Kalantar JS, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ. Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points. Aliment Pharmacol Ther. 2003 Jun 1; 17(11):1389-97.
    View PubMed
  634. Kalantar JS, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ. Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points. Aliment Pharmacol Ther. 2003 Jun 1; 17(11):1389-97.
    View PubMed
  635. Westbrook JI, Talley NJ. Diagnostic investigation rates and use of prescription and non-prescription medications amongst dyspeptics: a population-based study of 2300 Australians. Aliment Pharmacol Ther. 2003 May 1; 17(9):1171-8.
    View PubMed
  636. Westbrook JI, Talley NJ. Diagnostic investigation rates and use of prescription and non-prescription medications amongst dyspeptics: a population-based study of 2300 Australians. Aliment Pharmacol Ther. 2003 May 1; 17(9):1171-8.
    View PubMed
  637. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol. 2003 May; 98(5):1107-11.
    View PubMed
  638. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol. 2003 May; 98(5):1107-11.
    View PubMed
  639. Koloski NA, Talley NJ, Boyce PM. Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community Cohort study. Am J Gastroenterol. 2003 Apr; 98(4):789-97.
    View PubMed
  640. Koloski NA, Talley NJ, Boyce PM. Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community Cohort study. Am J Gastroenterol. 2003 Apr; 98(4):789-97.
    View PubMed
  641. Talley NJ. Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol. 2003 Apr; 98(4):750-8.
    View PubMed
  642. Talley NJ. Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol. 2003 Apr; 98(4):750-8.
    View PubMed
  643. Xia HHX, Talley NJ, Blum AL, O'Morain CA, Stolte M, Bolling-Sternevald E, Mitchell HM. Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia. Alimentary Pharmacology & Therapeutics. 2003 Apr 1; 17(7):935-43.
    View PubMed
  644. Xia HHX, Talley NJ, Blum AL, O'Morain CA, Stolte M, Bolling-Sternevald E, Mitchell HM. Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia. Alimentary Pharmacology & Therapeutics. 2003 Apr 1; 17(7):935-43.
    View PubMed
  645. Hammer J, Howell S, Bytzer P, Horowitz M, Talley NJ. Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15000 Australian adults. Am J Gastroenterol. 2003 Feb; 98(2):391-8.
    View PubMed
  646. Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol. 2003 Feb; 98(2):264-71.
    View PubMed
  647. Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol. 2003 Feb; 98(2):264-71.
    View PubMed
  648. Hammer J, Howell S, Bytzer P, Horowitz M, Talley NJ. Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15000 Australian adults. Am J Gastroenterol. 2003 Feb; 98(2):391-8.
    View PubMed
  649. Katelaris PH, Forbes GM, Talley NJ, Crotty B. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology. 2002 Dec; 123(6):1763-9.
    View PubMed
  650. Talley NJ, Howell S, Jones MP, Horowitz M. Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2002 Dec; 97(12):3087-94.
    View PubMed
  651. Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol. 2002 Dec; 97(12):2950-61.
    View PubMed
  652. Talley NJ, Howell S, Jones MP, Horowitz M. Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2002 Dec; 97(12):3087-94.
    View PubMed
  653. Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol. 2002 Dec; 97(12):2950-61.
    View PubMed
  654. Katelaris PH, Forbes GM, Talley NJ, Crotty B. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology. 2002 Dec; 123(6):1763-9.
    View PubMed
  655. Xia HH, Zhang GS, Talley NJ, Wong BC, Yang Y, Henwood C, Wyatt JM, Adams S, Cheung K, Xia B, Zhu YQ, Lam SK. Topographic association of gastric epithelial expression of Ki-67, Bax, and Bcl-2 with antralization in the gastric incisura, body, and fundus. Am J Gastroenterol. 2002 Dec; 97(12):3023-31.
    View PubMed
  656. Xia HH, Zhang GS, Talley NJ, Wong BC, Yang Y, Henwood C, Wyatt JM, Adams S, Cheung K, Xia B, Zhu YQ, Lam SK. Topographic association of gastric epithelial expression of Ki-67, Bax, and Bcl-2 with antralization in the gastric incisura, body, and fundus. Am J Gastroenterol. 2002 Dec; 97(12):3023-31.
    View PubMed
  657. Holtmann G, Gschossmann J, Buenger L, Gerken G, Talley NJ. Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? Gastroenterology. 2002 Nov; 123(5):1451-8.
    View PubMed
  658. Holtmann G, Gschossmann J, Buenger L, Gerken G, Talley NJ. Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? Gastroenterology. 2002 Nov; 123(5):1451-8.
    View PubMed
  659. Talley NJ, Moore MG, Sprogis A, Katelaris P. Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care. Med J Aust. 2002 Oct 21; 177(8):423-7.
    View PubMed
  660. Talley NJ, Moore MG, Sprogis A, Katelaris P. Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care. Med J Aust. 2002 Oct 21; 177(8):423-7.
    View PubMed
  661. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol. 2002 Sep; 97(9):2290-9.
    View PubMed
  662. Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther. 2002 Sep; 16(9):1677-82.
    View PubMed
  663. Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther. 2002 Sep; 16(9):1641-8.
    View PubMed
  664. Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther. 2002 Sep; 16(9):1677-82.
    View PubMed
  665. Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther. 2002 Sep; 16(9):1641-8.
    View PubMed
  666. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol. 2002 Sep; 97(9):2290-9.
    View PubMed
  667. Talley NJ, Venables TL, Green JR, Armstrong D, O'Kane KP, Giaffer M, Bardhan KD, Carlsson RG, Chen S, Hasselgren GS. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. Eur J Gastroenterol Hepatol. 2002 Aug; 14(8):857-63.
    View PubMed
  668. Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol. 2002 Aug; 37(8):917-23.
    View PubMed
  669. Talley NJ, Venables TL, Green JR, Armstrong D, O'Kane KP, Giaffer M, Bardhan KD, Carlsson RG, Chen S, Hasselgren GS. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. Eur J Gastroenterol Hepatol. 2002 Aug; 14(8):857-63.
    View PubMed
  670. Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol. 2002 Aug; 37(8):917-23.
    View PubMed
  671. Veldhuyzen van Zanten SJ, Talley NJ, Blum AL, Bolling-Sternevald E, Sundin M, Junghard O. Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms? Gut. 2002 May; 50(Suppl 4):iv26-30; discussion iv31-2.
    View PubMed
  672. Westbrook JI, Talley NJ, Westbrook MT. Gender differences in the symptoms and physical and mental well-being of dyspeptics: a population based study. Qual Life Res. 2002 May; 11(3):283-91.
    View PubMed
  673. Talley NJ. Dyspepsia: management guidelines for the millennium. Gut. 2002 May; 50(Suppl 4):iv72-8; discussion iv79.
    View PubMed
  674. Talley NJ, Lauritsen K. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut. 2002 May; 50(Suppl 4):iv36-41.
    View PubMed
  675. Talley NJ. Dyspepsia: management guidelines for the millennium. Gut. 2002 May; 50(Suppl 4):iv72-8; discussion iv79.
    View PubMed
  676. Talley NJ, Lauritsen K. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut. 2002 May; 50(Suppl 4):iv36-41.
    View PubMed
  677. Veldhuyzen van Zanten SJ, Talley NJ, Blum AL, Bolling-Sternevald E, Sundin M, Junghard O. Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms? Gut. 2002 May; 50(Suppl 4):iv26-30; discussion iv31-2.
    View PubMed
  678. Westbrook JI, Talley NJ, Westbrook MT. Gender differences in the symptoms and physical and mental well-being of dyspeptics: a population based study. Qual Life Res. 2002 May; 11(3):283-91.
    View PubMed
  679. Jones KL, Wishart JM, Berry M, Russo A, Xia HH, Talley NJ, Horowitz M. Helicobacter pylori infection is not associated with delayed gastric emptying or upper gastrointestinal symptoms in diabetes mellitus. Dig Dis Sci. 2002 Apr; 47(4):704-9.
    View PubMed
  680. Jones KL, Wishart JM, Berry M, Russo A, Xia HH, Talley NJ, Horowitz M. Helicobacter pylori infection is not associated with delayed gastric emptying or upper gastrointestinal symptoms in diabetes mellitus. Dig Dis Sci. 2002 Apr; 47(4):704-9.
    View PubMed
  681. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002 Mar; 97(3):604-11.
    View PubMed
  682. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002 Mar; 97(3):604-11.
    View PubMed
  683. Talley NJ. Serotoninergic neuroenteric modulators. Lancet. 2001 Dec 15; 358(9298):2061-8.
    View PubMed
  684. Talley NJ. Serotoninergic neuroenteric modulators. Lancet. 2001 Dec 15; 358(9298):2061-8.
    View PubMed
  685. Xia HH, Phung N, Altiparmak E, Berry A, Matheson M, Talley NJ. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci. 2001 Dec; 46(12):2716-23.
    View PubMed
  686. Xia HH, Phung N, Altiparmak E, Berry A, Matheson M, Talley NJ. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci. 2001 Dec; 46(12):2716-23.
    View PubMed
  687. Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol. 2001 Nov; 36(11):1155-61.
    View PubMed
  688. Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol. 2001 Nov; 36(11):1155-61.
    View PubMed
  689. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001 Sep 10; 161(16):1989-96.
    View PubMed
  690. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001 Sep 10; 161(16):1989-96.
    View PubMed
  691. Talley NJ. Irritable bowel syndrome. Best Practice of Medicine. 2001 Sep.
  692. Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, Mack RJ. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut. 2001 Sep; 49(3):395-401.
    View PubMed
  693. Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, Mack RJ. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut. 2001 Sep; 49(3):395-401.
    View PubMed
  694. Talley NJ. Irritable bowel syndrome. Best Practice of Medicine. 2001 Sep.
  695. Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol. 2001 Jul; 96(7):1998-2004.
    View PubMed
  696. Holtmann G, Gschossmann J, Holtmann M, Talley NJ. H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor? Dig Dis Sci. 2001 Jul; 46(7):1550-7.
    View PubMed
  697. Talley NJ. Drug therapy options for patients with irritable bowel syndrome. Am J Manag Care. 2001 Jul; 7(8 Suppl):S261-7.
    View PubMed
  698. Shaw MJ, Beebe TJ, Adlis SA, Talley NJ. Reliability and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients. Aliment Pharmacol Ther. 2001 Jul; 15(7):981-7.
    View PubMed
  699. Bytzer P, Howell S, Leemon M, Young LJ, Jones MP, Talley NJ. Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut. 2001 Jul; 49(1):66-72.
    View PubMed
  700. Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol. 2001 Jul; 96(7):1998-2004.
    View PubMed
  701. Shaw MJ, Beebe TJ, Adlis SA, Talley NJ. Reliability and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients. Aliment Pharmacol Ther. 2001 Jul; 15(7):981-7.
    View PubMed
  702. Bytzer P, Howell S, Leemon M, Young LJ, Jones MP, Talley NJ. Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut. 2001 Jul; 49(1):66-72.
    View PubMed
  703. Holtmann G, Gschossmann J, Holtmann M, Talley NJ. H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor? Dig Dis Sci. 2001 Jul; 46(7):1550-7.
    View PubMed
  704. Talley NJ. Drug therapy options for patients with irritable bowel syndrome. Am J Manag Care. 2001 Jul; 7(8 Suppl):S261-7.
    View PubMed
  705. Talley NJ, Thitiphuree S. Lump or split dyspepsia? A continuing controversy. Curr Gastroenterol Rep. 2001 Jun; 3(3):175-6.
    View PubMed
  706. Bytzer P, Talley NJ. Current indications for acid suppressants in dyspepsia. Best Pract Res Clin Gastroenterol. 2001 Jun; 15(3):385-400.
    View PubMed
  707. Talley NJ, Thitiphuree S. Lump or split dyspepsia? A continuing controversy. Curr Gastroenterol Rep. 2001 Jun; 3(3):175-6.
    View PubMed
  708. Bytzer P, Talley NJ. Current indications for acid suppressants in dyspepsia. Best Pract Res Clin Gastroenterol. 2001 Jun; 15(3):385-400.
    View PubMed
  709. Bytzer P, Talley NJ. Dyspepsia. Ann Intern Med. 2001 May 1; 134(9 Pt 2):815-22.
    View PubMed
  710. Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol. 2001 May; 96(5):1422-8.
    View PubMed
  711. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol. 2001 May; 96(5):1340-9.
    View PubMed
  712. Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol. 2001 May; 96(5):1422-8.
    View PubMed
  713. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol. 2001 May; 96(5):1340-9.
    View PubMed
  714. Bytzer P, Talley NJ. Dyspepsia. Ann Intern Med. 2001 May 1; 134(9 Pt 2):815-22.
    View PubMed
  715. McManis PG, Newall D, Talley NJ. Abdominal wall muscle activity in irritable bowel syndrome with bloating. Am J Gastroenterol. 2001 Apr; 96(4):1139-42.
    View PubMed
  716. Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol. 2001 Apr; 96(4):1072-9.
    View PubMed
  717. Talley NJ, Van Zanten SV, Saez LR, Dukes G, Perschy T, Heath M, Kleoudis C, Mangel AW. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther. 2001 Apr; 15(4):525-37.
    View PubMed
  718. Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2001 Apr; 96(4):1039-46.
    View PubMed
  719. McManis PG, Newall D, Talley NJ. Abdominal wall muscle activity in irritable bowel syndrome with bloating. Am J Gastroenterol. 2001 Apr; 96(4):1139-42.
    View PubMed
  720. Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol. 2001 Apr; 96(4):1072-9.
    View PubMed
  721. Talley NJ, Van Zanten SV, Saez LR, Dukes G, Perschy T, Heath M, Kleoudis C, Mangel AW. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther. 2001 Apr; 15(4):525-37.
    View PubMed
  722. Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2001 Apr; 96(4):1039-46.
    View PubMed
  723. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol. 2001 Mar; 96(3):689-96.
    View PubMed
  724. Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, Schulz T, Omland TM, Delle M, Junghard O. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther. 2001 Mar; 15(3):347-54.
    View PubMed
  725. Shaw MJ, Fendrick AM, Kane RL, Adlis SA, Talley NJ. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists. Am J Gastroenterol. 2001 Mar; 96(3):673-6.
    View PubMed
  726. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol. 2001 Mar; 96(3):689-96.
    View PubMed
  727. Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, Schulz T, Omland TM, Delle M, Junghard O. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther. 2001 Mar; 15(3):347-54.
    View PubMed
  728. Shaw MJ, Fendrick AM, Kane RL, Adlis SA, Talley NJ. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists. Am J Gastroenterol. 2001 Mar; 96(3):673-6.
    View PubMed
  729. Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther. 2001 Feb; 15(2):207-16.
    View PubMed
  730. Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther. 2001 Feb; 15(2):207-16.
    View PubMed
  731. Xia HH, Yu Wong BC, Talley NJ, Lam SK. Helicobacter pylori infection--current treatment practice. Expert Opin Pharmacother. 2001 Feb; 2(2):253-66.
    View PubMed
  732. Xia HH, Yu Wong BC, Talley NJ, Lam SK. Helicobacter pylori infection--current treatment practice. Expert Opin Pharmacother. 2001 Feb; 2(2):253-66.
    View PubMed
  733. Westbrook JI, McIntosh J, Talley NJ. Factors associated with consulting medical or non-medical practitioners for dyspepsia: an Australian population-based study. Aliment Pharmacol Ther. 2000 Dec; 14(12):1581-8.
    View PubMed
  734. Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, Brinkhoff H, Eaker E, Ohning G, Miner PB, Mathias JR, Fumagalli I, Staessen D, Mack RJ. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2000 Dec; 14(12):1653-61.
    View PubMed
  735. Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, Brinkhoff H, Eaker E, Ohning G, Miner PB, Mathias JR, Fumagalli I, Staessen D, Mack RJ. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2000 Dec; 14(12):1653-61.
    View PubMed
  736. Westbrook JI, McIntosh J, Talley NJ. Factors associated with consulting medical or non-medical practitioners for dyspepsia: an Australian population-based study. Aliment Pharmacol Ther. 2000 Dec; 14(12):1581-8.
    View PubMed
  737. Xia HH, Phung N, Kalantar JS, Talley NJ. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust. 2000 Nov 20; 173(10):515-9.
    View PubMed
  738. Xia HH, Phung N, Kalantar JS, Talley NJ. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust. 2000 Nov 20; 173(10):515-9.
    View PubMed
  739. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opin Gastroenterol. 2000 Nov; 16(6):503-7.
    View PubMed
  740. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opin Gastroenterol. 2000 Nov; 16(6):503-7.
    View PubMed
  741. Locke GR 3rd, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ 3rd. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000 Sep; 75 (9):907-12
    View PubMed
  742. Locke GR 3rd, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ 3rd. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000 Sep; 75 (9):907-12
    View PubMed
  743. Hu WH, Martin CJ, Talley NJ. Intraesophageal acid perfusion sensitizes the esophagus to mechanical distension: a Barostat study. Am J Gastroenterol. 2000 Sep; 95(9):2189-94.
    View PubMed
  744. Neri M, Laterza F, Howell S, Di Gioacchino M, Festi D, Ballone E, Cuccurullo F, Talley NJ. Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. Eur J Gastroenterol Hepatol. 2000 Sep; 12(9):981-8.
    View PubMed
  745. Holtmann G, Gschossmann J, Neufang-Huber J, Gerken G, Talley NJ. Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut. 2000 Sep; 47(3):332-6.
    View PubMed
  746. Hu WH, Martin CJ, Talley NJ. Intraesophageal acid perfusion sensitizes the esophagus to mechanical distension: a Barostat study. Am J Gastroenterol. 2000 Sep; 95(9):2189-94.
    View PubMed
  747. Neri M, Laterza F, Howell S, Di Gioacchino M, Festi D, Ballone E, Cuccurullo F, Talley NJ. Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. Eur J Gastroenterol Hepatol. 2000 Sep; 12(9):981-8.
    View PubMed
  748. Holtmann G, Gschossmann J, Neufang-Huber J, Gerken G, Talley NJ. Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut. 2000 Sep; 47(3):332-6.
    View PubMed
  749. Locke CR 3rd, Talley NJ, Nelson DK, Haruma K, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Helicobacter pylori and dyspepsia: a population-based study of the organism and host. Am J Gastroenterol. 2000 Aug; 95(8):1906-13.
    View PubMed
  750. Locke CR 3rd, Talley NJ, Nelson DK, Haruma K, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Helicobacter pylori and dyspepsia: a population-based study of the organism and host. Am J Gastroenterol. 2000 Aug; 95(8):1906-13.
    View PubMed
  751. Talley NJ, Holtmann G, Agreus L, Jones M. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol. 2000 Jun; 95(6):1439-47.
    View PubMed
  752. Talley NJ, Holtmann G, Agreus L, Jones M. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol. 2000 Jun; 95(6):1439-47.
    View PubMed
  753. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J. 2000 May 26; 113(1110):178-81.
    View PubMed
  754. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J. 2000 May 26; 113(1110):178-81.
    View PubMed
  755. Xia HH, Kalantar JS, Mitchell HM, Talley NJ. Can helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia? Aliment Pharmacol Ther. 2000 May; 14(5):615-24.
    View PubMed
  756. Xia HH, Kalantar JS, Mitchell HM, Talley NJ. Can helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia? Aliment Pharmacol Ther. 2000 May; 14(5):615-24.
    View PubMed
  757. Carpenter HA, Talley NJ. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol. 2000 Apr; 95 (4):878-96
    View PubMed
  758. Carpenter HA, Talley NJ. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol. 2000 Apr; 95 (4):878-96
    View PubMed
  759. Reilly WT, Talley NJ, Pemberton JH, Zinsmeister AR. Validation of a questionnaire to assess fecal incontinence and associated risk factors: Fecal Incontinence Questionnaire. Dis Colon Rectum. 2000 Feb; 43 (2):146-53; discussion 153-4
    View PubMed
  760. Reilly WT, Talley NJ, Pemberton JH, Zinsmeister AR. Validation of a questionnaire to assess fecal incontinence and associated risk factors: Fecal Incontinence Questionnaire. Dis Colon Rectum. 2000 Feb; 43 (2):146-53; discussion 153-4
    View PubMed
  761. Nandurkar S, Talley NJ, Martin CJ, Ng T, Adams S. Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy. Dig Dis Sci. 2000 Feb; 45(2):217-24.
    View PubMed
  762. Xia HH, Kalantar JS, Wyatt JM, Adams S, Cheung K, Eslick GD, Talley NJ. High sensitivity and specificity of a laboratory-based serological test, pylori DTect ELISA, for detection of Helicobacter pylori infection. Diagn Microbiol Infect Dis. 2000 Feb; 36(2):69-74.
    View PubMed
  763. Agreus L, Talley NJ, Svardsudd K, Tibblin G, Jones MP. Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort and bowel habit descriptors. Scand J Gastroenterol. 2000 Feb; 35(2):142-51.
    View PubMed
  764. Nandurkar S, Talley NJ, Martin CJ, Ng T, Adams S. Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy. Dig Dis Sci. 2000 Feb; 45(2):217-24.
    View PubMed
  765. Xia HH, Kalantar JS, Wyatt JM, Adams S, Cheung K, Eslick GD, Talley NJ. High sensitivity and specificity of a laboratory-based serological test, pylori DTect ELISA, for detection of Helicobacter pylori infection. Diagn Microbiol Infect Dis. 2000 Feb; 36(2):69-74.
    View PubMed
  766. Agreus L, Talley NJ, Svardsudd K, Tibblin G, Jones MP. Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort and bowel habit descriptors. Scand J Gastroenterol. 2000 Feb; 35(2):142-51.
    View PubMed
  767. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opin Gastroenterol. 1999 Nov; 15(6):492.
    View PubMed
  768. Kalantar JS, Talley NJ. The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol. 1999 Nov; 52(11):1117-22.
    View PubMed
  769. Xia HH, Gallagher C, Hyde D, Talley NJ, Keane CT, O'Morain CA. Comparison between McCoy cell line and HeLa cell line for detecting Helicobacter pylori cytotoxicity: clinical and pathological relevance. Ital J Gastroenterol Hepatol. 1999 Nov; 31(8):663-8.
    View PubMed
  770. Kalantar JS, Talley NJ. The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol. 1999 Nov; 52(11):1117-22.
    View PubMed
  771. Xia HH, Gallagher C, Hyde D, Talley NJ, Keane CT, O'Morain CA. Comparison between McCoy cell line and HeLa cell line for detecting Helicobacter pylori cytotoxicity: clinical and pathological relevance. Ital J Gastroenterol Hepatol. 1999 Nov; 31(8):663-8.
    View PubMed
  772. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opin Gastroenterol. 1999 Nov; 15(6):492.
    View PubMed
  773. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol. 1999 Sep; 94(9):2390-7.
    View PubMed
  774. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol. 1999 Sep; 94(9):2373-9.
    View PubMed
  775. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol. 1999 Sep; 94(9):2390-7.
    View PubMed
  776. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol. 1999 Sep; 94(9):2373-9.
    View PubMed
  777. van Zanten SJOV, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut. 1999 Sep; 45(Suppl 2):69-77.
  778. van Zanten SJOV, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut. 1999 Sep; 45(Suppl 2):69-77.
  779. Howell S, Talley NJ. Does fear of serious disease predict consulting behaviour amongst patients with dyspepsia in general practice? Eur J Gastroenterol Hepatol. 1999 Aug; 11(8):881-6.
    View PubMed
  780. Howell S, Talley NJ. Does fear of serious disease predict consulting behaviour amongst patients with dyspepsia in general practice? Eur J Gastroenterol Hepatol. 1999 Aug; 11(8):881-6.
    View PubMed
  781. Oliveria SA, Christos PJ, Talley NJ, Dannenberg AJ. Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. Arch Intern Med. 1999 Jul 26; 159(14):1592-8.
    View PubMed
  782. Oliveria SA, Christos PJ, Talley NJ, Dannenberg AJ. Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. Arch Intern Med. 1999 Jul 26; 159(14):1592-8.
    View PubMed
  783. Talley NJ. Gastro-esophageal reflux disease in adults. How to treat. Australian Doctor. 1999 Jul 2.
  784. Talley NJ. Gastro-esophageal reflux disease in adults. How to treat. Australian Doctor. 1999 Jul 2.
  785. Roberts RO, Jacobsen SJ, Reilly WT, Pemberton JH, Lieber MM, Talley NJ. Prevalence of combined fecal and urinary incontinence: a community-based study. J Am Geriatr Soc. 1999 Jul; 47 (7):837-41
    View PubMed
  786. Roberts RO, Jacobsen SJ, Reilly WT, Pemberton JH, Lieber MM, Talley NJ. Prevalence of combined fecal and urinary incontinence: a community-based study. J Am Geriatr Soc. 1999 Jul; 47 (7):837-41
    View PubMed
  787. Locke GR 3rd, Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd, Melton LJ 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999 Jun; 106 (6):642-9
    View PubMed
  788. Locke GR 3rd, Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd, Melton LJ 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999 Jun; 106 (6):642-9
    View PubMed
  789. Meineche-Schmidt V, Talley NJ, Pap A, Kordecki H, Schmid V, Ohlsson L, Wahlqvist P, Wiklund I, Bolling-Sternevald E. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment: a multicentre 3-month follow-up study. Scand J Gastroenterol. 1999 Jun; 34(6):566-74.
    View PubMed
  790. Meineche-Schmidt V, Talley NJ, Pap A, Kordecki H, Schmid V, Ohlsson L, Wahlqvist P, Wiklund I, Bolling-Sternevald E. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment: a multicentre 3-month follow-up study. Scand J Gastroenterol. 1999 Jun; 34(6):566-74.
    View PubMed
  791. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. Br Med J. 1999 Mar 27; 318(7187):833-7.
  792. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. Br Med J. 1999 Mar 27; 318(7187):833-7.
  793. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, Holtmann G, Verlinden M, Jones M. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999 Feb; 13(2):225-35.
    View PubMed
  794. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, Holtmann G, Verlinden M, Jones M. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999 Feb; 13(2):225-35.
    View PubMed
  795. Blum AL, Talley NJ, O'Morain C, Veldhuyzen van Zanten SJ, Labenz J, Stolte M, Louw JA, Stubberod A, Theodors A, Sundin M, Bolling-Sternevald E, Junghard O. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med. 1998 Dec 24; 339(26):1875-81.
    View PubMed
  796. Blum AL, Talley NJ, O'Morain C, Veldhuyzen van Zanten SJ, Labenz J, Stolte M, Louw JA, Stubberod A, Theodors A, Sundin M, Bolling-Sternevald E, Junghard O. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med. 1998 Dec 24; 339(26):1875-81.
    View PubMed
  797. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA. 1998 Nov 11; 280(18):1585-9.
    View PubMed
  798. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA. 1998 Nov 11; 280(18):1585-9.
    View PubMed
  799. Kato M, Kephart GM, Talley NJ, Wagner JM, Sarr MG, Bonno M, McGovern TW, Gleich GJ. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec. 1998 Nov; 252 (3):418-25
    View PubMed
  800. Kato M, Kephart GM, Talley NJ, Wagner JM, Sarr MG, Bonno M, McGovern TW, Gleich GJ. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec. 1998 Nov; 252 (3):418-25
    View PubMed
  801. Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey M. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther. 1998 Nov; 12(11):1067-78.
    View PubMed
  802. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, Kordecki H, Schmid V. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998 Nov; 12(11):1055-65.
    View PubMed
  803. Talley NJ, Jones M. Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking. Am J Gastroenterol. 1998 Nov; 93(11):2179-83.
    View PubMed
  804. Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey M. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther. 1998 Nov; 12(11):1067-78.
    View PubMed
  805. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, Kordecki H, Schmid V. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998 Nov; 12(11):1055-65.
    View PubMed
  806. Talley NJ, Jones M. Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking. Am J Gastroenterol. 1998 Nov; 93(11):2179-83.
    View PubMed
  807. Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol. 1998 Aug; 93(8):1311-7.
    View PubMed
  808. Holtmann G, Talley NJ, Mitchell H, Hazell S. Antibody response to specific H. pylori antigens in functional dyspepsia, duodenal ulcer, and health. Am J Gastroenterol. 1998 Aug; 93(8):1222-7.
    View PubMed
  809. Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K, Kajiyama G, Talley NJ. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol. 1998 Aug; 93(8):1271-6.
    View PubMed
  810. Holtmann G, Talley NJ, Mitchell H, Hazell S. Antibody response to specific H. pylori antigens in functional dyspepsia, duodenal ulcer, and health. Am J Gastroenterol. 1998 Aug; 93(8):1222-7.
    View PubMed
  811. Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K, Kajiyama G, Talley NJ. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol. 1998 Aug; 93(8):1271-6.
    View PubMed
  812. Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol. 1998 Aug; 93(8):1311-7.
    View PubMed
  813. Nandurkar S, Talley NJ, Xia H, Mitchell H, Hazel S, Jones M. Dyspepsia in the community is linked to smoking and aspirin use but not Helicobacter pylori. Arch Intern Med. 1998 Jul 13; 158(13):1427-33.
    View PubMed
  814. Nandurkar S, Talley NJ, Xia H, Mitchell H, Hazel S, Jones M. Dyspepsia in the community is linked to smoking and aspirin use but not Helicobacter pylori. Arch Intern Med. 1998 Jul 13; 158(13):1427-33.
    View PubMed
  815. Talley NJ, Lambert JR, Howell S, Xia HH, Lin SK, Agreus L. An evaluation of whole blood testing for Helicobacter pylori in general practice. Aliment Pharmacol Ther. 1998 Jul; 12(7):641-5.
    View PubMed
  816. Talley NJ, Lambert JR, Howell S, Xia HH, Lin SK, Agreus L. An evaluation of whole blood testing for Helicobacter pylori in general practice. Aliment Pharmacol Ther. 1998 Jul; 12(7):641-5.
    View PubMed
  817. Talley NJ, Chang FY, Wyatt JM, Adams S, Lau A, Borody T, Chen TS, Daskolopolos G, Cheung K, Talley NA, Full-Young C, Tseng-Shing C. Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1998 Jun; 12(6):527-32.
    View PubMed
  818. Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc. 1998 Jun; 47(6):449-54.
    View PubMed
  819. Talley NJ, Chang FY, Wyatt JM, Adams S, Lau A, Borody T, Chen TS, Daskolopolos G, Cheung K, Talley NA, Full-Young C, Tseng-Shing C. Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1998 Jun; 12(6):527-32.
    View PubMed
  820. Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc. 1998 Jun; 47(6):449-54.
    View PubMed
  821. Talley NJ, Boyce P, Jones M. Dyspepsia and health care seeking in a community: how important are psychological factors? Dig Dis Sci. 1998 May; 43(5):1016-22.
    View PubMed
  822. Talley NJ, Boyce P, Jones M. Identification of distrinct upper and lower gastrointestinal symptom groupings in an urban population. Gut. 1998 May; 42(5):690-5.
    View PubMed
  823. Talley NJ, Boyce P, Jones M. Dyspepsia and health care seeking in a community: how important are psychological factors? Dig Dis Sci. 1998 May; 43(5):1016-22.
    View PubMed
  824. Talley NJ, Boyce P, Jones M. Identification of distrinct upper and lower gastrointestinal symptom groupings in an urban population. Gut. 1998 May; 42(5):690-5.
    View PubMed
  825. Roberts RO, Jacobsen SJ, Rhodes T, Reilly WT, Girman CJ, Talley NJ, Lieber MM. Urinary incontinence in a community-based cohort: prevalence and healthcare-seeking. J Am Geriatr Soc. 1998 Apr; 46 (4):467-72
    View PubMed
  826. Roberts RO, Jacobsen SJ, Rhodes T, Reilly WT, Girman CJ, Talley NJ, Lieber MM. Urinary incontinence in a community-based cohort: prevalence and healthcare-seeking. J Am Geriatr Soc. 1998 Apr; 46 (4):467-72
    View PubMed
  827. Holtmann G, Goebell H, Jockenhoevel F, Talley NJ. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut. 1998 Apr; 42(4):501-6.
    View PubMed
  828. Holtmann G, Goebell H, Jockenhoevel F, Talley NJ. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut. 1998 Apr; 42(4):501-6.
    View PubMed
  829. Roberts RO, Jacobsen SJ, Jacobson DJ, Reilly WT, Talley NJ, Lieber MM. Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence. Urology. 1998 Feb; 51 (2):213-9
    View PubMed
  830. Roberts RO, Jacobsen SJ, Jacobson DJ, Reilly WT, Talley NJ, Lieber MM. Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence. Urology. 1998 Feb; 51 (2):213-9
    View PubMed
  831. Kalantar SJ, Marks R, Lambert JR, Badov D, Talley NJ. Dyspepsia due to eosinophilic gastroenteritis. Dig Dis Sci. 1997 Nov; 42(11):2327-32.
    View PubMed
  832. Kalantar SJ, Marks R, Lambert JR, Badov D, Talley NJ. Dyspepsia due to eosinophilic gastroenteritis. Dig Dis Sci. 1997 Nov; 42(11):2327-32.
    View PubMed
  833. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population-based study. Gut. 1997 Sep; 41(3):394-8.
    View PubMed
  834. Talley NA, Chen F, King D, Jones M, Talley NJ. Short chain fatty acids in the treatment of radiation proctitis: a randomized, placebo-controlled crossover trial. Dis Colon Rectum. 1997 Sep; 40(9):1046-50.
    View PubMed
  835. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population-based study. Gut. 1997 Sep; 41(3):394-8.
    View PubMed
  836. Talley NA, Chen F, King D, Jones M, Talley NJ. Short chain fatty acids in the treatment of radiation proctitis: a randomized, placebo-controlled crossover trial. Dis Colon Rectum. 1997 Sep; 40(9):1046-50.
    View PubMed
  837. Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol. 1997 Jun; 92(6):954-9.
    View PubMed
  838. Nandurkar S, Talley NJ, Martin CJ, Ng THK, Adams S. Short segment Barrett's oesophagus: prevalence, diagnosis, and associations. Gut. 1997 Jun; 40(6):710-5.
    View PubMed
  839. Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol. 1997 Jun; 92(6):954-9.
    View PubMed
  840. Nandurkar S, Talley NJ, Martin CJ, Ng THK, Adams S. Short segment Barrett's oesophagus: prevalence, diagnosis, and associations. Gut. 1997 Jun; 40(6):710-5.
    View PubMed
  841. Locke GR 3rd, Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997 May; 112 (5):1448-56
    View PubMed
  842. Friedrich WN, Talley NJ, Panser L, Fett S, Zinsmeister AR. Concordance of reports of childhood abuse by adults. Child Maltreat. 1997 May; 2(2):164-71.
  843. Locke GR 3rd, Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997 May; 112 (5):1448-56
    View PubMed
  844. Friedrich WN, Talley NJ, Panser L, Fett S, Zinsmeister AR. Concordance of reports of childhood abuse by adults. Child Maltreat. 1997 May; 2(2):164-71.
  845. Frankum B, Talley NJ. The tired listless patient. Curr Ther. 1997 Mar; 41-5.
  846. Frankum B, Talley NJ. The tired listless patient. Curr Ther. 1997 Mar; 41-5.
  847. Holtmann G, Talley NJ, Goebell H. Association between Helicobacter pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci. 1996 Jul; 41(7):1285-91.
    View PubMed
  848. Holtmann G, Talley NJ, Goebell H. Association between Helicobacter pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci. 1996 Jul; 41(7):1285-91.
    View PubMed
  849. Loy C, Irwig L, Katelaris PH, Talley NJ. Do commercial serological kits for Helicobacter pylori infection differ in accuracy?: a meta-analysis. Am J Gastroenterol. 1996 Jun; 91(6):1138-44.
    View PubMed
  850. Loy C, Irwig L, Katelaris PH, Talley NJ. Do commercial serological kits for Helicobacter pylori infection differ in accuracy?: a meta-analysis. Am J Gastroenterol. 1996 Jun; 91(6):1138-44.
    View PubMed
  851. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, Verlinden M, Tytgat GN. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for the design of future trials. Am J Gastroenterol. 1996 Apr; 91(4):660-73.
    View PubMed
  852. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, Verlinden M, Tytgat GN. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for the design of future trials. Am J Gastroenterol. 1996 Apr; 91(4):660-73.
    View PubMed
  853. Toma TP, Zighelboim J, Phillips SF, Talley NJ. Methods for studying intestinal sensitivity and compliance: in vitro studies of balloons and a barostat. Neurogastroenterol Motil. 1996 Mar; 8 (1):19-28
    View PubMed
  854. Toma TP, Zighelboim J, Phillips SF, Talley NJ. Methods for studying intestinal sensitivity and compliance: in vitro studies of balloons and a barostat. Neurogastroenterol Motil. 1996 Mar; 8 (1):19-28
    View PubMed
  855. Holtmann G, Goebell H, Talley NJ. Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol. 1996 Mar; 91(3):485-91.
    View PubMed
  856. Talley NJ, Hu WHC. Commentary on "Misoprostol reduced serious NSAID-induced gastrointestinal complications in rheumatoid arthritis.". Ann Intern Med. 1996 Mar-Apr; 124:38.
  857. Holtmann G, Goebell H, Talley NJ. Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol. 1996 Mar; 91(3):485-91.
    View PubMed
  858. Talley NJ, Hu WHC. Commentary on "Misoprostol reduced serious NSAID-induced gastrointestinal complications in rheumatoid arthritis.". Ann Intern Med. 1996 Mar-Apr; 124:38.
  859. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatment for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol. 1996 Feb; 91(2):277-83.
    View PubMed
  860. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatment for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol. 1996 Feb; 91(2):277-83.
    View PubMed
  861. Locke GR 3rd, Locke GR III, Talley NJ, Carpenter HA, Harmsen WS, Zinsmeister AR, Melton LJ 3rd, Melton J. Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology. 1995 Dec; 109 (6):1750-6
    View PubMed
  862. Locke GR 3rd, Locke GR III, Talley NJ, Carpenter HA, Harmsen WS, Zinsmeister AR, Melton LJ 3rd, Melton J. Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology. 1995 Dec; 109 (6):1750-6
    View PubMed
  863. Talley NJ, Boyce P, Owen BK. Psychological distress and seasonal symptom changes in irritable bowel syndrome. Am J Gastroenterol. 1995 Dec; 90(12):2115-9.
    View PubMed
  864. Talley NJ, Boyce P, Owen BK. Psychological distress and seasonal symptom changes in irritable bowel syndrome. Am J Gastroenterol. 1995 Dec; 90(12):2115-9.
    View PubMed
  865. Talley NJ, Hu WHC, Holtmann G. Symptoms, investigation and treatment of gastroparesis. Mod Med Aust. 1995 Dec; 27-33.
  866. Talley NJ, Hu WHC, Holtmann G. Symptoms, investigation and treatment of gastroparesis. Mod Med Aust. 1995 Dec; 27-33.
  867. Drossman DA, Talley NJ, Leserman J, Olden KW, Barreiro MA. Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med. 1995 Nov 15; 123(10):782-94.
    View PubMed
  868. Drossman DA, Talley NJ, Leserman J, Olden KW, Barreiro MA. Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med. 1995 Nov 15; 123(10):782-94.
    View PubMed
  869. Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med. 1995 Aug; 25(4):302-8.
    View PubMed
  870. Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med. 1995 Aug; 25(4):302-8.
    View PubMed
  871. Talley NJ, Zinsmeister AR, Melton LJ 3rd, Melton LJ. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995 Jul 1; 142 (1):76-83
    View PubMed
  872. Talley NJ, Zinsmeister AR, Melton LJ 3rd, Melton LJ. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995 Jul 1; 142 (1):76-83
    View PubMed
  873. O'Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci. 1995 Jul; 50 (4):M184-9
    View PubMed
  874. O'Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci. 1995 Jul; 50 (4):M184-9
    View PubMed
  875. Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton LJ 3rd. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci. 1995 Jun; 40 (6):1345-50
    View PubMed
  876. Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton LJ 3rd. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci. 1995 Jun; 40 (6):1345-50
    View PubMed
  877. Talley NJ, Hu WHC. Commentary on "Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy.". Ann Intern Med. 1995 May-Jun; 122:81.
  878. Talley NJ, Hu WHC. Commentary on "Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy.". Ann Intern Med. 1995 May-Jun; 122:81.
  879. Zighelboim J, Talley NJ, Phillips SF, Harmsen WS, Zinsmeister AR. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci. 1995 Apr; 40 (4):819-27
    View PubMed
  880. Zighelboim J, Talley NJ, Phillips SF, Harmsen WS, Zinsmeister AR. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci. 1995 Apr; 40 (4):819-27
    View PubMed
  881. Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology. 1995 Mar; 108 (3):917-24
    View PubMed
  882. Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology. 1995 Mar; 108 (3):917-24
    View PubMed
  883. Talley NJ, Weaver AL, Zinsmeister AR. Impact on functional dyspepsia on quality of life. Dig Dis Sci. 1995 Mar; 40:584-589.
    View PubMed
  884. Talley NJ, Fett SL, Zinsmeister AR. Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol. 1995 Mar; 90(3):366-71.
    View PubMed
  885. Talley NJ, Weaver AL, Zinsmeister AR. Impact on functional dyspepsia on quality of life. Dig Dis Sci. 1995 Mar; 40:584-589.
    View PubMed
  886. Talley NJ, Fett SL, Zinsmeister AR. Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol. 1995 Mar; 90(3):366-71.
    View PubMed
  887. Talley NJ. Dyspepsia in the elderly. Mod Med Aust. 1995 Feb; 72-6.
  888. Talley NJ. Dyspepsia in the elderly. Mod Med Aust. 1995 Feb; 72-6.
  889. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Self-reported diarrhea: what does it mean? Am J Gastroenterol. 1994 Aug; 89(8):1160-4.
    View PubMed
  890. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Self-reported diarrhea: what does it mean? Am J Gastroenterol. 1994 Aug; 89(8):1160-4.
    View PubMed
  891. Zighelboim J, Talley NJ, Phillips SF. Response of gastric fundus to rectal distension in healthy persons. Dig Dis Sci. 1994 Jul; 39 (7):1441-5
    View PubMed
  892. Zighelboim J, Talley NJ, Phillips SF. Response of gastric fundus to rectal distension in healthy persons. Dig Dis Sci. 1994 Jul; 39 (7):1441-5
    View PubMed
  893. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994 Jun; 69 (6):539-47
    View PubMed
  894. Talley NJ, Valdovinos M, Petterson TM, Carpenter HA, Melton LJ III. Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol. 1994 Jun; 89(6):843-6.
    View PubMed
  895. Grotz RL, Pemberton JH, Talley NJ, Rath DM, Zinsmeister AR. Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation. Gut. 1994 Jun; 35 (6):798-802
    View PubMed
  896. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994 Jun; 69 (6):539-47
    View PubMed
  897. Talley NJ, Valdovinos M, Petterson TM, Carpenter HA, Melton LJ III. Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol. 1994 Jun; 89(6):843-6.
    View PubMed
  898. Grotz RL, Pemberton JH, Talley NJ, Rath DM, Zinsmeister AR. Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation. Gut. 1994 Jun; 35 (6):798-802
    View PubMed
  899. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut. 1994 May; 35 (5):619-24
    View PubMed
  900. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut. 1994 May; 35 (5):619-24
    View PubMed
  901. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology. 1994 May; 106(5):1174-83.
    View PubMed
  902. Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors: pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci. 1994 May; 39(5):1090-8.
    View PubMed
  903. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology. 1994 May; 106(5):1174-83.
    View PubMed
  904. Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors: pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci. 1994 May; 39(5):1090-8.
    View PubMed
  905. Holtmann G, Talley NJ. Functional dyspepsia. Current treatment recommendations. Curr Ther. 1994 May; 55-63.
  906. Holtmann G, Talley NJ. Functional dyspepsia. Current treatment recommendations. Curr Ther. 1994 May; 55-63.
  907. Talley NJ, Weaver AL, Zinsmeister AR. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol. 1994 Apr; 89(4):524-8.
    View PubMed
  908. Talley NJ, Weaver AL, Zinsmeister AR. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol. 1994 Apr; 89(4):524-8.
    View PubMed
  909. Talley NJ. Epidemiology of Helicobacter pylori infection. NIH Consens Statement. 1994 Feb 7-9; 12:1-15.
  910. Talley NJ. Epidemiology of Helicobacter pylori infection. NIH Consens Statement. 1994 Feb 7-9; 12:1-15.
  911. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology. 1993 Nov; 105 (5):1378-86
    View PubMed
  912. Kim CH, Cameron AJ, Hsu JJ, Talley NJ, Trastek VF, Pairolero PC, O'Connor MK, Colwell LJ, Zinsmeister AR. Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilation. Mayo Clin Proc. 1993 Nov; 68 (11):1067-73
    View PubMed
  913. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology. 1993 Nov; 105 (5):1378-86
    View PubMed
  914. Kim CH, Cameron AJ, Hsu JJ, Talley NJ, Trastek VF, Pairolero PC, O'Connor MK, Colwell LJ, Zinsmeister AR. Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilation. Mayo Clin Proc. 1993 Nov; 68 (11):1067-73
    View PubMed
  915. Zighelboim J, Carpenter HA, Talley NJ. A patient with diarrhea, arthralgias, and fever. Gastroenterology. 1993 Sep; 105 (3):923-30
    View PubMed
  916. Zighelboim J, Carpenter HA, Talley NJ. A patient with diarrhea, arthralgias, and fever. Gastroenterology. 1993 Sep; 105 (3):923-30
    View PubMed
  917. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd, Melton LJ 3rd. Functional constipation and outlet delay: a population-based study. Gastroenterology. 1993 Sep; 105 (3):781-90
    View PubMed
  918. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd, Melton LJ 3rd. Functional constipation and outlet delay: a population-based study. Gastroenterology. 1993 Sep; 105 (3):781-90
    View PubMed
  919. Holtmann G, Talley NJ. Functional dyspepsia. Current treatment recommendations. Drugs. 1993 Jun; 45 (6):918-930
    View PubMed
  920. Holtmann G, Talley NJ. Functional dyspepsia. Current treatment recommendations. Drugs. 1993 Jun; 45 (6):918-930
    View PubMed
  921. Wolfsen HC, Carpenter HA, Talley NJ. Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology. 1993 May; 104 (5):1310-9
    View PubMed
  922. Wolfsen HC, Carpenter HA, Talley NJ. Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology. 1993 May; 104 (5):1310-9
    View PubMed
  923. Talley NJ. Non-ulcer dyspepisa: current approaches to diagnosis and management. Am Fam Physician 1. 1993 May; 47: (6)1407-16.
  924. Talley NJ. Non-ulcer dyspepisa: current approaches to diagnosis and management. Am Fam Physician 1. 1993 May; 47: (6)1407-16.
  925. Locke GR, Locke GR, Talley NJ. Management of non-ulcer dyspepsia. J Gastroenterol Hepatol. 1993 May-Jun; 8 (3):279-86
    View PubMed
  926. Locke GR, Locke GR, Talley NJ. Management of non-ulcer dyspepsia. J Gastroenterol Hepatol. 1993 May-Jun; 8 (3):279-86
    View PubMed
  927. Zighelboim J, Talley NJ. What are functional bowel disorders? Gastroenterology. 1993 Apr; 104 (4):1196-201
    View PubMed
  928. Zighelboim J, Talley NJ. What are functional bowel disorders? Gastroenterology. 1993 Apr; 104 (4):1196-201
    View PubMed
  929. Talley NJ. The role of Helicobacter pylori in non-ulcer dyspepsia. Gastroenterol Clin North Am. 1993 Mar; 22:153-67.
    View PubMed
  930. Talley NJ. The role of Helicobacter pylori in non-ulcer dyspepsia. Gastroenterol Clin North Am. 1993 Mar; 22:153-67.
    View PubMed
  931. Miralles GD, O'Fallon JR, Talley NJ. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med. 1992 Dec 31; 327(27):1919-23.
    View PubMed
  932. Miralles GD, O'Fallon JR, Talley NJ. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med. 1992 Dec 31; 327(27):1919-23.
    View PubMed
  933. Talley NJ, Kost L, Haddad A, Zinsmeister AR. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol. 1992 Dec; 30 (12):3146-50
    View PubMed
  934. Talley NJ, Kost L, Haddad A, Zinsmeister AR. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol. 1992 Dec; 30 (12):3146-50
    View PubMed
  935. Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc. 1992 Aug; 67 (8):725-31
    View PubMed
  936. Steadman CJ, Talley NJ, Phillips SF, Zinsmeister AR. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc. 1992 Aug; 67 (8):732-8
    View PubMed
  937. Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc. 1992 Aug; 67 (8):725-31
    View PubMed
  938. Steadman CJ, Talley NJ, Phillips SF, Zinsmeister AR. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc. 1992 Aug; 67 (8):732-8
    View PubMed
  939. Talley NJ. Symptom patterns in functional dyspepsia. Eur J Gastroenterol Hepatol. 1992 Aug; 4:597-601.
  940. Talley NJ. Symptom patterns in functional dyspepsia. Eur J Gastroenterol Hepatol. 1992 Aug; 4:597-601.
  941. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd, Melton LJ 3rd. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol. 1992 Jul 15; 136 (2):165-77
    View PubMed
  942. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd, Melton LJ 3rd. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol. 1992 Jul 15; 136 (2):165-77
    View PubMed
  943. O'Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol. 1992 Jul; 47 (4):M116-21
    View PubMed
  944. O'Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol. 1992 Jul; 47 (4):M116-21
    View PubMed
  945. Talley NJ, Kephart GM, McGovern TW, Carpenter HA, Gleich GJ. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology. 1992 Jul; 103 (1):137-45
    View PubMed
  946. Talley NJ, Kephart GM, McGovern TW, Carpenter HA, Gleich GJ. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology. 1992 Jul; 103 (1):137-45
    View PubMed
  947. Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology. 1992 Jun; 102 (6):1899-905
    View PubMed
  948. Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology. 1992 Jun; 102 (6):1899-905
    View PubMed
  949. Talley NJ. Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther. 1992 Jun; 6 (3):273-89
    View PubMed
  950. Talley NJ. Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther. 1992 Jun; 6 (3):273-89
    View PubMed
  951. Talley NJ, Ormand JE, Frie CA, Zinsmeister AR. Stability of pH gradients in vivo across the stomach in Helicobacter pylori gastritis, dyspepsia, and health. Am J Gastroenterol. 1992 May; 87 (5):590-4
    View PubMed
  952. Talley NJ, Ormand JE, Frie CA, Zinsmeister AR. Stability of pH gradients in vivo across the stomach in Helicobacter pylori gastritis, dyspepsia, and health. Am J Gastroenterol. 1992 May; 87 (5):590-4
    View PubMed
  953. Loeb DS, Ahlquist DA, Talley NJ. Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs. Mayo Clin Proc. 1992 Apr; 67 (4):354-64
    View PubMed
  954. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992 Apr; 102 (4 Pt 1):1259-68
    View PubMed
  955. Steadman CJ, Phillips SF, Camilleri M, Talley NJ, Haddad A, Hanson R. Control of muscle tone in the human colon. Gut. 1992 Apr; 33 (4):541-6
    View PubMed
  956. Loeb DS, Ahlquist DA, Talley NJ. Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs. Mayo Clin Proc. 1992 Apr; 67 (4):354-64
    View PubMed
  957. Steadman CJ, Phillips SF, Camilleri M, Talley NJ, Haddad A, Hanson R. Control of muscle tone in the human colon. Gut. 1992 Apr; 33 (4):541-6
    View PubMed
  958. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992 Apr; 102 (4 Pt 1):1259-68
    View PubMed
  959. Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ 3rd, Melton LJ 3rd. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology. 1992 Mar; 102 (3):895-901
    View PubMed
  960. Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ 3rd, Melton LJ 3rd. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology. 1992 Mar; 102 (3):895-901
    View PubMed
  961. Talley NJ, Zinsmeister AR, Weaver A, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst. 1991 Dec 4; 83 (23):1734-9
    View PubMed
  962. Talley NJ, Zinsmeister AR, Weaver A, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst. 1991 Dec 4; 83 (23):1734-9
    View PubMed
  963. Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ. Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol. 1991 Aug; 29 (8):1635-9
    View PubMed
  964. Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ. Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol. 1991 Aug; 29 (8):1635-9
    View PubMed
  965. O'Keefe E, Talley NJ. The irritable bowel syndrome in the elderly. Gastroenterol Clin North Am. 1991 Jun; 20:369-90.
  966. O'Keefe E, Talley NJ. The irritable bowel syndrome in the elderly. Gastroenterol Clin North Am. 1991 Jun; 20:369-90.
  967. Myers BM, Miralles GD, Taylor CA, Gastineau DA, Pisani RJ, Talley NJ. POEMS syndrome with idiopathic flushing mimicking carcinoid syndrome. Am J Med. 1991 May; 90 (5):646-8
    View PubMed
  968. Myers BM, Miralles GD, Taylor CA, Gastineau DA, Pisani RJ, Talley NJ. POEMS syndrome with idiopathic flushing mimicking carcinoid syndrome. Am J Med. 1991 May; 90 (5):646-8
    View PubMed
  969. O'Keefe E, Talley NJ. Irritable bowel syndrome in the elderly. Clin Geriatr Med. 1991 May; 7(2):265-86.
    View PubMed
  970. O'Keefe E, Talley NJ. Irritable bowel syndrome in the elderly. Clin Geriatr Med. 1991 May; 7(2):265-86.
    View PubMed
  971. McGovern TW, Talley NJ, Kephart GM, Carpenter HA, Gleich GJ. Eosinophil infiltration and degranulation in Helicobacter pylori-associated chronic gastritis. Dig Dis Sci. 1991 Apr; 36 (4):435-40
    View PubMed
  972. McGovern TW, Talley NJ, Kephart GM, Carpenter HA, Gleich GJ. Eosinophil infiltration and degranulation in Helicobacter pylori-associated chronic gastritis. Dig Dis Sci. 1991 Apr; 36 (4):435-40
    View PubMed
  973. Ormand JE, Talley NJ, Shorter RG, Conley CR, Carpenter HA, Fich A, Wilson WR, Phillips SF. Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci. 1991 Feb; 36 (2):142-5
    View PubMed
  974. Ormand JE, Talley NJ, Shorter RG, Conley CR, Carpenter HA, Fich A, Wilson WR, Phillips SF. Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci. 1991 Feb; 36 (2):142-5
    View PubMed
  975. Drossman DA, Thompson WG, Talley NJ, Funch-Jensen P, Janssens J, Whitehead WE. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterology International. 1990 Dec; 3:159-172.
  976. Drossman DA, Thompson WG, Talley NJ, Funch-Jensen P, Janssens J, Whitehead WE. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterology International. 1990 Dec; 3:159-172.
  977. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ 3rd. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc. 1990 Nov; 65 (11):1456-79
    View PubMed
  978. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ 3rd. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc. 1990 Nov; 65 (11):1456-79
    View PubMed
  979. Talley NJ, Phillips SF, Bruce B, Twomey CK, Bruce B, Zinsmeister AR, Melton LJ 3rd, Melton LJ 3rd. Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology. 1990 Aug; 99 (2):327-33
    View PubMed
  980. Talley NJ, Phillips SF, Bruce B, Twomey CK, Bruce B, Zinsmeister AR, Melton LJ 3rd, Melton LJ 3rd. Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology. 1990 Aug; 99 (2):327-33
    View PubMed
  981. Ormand JE, Talley NJ, Carpenter HA, Shorter RG, Conley CR, Wilson WR, DiMagno EP, Zinsmeister AR, Phillips SF. [14C]urea breath test for diagnosis of Helicobacter pylori. Dig Dis Sci. 1990 Jul; 35 (7):879-84
    View PubMed
  982. Ormand JE, Talley NJ, Carpenter HA, Shorter RG, Conley CR, Wilson WR, DiMagno EP, Zinsmeister AR, Phillips SF. [14C]urea breath test for diagnosis of Helicobacter pylori. Dig Dis Sci. 1990 Jul; 35 (7):879-84
    View PubMed
  983. MacCarty RL, Talley NJ. Barium studies in diffuse eosinophilic gastroenteritis. Gastrointest Radiol. 1990 Summer; 15 (3):183-7
    View PubMed
  984. MacCarty RL, Talley NJ. Barium studies in diffuse eosinophilic gastroenteritis. Gastrointest Radiol. 1990 Summer; 15 (3):183-7
    View PubMed
  985. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, MacCarty RL, Ciociola A. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci. 1990 Apr; 35 (4):477-80
    View PubMed
  986. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, MacCarty RL, Ciociola A. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci. 1990 Apr; 35 (4):477-80
    View PubMed
  987. Ormand JE, Talley NJ. Helicobacter pylori: controversies and an approach to management. Mayo Clin Proc. 1990 Mar; 65 (3):414-26
    View PubMed
  988. Ormand JE, Talley NJ. Helicobacter pylori: controversies and an approach to management. Mayo Clin Proc. 1990 Mar; 65 (3):414-26
    View PubMed
  989. Fich A, Talley NJ, Shorter RG, Phillips SF. Does Helicobacter pylori colonize the gastric mucosa of Meckel's diverticulum? Mayo Clin Proc. 1990 Feb; 65 (2):187-91
    View PubMed
  990. Fich A, Talley NJ, Shorter RG, Phillips SF. Does Helicobacter pylori colonize the gastric mucosa of Meckel's diverticulum? Mayo Clin Proc. 1990 Feb; 65 (2):187-91
    View PubMed
  991. Talley NJ, Chute CG, Larson DE, Epstein R, Lydick EG, Melton LJ 3rd. Risk for colorectal adenocarcinoma in pernicious anemia. A population-based cohort study. Ann Intern Med. 1989 Nov 1; 111 (9):738-42
    View PubMed
  992. Talley NJ, Chute CG, Larson DE, Epstein R, Lydick EG, Melton LJ 3rd. Risk for colorectal adenocarcinoma in pernicious anemia. A population-based cohort study. Ann Intern Med. 1989 Nov 1; 111 (9):738-42
    View PubMed
  993. Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Melton J 3rd, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989 Oct 15; 111 (8):671-4
    View PubMed
  994. Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Melton J 3rd, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989 Oct 15; 111 (8):671-4
    View PubMed
  995. Talley NJ, Camilleri M, Orkin BA, Kramlinger KG. Effect of cyclical unipolar depression on upper gastrointestinal motility and sleep. Gastroenterology. 1989 Sep; 97 (3):775-7
    View PubMed
  996. Talley NJ, Camilleri M, Orkin BA, Kramlinger KG. Effect of cyclical unipolar depression on upper gastrointestinal motility and sleep. Gastroenterology. 1989 Sep; 97 (3):775-7
    View PubMed
  997. Talley NJ, Cameron AJ, Shorter RG, Zinsmeister AR, Phillips SF. Campylobacter pylori and Barrett's esophagus. Mayo Clin Proc. 1988 Dec; 63 (12):1176-80
    View PubMed
  998. Talley NJ, Cameron AJ, Shorter RG, Zinsmeister AR, Phillips SF. Campylobacter pylori and Barrett's esophagus. Mayo Clin Proc. 1988 Dec; 63 (12):1176-80
    View PubMed
  999. Talley NJ, Phillips SF. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med. 1988 Jun; 108 (6):865-79
    View PubMed
  1000. Talley NJ, Phillips SF. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med. 1988 Jun; 108 (6):865-79
    View PubMed